[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	756.0624	3	1.9	LTGMAFRVPTANVSVVDLTCR	LTGM(Oxidation)AFRVPTANVSVVDLTCR	Oxidation@231	21	V20130429-10_FTMSms2hcd	52.595	228	248	54.8	4.9e-19	7.6e-22	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	865.7940	3	2.9	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLMTTVHAITATQK		24	V20130429-10_FTMSms2hcd	70.930	163	186	52.8	4.5e-16	1.0e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	871.1252	3	2.4	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLM(Oxidation)TTVHAITATQK	Oxidation@175	24	V20130429-10_FTMSms2hcd	61.740	163	186	51.8	6.4e-16	1.2e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	989.1536	3	0.96	VIISAPSADAPMFVMGVNHEKYDNSLK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEKYDNSLK	Oxidation@130;Oxidation@133	27	V20130429-10_FTMSms2hcd	42.891	119	145	41.2	2.5e-15	2.6e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	681.8227	2	-0.79	VVDLMAHMASKE	VVDLM(Oxidation)AHM(Oxidation)ASKE	Oxidation@328;Oxidation@331	12	V20130429-10_FTMSms2hcd	16.225	324	335	40.8	9.1e-14	1.2e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	882.4047	2	-0.14	LISWYDNEFGYSNR	LISWYDNEFGYSNR		14	V20130429-10_FTMSms2hcd	49.534	310	323	54.3	1.2e-13	1.3e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	845.4100	3	1.4	IKWGDAGAEYVVESTGVFTTMEK	IKWGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	23	V20130429-10_FTMSms2hcd	53.781	85	107	46.7	1.3e-11	1.2e-14	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	737.3887	2	-1.9	VPTANVSVVDLTCR	VPTANVSVVDLTCR		14	V20130429-10_FTMSms2hcd	43.225	235	248	54.2	3.4e-10	5.5e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	847.4532	3	-0.66	AENGKLVINGNPITIFQERDPSK	AENGKLVINGNPITIFQERDPSK		23	V20130429-10_FTMSms2hcd	48.489	62	84	35.7	4.3e-10	9.3e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	681.0403	3	-0.65	LVINGNPITIFQERDPSK	LVINGNPITIFQERDPSK		18	V20130429-10_FTMSms2hcd	52.273	67	84	36.8	8.7e-9	2.2e-11	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	706.4004	2	2.2	GALQNIIPASTGAAK	GALQNIIPASTGAAK		15	V20130429-10_FTMSms2hcd	38.791	201	215	32.2	1.6e-8	4.7e-11	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	362.7096	4	0.74	LEKPAKYDDIKK	LEKPAKYDDIKK		12	V20130429-10_FTMSms2hcd	14.041	249	260	28.9	8.9e-8	2.7e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	749.0386	3	0.93	VIISAPSADAPMFVMGVNHEK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEK	Oxidation@130;Oxidation@133	21	V20130429-10_FTMSms2hcd	41.336	119	139	21.8	3.6e-7	3.8e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	403.2196	2	0.51	VGVNGFGR	VGVNGFGR		8	V20130429-10_FTMSms2hcd	22.182	6	13	36.4	1.1e-6	2.0e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	840.0759	3	-1.5	IKWGDAGAEYVVESTGVFTTMEK	IKWGDAGAEYVVESTGVFTTMEK		23	V20130429-10_FTMSms2hcd	58.874	85	107	19.1	2.5e-6	2.4e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	435.2600	2	4.2	VIPELNGK	VIPELNGK		8	V20130429-10_FTMSms2hcd	24.904	220	227	26.4	2.6e-6	1.5e-8	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	17	55.8	10.61	4.9e-19	406.2096	2	-1.4	LTGMAFR	LTGM(Oxidation)AFR	Oxidation@231	7	V20130429-10_FTMSms2hcd	17.025	228	234	33.3	1.3e-5	2.2e-8	2	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1-1]	0	O14556	G3PT_HUMAN	GAPDHS	1	1.7	2.68	1.3e-5	406.2096	2	-1.4	LTGMAFR	LTGM(Oxidation)AFR	Oxidation@303	7	V20130429-10_FTMSms2hcd	17.025	300	306	33.3	1.3e-5	2.2e-8	2	44501.6	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	890.8914	2	1.5	MDDDIAALVVDNGSGMCK	M(Met-loss+Acetyl)DDDIAALVVDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-10_FTMSms2hcd	52.355	1	18	58.5	9.7e-22	1.3e-24	1	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	790.9045	2	-0.33	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-10_FTMSms2hcd	23.195	313	326	49.7	3.0e-17	3.9e-20	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	1116.0405	2	4.0	DLYANTVLSGGTTMYPGIADR	DLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	21	V20130429-10_FTMSms2hcd	47.995	292	312	52.1	1.4e-15	1.4e-18	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	800.6610	4	4.0	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-10_FTMSms2hcd	53.308	148	177	32.6	1.7e-14	2.3e-17	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	977.5381	2	2.3	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-10_FTMSms2hcd	40.954	96	113	50.2	3.8e-14	1.0e-16	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	895.9499	2	0.34	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-10_FTMSms2hcd	47.702	239	254	49.9	2.4e-13	2.8e-16	10	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	1029.7706	4	11	YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR	YSVWIGGSILASLSTFQQM(Oxidation)WISKQEYDESGPSIVHR	Oxidation@355	36	V20130429-10_FTMSms2hcd	77.201	337	372	36.5	5.8e-12	9.9e-15	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	505.9218	3	1.1	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-10_FTMSms2hcd	31.127	85	95	30.4	8.4e-12	1.1e-14	9	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	677.8170	2	2.5	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-10_FTMSms2hcd	11.548	51	62	29.4	1.7e-11	2.1e-14	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	599.7637	2	-1.8	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-10_FTMSms2hcd	13.107	51	61	39.0	7.9e-11	1.6e-13	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	400.2397	3	-0.80	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-10_FTMSms2hcd	35.302	29	39	41.7	5.2e-10	1.9e-12	9	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	589.3104	2	0.19	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-10_FTMSms2hcd	25.012	316	326	38.4	7.8e-9	1.2e-11	6	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	398.2395	2	-0.74	IIAPPER	IIAPPER		7	V20130429-10_FTMSms2hcd	19.003	329	335	24.4	3.2e-5	1.7e-7	7	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	566.7665	2	-1.1	GYSFTTTAER	GYSFTTTAER		10	V20130429-10_FTMSms2hcd	25.076	197	206	20.0	7.5e-5	1.2e-7	2	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	360.6709	2	0.032	CDVDIR	CDVDIR		6	V20130429-10_FTMSms2hcd	16.441	285	290	20.9	5.8e-4	2.0e-6	3	41737.1	HUMAN	Actin, cytoplasmic 1
[2]		P60709	ACTB_HUMAN	ACTB	16	57.6	12.07	9.7e-22	400.7710	2	-0.66	RGILTLK	RGILTLK		7	V20130429-10_FTMSms2hcd	25.608	62	68	18.4	0.019	1.2e-4	10	41737.1	HUMAN	Actin, cytoplasmic 1
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	918.9220	2	0.73	MEEEIAALVIDNGSGMCK	M(Met-loss+Acetyl)EEEIAALVIDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-10_FTMSms2hcd	60.417	1	18	58.0	2.1e-18	2.3e-21	1	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	790.9045	2	-0.33	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-10_FTMSms2hcd	23.195	313	326	49.7	3.0e-17	3.9e-20	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	1116.0405	2	4.0	DLYANTVLSGGTTMYPGIADR	DLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	21	V20130429-10_FTMSms2hcd	47.995	292	312	52.1	1.4e-15	1.4e-18	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	800.6610	4	4.0	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-10_FTMSms2hcd	53.308	148	177	32.6	1.7e-14	2.3e-17	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	977.5381	2	2.3	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-10_FTMSms2hcd	40.954	96	113	50.2	3.8e-14	1.0e-16	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	895.9499	2	0.34	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-10_FTMSms2hcd	47.702	239	254	49.9	2.4e-13	2.8e-16	10	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	1029.7706	4	11	YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR	YSVWIGGSILASLSTFQQM(Oxidation)WISKQEYDESGPSIVHR	Oxidation@355	36	V20130429-10_FTMSms2hcd	77.201	337	372	36.5	5.8e-12	9.9e-15	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	505.9218	3	1.1	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-10_FTMSms2hcd	31.127	85	95	30.4	8.4e-12	1.1e-14	9	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	677.8170	2	2.5	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-10_FTMSms2hcd	11.548	51	62	29.4	1.7e-11	2.1e-14	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	599.7637	2	-1.8	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-10_FTMSms2hcd	13.107	51	61	39.0	7.9e-11	1.6e-13	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	400.2397	3	-0.80	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-10_FTMSms2hcd	35.302	29	39	41.7	5.2e-10	1.9e-12	9	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	589.3104	2	0.19	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-10_FTMSms2hcd	25.012	316	326	38.4	7.8e-9	1.2e-11	6	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	398.2395	2	-0.74	IIAPPER	IIAPPER		7	V20130429-10_FTMSms2hcd	19.003	329	335	24.4	3.2e-5	1.7e-7	7	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	566.7665	2	-1.1	GYSFTTTAER	GYSFTTTAER		10	V20130429-10_FTMSms2hcd	25.076	197	206	20.0	7.5e-5	1.2e-7	2	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	360.6709	2	0.032	CDVDIR	CDVDIR		6	V20130429-10_FTMSms2hcd	16.441	285	290	20.9	5.8e-4	2.0e-6	3	41793.2	HUMAN	Actin, cytoplasmic 2
[2-1]	1	P63261	ACTG_HUMAN	ACTG1	16	57.6	10.27	2.1e-18	400.7710	2	-0.66	RGILTLK	RGILTLK		7	V20130429-10_FTMSms2hcd	25.608	62	68	18.4	0.019	1.2e-4	10	41793.2	HUMAN	Actin, cytoplasmic 2
[2-2]	1	P68032	ACTC_HUMAN	ACTC1	10	27.9	9.64	3.0e-17	790.9045	2	-0.33	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-10_FTMSms2hcd	23.195	315	328	49.7	3.0e-17	3.9e-20	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	1	P68032	ACTC_HUMAN	ACTC1	10	27.9	9.64	3.0e-17	895.9499	2	0.34	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-10_FTMSms2hcd	47.702	241	256	49.9	2.4e-13	2.8e-16	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	1	P68032	ACTC_HUMAN	ACTC1	10	27.9	9.64	3.0e-17	505.9218	3	1.1	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-10_FTMSms2hcd	31.127	87	97	30.4	8.4e-12	1.1e-14	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	1	P68032	ACTC_HUMAN	ACTC1	10	27.9	9.64	3.0e-17	677.8170	2	2.5	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-10_FTMSms2hcd	11.548	53	64	29.4	1.7e-11	2.1e-14	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	1	P68032	ACTC_HUMAN	ACTC1	10	27.9	9.64	3.0e-17	599.7637	2	-1.8	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-10_FTMSms2hcd	13.107	53	63	39.0	7.9e-11	1.6e-13	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	1	P68032	ACTC_HUMAN	ACTC1	10	27.9	9.64	3.0e-17	400.2397	3	-0.80	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-10_FTMSms2hcd	35.302	31	41	41.7	5.2e-10	1.9e-12	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	1	P68032	ACTC_HUMAN	ACTC1	10	27.9	9.64	3.0e-17	589.3104	2	0.19	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-10_FTMSms2hcd	25.012	318	328	38.4	7.8e-9	1.2e-11	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	1	P68032	ACTC_HUMAN	ACTC1	10	27.9	9.64	3.0e-17	1049.8129	3	-7.3	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=38	28	V20130429-10_FTMSms2hcd	59.210	259	286	17.8	5.9e-6	5.6e-9	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	1	P68032	ACTC_HUMAN	ACTC1	10	27.9	9.64	3.0e-17	398.2395	2	-0.74	IIAPPER	IIAPPER		7	V20130429-10_FTMSms2hcd	19.003	331	337	24.4	3.2e-5	1.7e-7	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-2]	1	P68032	ACTC_HUMAN	ACTC1	10	27.9	9.64	3.0e-17	400.7710	2	-0.66	RGILTLK	RGILTLK		7	V20130429-10_FTMSms2hcd	25.608	64	70	18.4	0.019	1.2e-4	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[2-3]	1	P68133	ACTS_HUMAN	ACTA1	10	27.9	9.64	3.0e-17	790.9045	2	-0.33	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-10_FTMSms2hcd	23.195	315	328	49.7	3.0e-17	3.9e-20	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	1	P68133	ACTS_HUMAN	ACTA1	10	27.9	9.64	3.0e-17	895.9499	2	0.34	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-10_FTMSms2hcd	47.702	241	256	49.9	2.4e-13	2.8e-16	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	1	P68133	ACTS_HUMAN	ACTA1	10	27.9	9.64	3.0e-17	505.9218	3	1.1	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-10_FTMSms2hcd	31.127	87	97	30.4	8.4e-12	1.1e-14	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	1	P68133	ACTS_HUMAN	ACTA1	10	27.9	9.64	3.0e-17	677.8170	2	2.5	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-10_FTMSms2hcd	11.548	53	64	29.4	1.7e-11	2.1e-14	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	1	P68133	ACTS_HUMAN	ACTA1	10	27.9	9.64	3.0e-17	599.7637	2	-1.8	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-10_FTMSms2hcd	13.107	53	63	39.0	7.9e-11	1.6e-13	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	1	P68133	ACTS_HUMAN	ACTA1	10	27.9	9.64	3.0e-17	400.2397	3	-0.80	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-10_FTMSms2hcd	35.302	31	41	41.7	5.2e-10	1.9e-12	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	1	P68133	ACTS_HUMAN	ACTA1	10	27.9	9.64	3.0e-17	589.3104	2	0.19	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-10_FTMSms2hcd	25.012	318	328	38.4	7.8e-9	1.2e-11	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	1	P68133	ACTS_HUMAN	ACTA1	10	27.9	9.64	3.0e-17	1049.8129	3	-7.3	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=38	28	V20130429-10_FTMSms2hcd	59.210	259	286	17.8	5.9e-6	5.6e-9	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	1	P68133	ACTS_HUMAN	ACTA1	10	27.9	9.64	3.0e-17	398.2395	2	-0.74	IIAPPER	IIAPPER		7	V20130429-10_FTMSms2hcd	19.003	331	337	24.4	3.2e-5	1.7e-7	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-3]	1	P68133	ACTS_HUMAN	ACTA1	10	27.9	9.64	3.0e-17	400.7710	2	-0.66	RGILTLK	RGILTLK		7	V20130429-10_FTMSms2hcd	25.608	64	70	18.4	0.019	1.2e-4	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	9	24.9	9.64	3.0e-17	790.9045	2	-0.33	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-10_FTMSms2hcd	23.195	315	328	49.7	3.0e-17	3.9e-20	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	9	24.9	9.64	3.0e-17	895.9499	2	0.34	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-10_FTMSms2hcd	47.702	241	256	49.9	2.4e-13	2.8e-16	10	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	9	24.9	9.64	3.0e-17	677.8170	2	2.5	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-10_FTMSms2hcd	11.548	53	64	29.4	1.7e-11	2.1e-14	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	9	24.9	9.64	3.0e-17	599.7637	2	-1.8	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-10_FTMSms2hcd	13.107	53	63	39.0	7.9e-11	1.6e-13	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	9	24.9	9.64	3.0e-17	400.2397	3	-0.80	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-10_FTMSms2hcd	35.302	31	41	41.7	5.2e-10	1.9e-12	9	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	9	24.9	9.64	3.0e-17	589.3104	2	0.19	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-10_FTMSms2hcd	25.012	318	328	38.4	7.8e-9	1.2e-11	6	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	9	24.9	9.64	3.0e-17	1049.8129	3	-7.3	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=38	28	V20130429-10_FTMSms2hcd	59.210	259	286	17.8	5.9e-6	5.6e-9	4	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	9	24.9	9.64	3.0e-17	398.2395	2	-0.74	IIAPPER	IIAPPER		7	V20130429-10_FTMSms2hcd	19.003	331	337	24.4	3.2e-5	1.7e-7	7	42009.4	HUMAN	Actin, aortic smooth muscle
[2-4]	1	P62736	ACTA_HUMAN	ACTA2	9	24.9	9.64	3.0e-17	400.7710	2	-0.66	RGILTLK	RGILTLK		7	V20130429-10_FTMSms2hcd	25.608	64	70	18.4	0.019	1.2e-4	10	42009.4	HUMAN	Actin, aortic smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	9	25.0	9.64	3.0e-17	790.9045	2	-0.33	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@314;Oxidation@326	14	V20130429-10_FTMSms2hcd	23.195	314	327	49.7	3.0e-17	3.9e-20	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	9	25.0	9.64	3.0e-17	895.9499	2	0.34	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-10_FTMSms2hcd	47.702	240	255	49.9	2.4e-13	2.8e-16	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	9	25.0	9.64	3.0e-17	677.8170	2	2.5	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-10_FTMSms2hcd	11.548	52	63	29.4	1.7e-11	2.1e-14	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	9	25.0	9.64	3.0e-17	599.7637	2	-1.8	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-10_FTMSms2hcd	13.107	52	62	39.0	7.9e-11	1.6e-13	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	9	25.0	9.64	3.0e-17	400.2397	3	-0.80	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-10_FTMSms2hcd	35.302	30	40	41.7	5.2e-10	1.9e-12	9	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	9	25.0	9.64	3.0e-17	589.3104	2	0.19	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@326	11	V20130429-10_FTMSms2hcd	25.012	317	327	38.4	7.8e-9	1.2e-11	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	9	25.0	9.64	3.0e-17	1049.8129	3	-7.3	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@270=38	28	V20130429-10_FTMSms2hcd	59.210	258	285	17.8	5.9e-6	5.6e-9	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	9	25.0	9.64	3.0e-17	398.2395	2	-0.74	IIAPPER	IIAPPER		7	V20130429-10_FTMSms2hcd	19.003	330	336	24.4	3.2e-5	1.7e-7	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-5]	1	P63267	ACTH_HUMAN	ACTG2	9	25.0	9.64	3.0e-17	400.7710	2	-0.66	RGILTLK	RGILTLK		7	V20130429-10_FTMSms2hcd	25.608	63	69	18.4	0.019	1.2e-4	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[2-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	4.2	7.53	2.4e-13	895.9499	2	0.34	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-10_FTMSms2hcd	47.702	939	954	49.9	2.4e-13	2.8e-16	10	121364.6	HUMAN	POTE ankyrin domain family member E
[2-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	4.2	7.53	2.4e-13	505.9218	3	1.1	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-10_FTMSms2hcd	31.127	785	795	30.4	8.4e-12	1.1e-14	9	121364.6	HUMAN	POTE ankyrin domain family member E
[2-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	4.2	7.53	2.4e-13	400.2397	3	-0.80	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-10_FTMSms2hcd	35.302	729	739	41.7	5.2e-10	1.9e-12	9	121364.6	HUMAN	POTE ankyrin domain family member E
[2-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	4.2	7.53	2.4e-13	400.7710	2	-0.66	RGILTLK	RGILTLK		7	V20130429-10_FTMSms2hcd	25.608	762	768	18.4	0.019	1.2e-4	10	121364.6	HUMAN	POTE ankyrin domain family member E
[2-7]	0	A5A3E0	POTEF_HUMAN	POTEF	4	4.2	7.53	2.4e-13	895.9499	2	0.34	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-10_FTMSms2hcd	47.702	939	954	49.9	2.4e-13	2.8e-16	10	121445.7	HUMAN	POTE ankyrin domain family member F
[2-7]	0	A5A3E0	POTEF_HUMAN	POTEF	4	4.2	7.53	2.4e-13	505.9218	3	1.1	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-10_FTMSms2hcd	31.127	785	795	30.4	8.4e-12	1.1e-14	9	121445.7	HUMAN	POTE ankyrin domain family member F
[2-7]	0	A5A3E0	POTEF_HUMAN	POTEF	4	4.2	7.53	2.4e-13	400.2397	3	-0.80	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-10_FTMSms2hcd	35.302	729	739	41.7	5.2e-10	1.9e-12	9	121445.7	HUMAN	POTE ankyrin domain family member F
[2-7]	0	A5A3E0	POTEF_HUMAN	POTEF	4	4.2	7.53	2.4e-13	400.7710	2	-0.66	RGILTLK	RGILTLK		7	V20130429-10_FTMSms2hcd	25.608	762	768	18.4	0.019	1.2e-4	10	121445.7	HUMAN	POTE ankyrin domain family member F
[2-8]	1	Q562R1	ACTBL_HUMAN	ACTBL2	4	10.9	7.53	2.4e-13	895.9499	2	0.34	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-10_FTMSms2hcd	47.702	240	255	49.9	2.4e-13	2.8e-16	10	42003.6	HUMAN	Beta-actin-like protein 2
[2-8]	1	Q562R1	ACTBL_HUMAN	ACTBL2	4	10.9	7.53	2.4e-13	685.8124	2	12	DCYVGDEAQSKR	DCYVGDEAQSKR		12	V20130429-10_FTMSms2hcd	11.983	52	63	16.6	2.4e-7	3.5e-10	1	42003.6	HUMAN	Beta-actin-like protein 2
[2-8]	1	Q562R1	ACTBL_HUMAN	ACTBL2	4	10.9	7.53	2.4e-13	398.2395	2	-0.74	IIAPPER	IIAPPER		7	V20130429-10_FTMSms2hcd	19.003	330	336	24.4	3.2e-5	1.7e-7	7	42003.6	HUMAN	Beta-actin-like protein 2
[2-8]	1	Q562R1	ACTBL_HUMAN	ACTBL2	4	10.9	7.53	2.4e-13	360.6709	2	0.032	CDVDIR	CDVDIR		6	V20130429-10_FTMSms2hcd	16.441	286	291	20.9	5.8e-4	2.0e-6	3	42003.6	HUMAN	Beta-actin-like protein 2
[2-9]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	2	7.2	7.53	2.4e-13	895.9499	2	0.34	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-10_FTMSms2hcd	47.702	239	254	49.9	2.4e-13	2.8e-16	10	42016.6	HUMAN	Putative beta-actin-like protein 3
[2-9]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	2	7.2	7.53	2.4e-13	505.9218	3	1.1	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-10_FTMSms2hcd	31.127	85	95	30.4	8.4e-12	1.1e-14	9	42016.6	HUMAN	Putative beta-actin-like protein 3
[2-10]	0	P0CG38	POTEI_HUMAN	POTEI	3	2.7	6.70	8.4e-12	505.9218	3	1.1	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-10_FTMSms2hcd	31.127	785	795	30.4	8.4e-12	1.1e-14	9	121283.5	HUMAN	POTE ankyrin domain family member I
[2-10]	0	P0CG38	POTEI_HUMAN	POTEI	3	2.7	6.70	8.4e-12	400.2397	3	-0.80	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-10_FTMSms2hcd	35.302	729	739	41.7	5.2e-10	1.9e-12	9	121283.5	HUMAN	POTE ankyrin domain family member I
[2-10]	0	P0CG38	POTEI_HUMAN	POTEI	3	2.7	6.70	8.4e-12	400.7710	2	-0.66	RGILTLK	RGILTLK		7	V20130429-10_FTMSms2hcd	25.608	762	768	18.4	0.019	1.2e-4	10	121283.5	HUMAN	POTE ankyrin domain family member I
[2-11]	0	P0CG39	POTEJ_HUMAN	POTEJ	2	1.7	5.74	8.4e-12	505.9218	3	1.1	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-10_FTMSms2hcd	31.127	748	758	30.4	8.4e-12	1.1e-14	9	117391.0	HUMAN	POTE ankyrin domain family member J
[2-11]	0	P0CG39	POTEJ_HUMAN	POTEJ	2	1.7	5.74	8.4e-12	400.7710	2	-0.66	RGILTLK	RGILTLK		7	V20130429-10_FTMSms2hcd	25.608	725	731	18.4	0.019	1.2e-4	10	117391.0	HUMAN	POTE ankyrin domain family member J
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	776.3571	4	-0.32	FWEVISDEHGIDPTGTYHGDSDLQLDR	FWEVISDEHGIDPTGTYHGDSDLQLDR		27	V20130429-10_FTMSms2hcd	50.712	20	46	49.4	1.4e-16	1.4e-19	1	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	681.3663	3	5.1	MAVTFIGNSTAIQELFKR	M(Oxidation)AVTFIGNSTAIQELFKR	Oxidation@363	18	V20130429-10_FTMSms2hcd	58.822	363	380	46.5	1.1e-13	2.2e-16	1	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	818.9196	2	0.90	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-10_FTMSms2hcd	51.643	263	276	42.6	5.6e-13	6.9e-16	9	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	696.3640	3	0.33	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-10_FTMSms2hcd	58.003	104	122	44.0	1.1e-12	1.6e-15	5	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	883.4554	2	1.2	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-10_FTMSms2hcd	29.838	3	19	41.3	3.2e-12	4.3e-15	6	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	933.4532	3	0.60	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-10_FTMSms2hcd	61.244	78	103	44.0	6.4e-12	6.3e-15	5	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	889.7780	3	2.9	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-10_FTMSms2hcd	60.175	217	241	40.1	1.1e-11	1.3e-14	5	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-10_FTMSms2hcd	53.953	337	350	31.9	2.8e-11	3.2e-14	7	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	830.4528	2	1.9	ALTVPELTQQVFDAK	ALTVPELTQQVFDAK		15	V20130429-10_FTMSms2hcd	56.809	283	297	40.2	4.0e-11	8.4e-14	1	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	668.3520	2	-0.73	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-10_FTMSms2hcd	36.190	163	174	38.5	6.3e-10	1.0e-12	4	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	606.3140	3	2.5	ISVYYNEATGGKYVPR	ISVYYNEATGGKYVPR		16	V20130429-10_FTMSms2hcd	33.726	47	62	24.8	1.3e-9	1.7e-12	1	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	520.3007	2	0.61	YLTVAAVFR	YLTVAAVFR		9	V20130429-10_FTMSms2hcd	48.197	310	318	40.4	4.9e-9	1.9e-11	3	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	945.4808	4	3.2	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLR	Oxidation@233	35	V20130429-10_FTMSms2hcd	71.570	217	251	29.1	5.8e-8	1.0e-10	5	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	690.3486	3	-3.2	MREIVHIQAGQCGNQIGAK	M(Oxidation)REIVHIQAGQCGNQIGAK	Oxidation@1	19	V20130429-10_FTMSms2hcd	27.473	1	19	31.0	1.5e-7	1.7e-10	6	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	539.2697	2	-0.21	IREEYPDR	IREEYPDR		8	V20130429-10_FTMSms2hcd	12.061	155	162	39.0	5.5e-7	8.9e-10	8	49671.3	HUMAN	Tubulin beta chain
[3]		P07437	TBB5_HUMAN	TUBB	16	52.5	9.28	1.4e-16	977.5049	4	3.5	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-10_FTMSms2hcd	68.979	217	252	22.1	3.8e-6	8.4e-9	5	49671.3	HUMAN	Tubulin beta chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	818.9196	2	0.90	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-10_FTMSms2hcd	51.643	263	276	42.6	5.6e-13	6.9e-16	9	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	696.3640	3	0.33	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-10_FTMSms2hcd	58.003	104	122	44.0	1.1e-12	1.6e-15	5	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	883.4554	2	1.2	EIVHLQAGQCGNQIGAK	EIVHLQAGQCGNQIGAK		17	V20130429-10_FTMSms2hcd	29.838	3	19	41.3	3.2e-12	4.3e-15	6	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	933.4532	3	0.60	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-10_FTMSms2hcd	61.244	78	103	44.0	6.4e-12	6.3e-15	5	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	889.7780	3	2.9	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-10_FTMSms2hcd	60.175	217	241	40.1	1.1e-11	1.3e-14	5	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-10_FTMSms2hcd	53.953	337	350	31.9	2.8e-11	3.2e-14	7	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	668.3520	2	-0.73	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-10_FTMSms2hcd	36.190	163	174	38.5	6.3e-10	1.0e-12	4	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	520.3007	2	0.61	YLTVAAVFR	YLTVAAVFR		9	V20130429-10_FTMSms2hcd	48.197	310	318	40.4	4.9e-9	1.9e-11	3	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	945.4808	4	3.2	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLR	Oxidation@233	35	V20130429-10_FTMSms2hcd	71.570	217	251	29.1	5.8e-8	1.0e-10	5	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	690.3486	3	-3.2	MREIVHLQAGQCGNQIGAK	M(Oxidation)REIVHLQAGQCGNQIGAK	Oxidation@1	19	V20130429-10_FTMSms2hcd	27.473	1	19	31.0	1.5e-7	1.7e-10	6	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	539.2697	2	-0.21	IREEYPDR	IREEYPDR		8	V20130429-10_FTMSms2hcd	12.061	155	162	39.0	5.5e-7	8.9e-10	8	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	977.5049	4	3.5	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-10_FTMSms2hcd	68.979	217	252	22.1	3.8e-6	8.4e-9	5	49831.5	HUMAN	Tubulin beta-4B chain
[3-1]	1	P68371	TBB4B_HUMAN	TUBB4B	13	38.7	7.34	5.6e-13	846.4379	2	0.73	ALTVPELTQQMFDAK	ALTVPELTQQMFDAK		15	V20130429-10_FTMSms2hcd	57.654	283	297	16.6	9.0e-6	1.1e-8	3	49831.5	HUMAN	Tubulin beta-4B chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	818.9196	2	0.90	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-10_FTMSms2hcd	51.643	263	276	42.6	5.6e-13	6.9e-16	9	49586.2	HUMAN	Tubulin beta-4A chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	883.4554	2	1.2	EIVHLQAGQCGNQIGAK	EIVHLQAGQCGNQIGAK		17	V20130429-10_FTMSms2hcd	29.838	3	19	41.3	3.2e-12	4.3e-15	6	49586.2	HUMAN	Tubulin beta-4A chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	933.4532	3	0.60	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-10_FTMSms2hcd	61.244	78	103	44.0	6.4e-12	6.3e-15	5	49586.2	HUMAN	Tubulin beta-4A chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	889.7780	3	2.9	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-10_FTMSms2hcd	60.175	217	241	40.1	1.1e-11	1.3e-14	5	49586.2	HUMAN	Tubulin beta-4A chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-10_FTMSms2hcd	53.953	337	350	31.9	2.8e-11	3.2e-14	7	49586.2	HUMAN	Tubulin beta-4A chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	668.3520	2	-0.73	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-10_FTMSms2hcd	36.190	163	174	38.5	6.3e-10	1.0e-12	4	49586.2	HUMAN	Tubulin beta-4A chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	520.3007	2	0.61	YLTVAAVFR	YLTVAAVFR		9	V20130429-10_FTMSms2hcd	48.197	310	318	40.4	4.9e-9	1.9e-11	3	49586.2	HUMAN	Tubulin beta-4A chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	945.4808	4	3.2	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLR	Oxidation@233	35	V20130429-10_FTMSms2hcd	71.570	217	251	29.1	5.8e-8	1.0e-10	5	49586.2	HUMAN	Tubulin beta-4A chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	690.3486	3	-3.2	MREIVHLQAGQCGNQIGAK	M(Oxidation)REIVHLQAGQCGNQIGAK	Oxidation@1	19	V20130429-10_FTMSms2hcd	27.473	1	19	31.0	1.5e-7	1.7e-10	6	49586.2	HUMAN	Tubulin beta-4A chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	977.5049	4	3.5	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-10_FTMSms2hcd	68.979	217	252	22.1	3.8e-6	8.4e-9	5	49586.2	HUMAN	Tubulin beta-4A chain
[3-2]	1	P04350	TBB4A_HUMAN	TUBB4A	11	32.7	7.34	5.6e-13	846.4379	2	0.73	ALTVPELTQQMFDAK	ALTVPELTQQMFDAK		15	V20130429-10_FTMSms2hcd	57.654	283	297	16.6	9.0e-6	1.1e-8	3	49586.2	HUMAN	Tubulin beta-4A chain
[3-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	10	30.6	7.34	5.6e-13	818.9196	2	0.90	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-10_FTMSms2hcd	51.643	263	276	42.6	5.6e-13	6.9e-16	9	49907.4	HUMAN	Tubulin beta-2A chain
[3-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	10	30.6	7.34	5.6e-13	696.3640	3	0.33	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-10_FTMSms2hcd	58.003	104	122	44.0	1.1e-12	1.6e-15	5	49907.4	HUMAN	Tubulin beta-2A chain
[3-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	10	30.6	7.34	5.6e-13	883.4554	2	1.2	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-10_FTMSms2hcd	29.838	3	19	41.3	3.2e-12	4.3e-15	6	49907.4	HUMAN	Tubulin beta-2A chain
[3-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	10	30.6	7.34	5.6e-13	933.4532	3	0.60	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-10_FTMSms2hcd	61.244	78	103	44.0	6.4e-12	6.3e-15	5	49907.4	HUMAN	Tubulin beta-2A chain
[3-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	10	30.6	7.34	5.6e-13	889.7780	3	2.9	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-10_FTMSms2hcd	60.175	217	241	40.1	1.1e-11	1.3e-14	5	49907.4	HUMAN	Tubulin beta-2A chain
[3-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	10	30.6	7.34	5.6e-13	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-10_FTMSms2hcd	53.953	337	350	31.9	2.8e-11	3.2e-14	7	49907.4	HUMAN	Tubulin beta-2A chain
[3-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	10	30.6	7.34	5.6e-13	945.4808	4	3.2	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLR	Oxidation@233	35	V20130429-10_FTMSms2hcd	71.570	217	251	29.1	5.8e-8	1.0e-10	5	49907.4	HUMAN	Tubulin beta-2A chain
[3-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	10	30.6	7.34	5.6e-13	690.3486	3	-3.2	MREIVHIQAGQCGNQIGAK	M(Oxidation)REIVHIQAGQCGNQIGAK	Oxidation@1	19	V20130429-10_FTMSms2hcd	27.473	1	19	31.0	1.5e-7	1.7e-10	6	49907.4	HUMAN	Tubulin beta-2A chain
[3-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	10	30.6	7.34	5.6e-13	539.2697	2	-0.21	IREEYPDR	IREEYPDR		8	V20130429-10_FTMSms2hcd	12.061	155	162	39.0	5.5e-7	8.9e-10	8	49907.4	HUMAN	Tubulin beta-2A chain
[3-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	10	30.6	7.34	5.6e-13	977.5049	4	3.5	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-10_FTMSms2hcd	68.979	217	252	22.1	3.8e-6	8.4e-9	5	49907.4	HUMAN	Tubulin beta-2A chain
[3-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	10	30.6	7.34	5.6e-13	818.9196	2	0.90	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-10_FTMSms2hcd	51.643	263	276	42.6	5.6e-13	6.9e-16	9	49953.5	HUMAN	Tubulin beta-2B chain
[3-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	10	30.6	7.34	5.6e-13	696.3640	3	0.33	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-10_FTMSms2hcd	58.003	104	122	44.0	1.1e-12	1.6e-15	5	49953.5	HUMAN	Tubulin beta-2B chain
[3-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	10	30.6	7.34	5.6e-13	883.4554	2	1.2	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-10_FTMSms2hcd	29.838	3	19	41.3	3.2e-12	4.3e-15	6	49953.5	HUMAN	Tubulin beta-2B chain
[3-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	10	30.6	7.34	5.6e-13	933.4532	3	0.60	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-10_FTMSms2hcd	61.244	78	103	44.0	6.4e-12	6.3e-15	5	49953.5	HUMAN	Tubulin beta-2B chain
[3-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	10	30.6	7.34	5.6e-13	889.7780	3	2.9	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-10_FTMSms2hcd	60.175	217	241	40.1	1.1e-11	1.3e-14	5	49953.5	HUMAN	Tubulin beta-2B chain
[3-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	10	30.6	7.34	5.6e-13	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-10_FTMSms2hcd	53.953	337	350	31.9	2.8e-11	3.2e-14	7	49953.5	HUMAN	Tubulin beta-2B chain
[3-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	10	30.6	7.34	5.6e-13	945.4808	4	3.2	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLR	Oxidation@233	35	V20130429-10_FTMSms2hcd	71.570	217	251	29.1	5.8e-8	1.0e-10	5	49953.5	HUMAN	Tubulin beta-2B chain
[3-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	10	30.6	7.34	5.6e-13	690.3486	3	-3.2	MREIVHIQAGQCGNQIGAK	M(Oxidation)REIVHIQAGQCGNQIGAK	Oxidation@1	19	V20130429-10_FTMSms2hcd	27.473	1	19	31.0	1.5e-7	1.7e-10	6	49953.5	HUMAN	Tubulin beta-2B chain
[3-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	10	30.6	7.34	5.6e-13	539.2697	2	-0.21	IREEYPDR	IREEYPDR		8	V20130429-10_FTMSms2hcd	12.061	155	162	39.0	5.5e-7	8.9e-10	8	49953.5	HUMAN	Tubulin beta-2B chain
[3-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	10	30.6	7.34	5.6e-13	977.5049	4	3.5	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-10_FTMSms2hcd	68.979	217	252	22.1	3.8e-6	8.4e-9	5	49953.5	HUMAN	Tubulin beta-2B chain
[3-5]	1	Q13509	TBB3_HUMAN	TUBB3	6	17.6	7.17	1.1e-12	696.3640	3	0.33	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-10_FTMSms2hcd	58.003	104	122	44.0	1.1e-12	1.6e-15	5	50433.2	HUMAN	Tubulin beta-3 chain
[3-5]	1	Q13509	TBB3_HUMAN	TUBB3	6	17.6	7.17	1.1e-12	883.4554	2	1.2	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-10_FTMSms2hcd	29.838	3	19	41.3	3.2e-12	4.3e-15	6	50433.2	HUMAN	Tubulin beta-3 chain
[3-5]	1	Q13509	TBB3_HUMAN	TUBB3	6	17.6	7.17	1.1e-12	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-10_FTMSms2hcd	53.953	337	350	31.9	2.8e-11	3.2e-14	7	50433.2	HUMAN	Tubulin beta-3 chain
[3-5]	1	Q13509	TBB3_HUMAN	TUBB3	6	17.6	7.17	1.1e-12	668.3520	2	-0.73	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-10_FTMSms2hcd	36.190	163	174	38.5	6.3e-10	1.0e-12	4	50433.2	HUMAN	Tubulin beta-3 chain
[3-5]	1	Q13509	TBB3_HUMAN	TUBB3	6	17.6	7.17	1.1e-12	690.3486	3	-3.2	MREIVHIQAGQCGNQIGAK	M(Oxidation)REIVHIQAGQCGNQIGAK	Oxidation@1	19	V20130429-10_FTMSms2hcd	27.473	1	19	31.0	1.5e-7	1.7e-10	6	50433.2	HUMAN	Tubulin beta-3 chain
[3-5]	1	Q13509	TBB3_HUMAN	TUBB3	6	17.6	7.17	1.1e-12	846.4379	2	0.73	ALTVPELTQQMFDAK	ALTVPELTQQMFDAK		15	V20130429-10_FTMSms2hcd	57.654	283	297	16.6	9.0e-6	1.1e-8	3	50433.2	HUMAN	Tubulin beta-3 chain
[3-6]	0	Q9BUF5	TBB6_HUMAN	TUBB6	2	6.3	7.34	5.6e-13	818.9196	2	0.90	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-10_FTMSms2hcd	51.643	263	276	42.6	5.6e-13	6.9e-16	9	49857.6	HUMAN	Tubulin beta-6 chain
[3-6]	0	Q9BUF5	TBB6_HUMAN	TUBB6	2	6.3	7.34	5.6e-13	848.9210	2	1.0	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-10_FTMSms2hcd	53.953	337	350	31.9	2.8e-11	3.2e-14	7	49857.6	HUMAN	Tubulin beta-6 chain
[3-7]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	2	5.0	7.34	5.6e-13	818.9196	2	0.90	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-10_FTMSms2hcd	51.643	263	276	42.6	5.6e-13	6.9e-16	9	49776.5	HUMAN	Tubulin beta-8 chain
[3-7]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	2	5.0	7.34	5.6e-13	539.2697	2	-0.21	IREEYPDR	IREEYPDR		8	V20130429-10_FTMSms2hcd	12.061	155	162	39.0	5.5e-7	8.9e-10	8	49776.5	HUMAN	Tubulin beta-8 chain
[3-8]	0	A6NKZ8	YI016_HUMAN		2	5.9	7.34	5.6e-13	818.9196	2	0.90	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@195	14	V20130429-10_FTMSms2hcd	51.643	191	204	42.6	5.6e-13	6.9e-16	9	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[3-8]	0	A6NKZ8	YI016_HUMAN		2	5.9	7.34	5.6e-13	539.2697	2	-0.21	IREEYPDR	IREEYPDR		8	V20130429-10_FTMSms2hcd	12.061	83	90	39.0	5.5e-7	8.9e-10	8	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[3-9]	0	A6NNZ2	TBB8B_HUMAN		2	5.0	7.34	5.6e-13	818.9196	2	0.90	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-10_FTMSms2hcd	51.643	263	276	42.6	5.6e-13	6.9e-16	9	49573.1	HUMAN	Tubulin beta-8 chain B
[3-9]	0	A6NNZ2	TBB8B_HUMAN		2	5.0	7.34	5.6e-13	539.2697	2	-0.21	IREEYPDR	IREEYPDR		8	V20130429-10_FTMSms2hcd	12.061	155	162	39.0	5.5e-7	8.9e-10	8	49573.1	HUMAN	Tubulin beta-8 chain B
[3-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	1	1.8	4.00	5.5e-7	539.2697	2	-0.21	IREEYPDR	IREEYPDR		8	V20130429-10_FTMSms2hcd	12.061	155	162	39.0	5.5e-7	8.9e-10	8	50327.4	HUMAN	Tubulin beta-1 chain
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	1148.5886	2	14	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-10_FTMSms2hcd	77.765	373	394	46.0	4.4e-18	6.1e-21	3	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	771.3867	2	1.3	LAQANGWGVMVSHR	LAQANGWGVM(Oxidation)VSHR	Oxidation@368	14	V20130429-10_FTMSms2hcd	28.359	359	372	46.9	2.8e-14	3.4e-17	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	1031.1936	3	2.6	YGKDATNVGDEGGFAPNILENKEGLELLK	YGKDATNVGDEGGFAPNILENKEGLELLK		29	V20130429-10_FTMSms2hcd	54.570	200	228	46.0	2.1e-13	2.7e-16	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	726.0306	3	1.3	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGMDVAASEFFR		20	V20130429-10_FTMSms2hcd	64.310	234	253	35.7	2.4e-13	2.5e-16	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	995.8033	3	0.41	SFIKDYPVVSIEDPFDQDDWGAWQK	SFIKDYPVVSIEDPFDQDDWGAWQK		25	V20130429-10_FTMSms2hcd	65.481	282	306	47.9	2.5e-13	2.4e-16	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	731.9078	2	-0.22	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-10_FTMSms2hcd	60.188	106	120	38.3	5.8e-13	1.4e-15	3	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	634.3265	4	-0.14	AAVPSGASTGIYEALELRDNDKTR	AAVPSGASTGIYEALELRDNDKTR		24	V20130429-10_FTMSms2hcd	43.358	33	56	53.6	8.1e-13	1.1e-15	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	703.8616	2	-0.19	GNPTVEVDLFTSK	GNPTVEVDLFTSK		13	V20130429-10_FTMSms2hcd	44.406	16	28	35.5	2.4e-11	3.2e-14	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	915.1313	3	0.32	DATNVGDEGGFAPNILENKEGLELLK	DATNVGDEGGFAPNILENKEGLELLK		26	V20130429-10_FTMSms2hcd	58.391	203	228	43.2	3.7e-11	4.7e-14	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	788.9043	2	0.88	VNQIGSVTESLQACK	VNQIGSVTESLQACK		15	V20130429-10_FTMSms2hcd	39.376	344	358	40.4	1.5e-9	2.2e-12	2	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	713.3669	2	0.35	YISPDQLADLYK	YISPDQLADLYK		12	V20130429-10_FTMSms2hcd	48.688	270	281	35.5	1.6e-8	2.2e-11	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	731.3727	3	16	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGM(Oxidation)DVAASEFFR	Oxidation@244	20	V20130429-10_FTMSms2hcd	51.122	234	253	21.3	6.1e-7	7.4e-10	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	450.2820	2	0.76	TIAPALVSK	TIAPALVSK		9	V20130429-10_FTMSms2hcd	26.685	72	80	29.4	1.6e-6	5.8e-9	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	381.8769	3	0.40	IGAEVYHNLK	IGAEVYHNLK		10	V20130429-10_FTMSms2hcd	23.130	184	193	25.4	3.2e-5	5.2e-8	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	482.2717	3	-0.026	KLNVTEQEKIDK	KLNVTEQEKIDK		12	V20130429-10_FTMSms2hcd	17.232	81	92	20.9	1.6e-4	3.7e-7	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	452.7345	2	-0.53	IEEELGSK	IEEELGSK		8	V20130429-10_FTMSms2hcd	14.277	413	420	33.9	4.5e-4	7.5e-7	1	47169.4	HUMAN	Alpha-enolase
[4]		P06733	ENOA_HUMAN	ENO1	17	54.4	10.09	4.4e-18	480.2753	2	1.2	NFRNPLAK	NFRNPLAK		8	V20130429-10_FTMSms2hcd	24.853	427	434	19.8	0.0027	4.7e-6	1	47169.4	HUMAN	Alpha-enolase
[4-1]	0	P13929	ENOB_HUMAN	ENO3	3	12.0	10.09	4.4e-18	1148.5886	2	14	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-10_FTMSms2hcd	77.765	373	394	46.0	4.4e-18	6.1e-21	3	46932.2	HUMAN	Beta-enolase
[4-1]	0	P13929	ENOB_HUMAN	ENO3	3	12.0	10.09	4.4e-18	731.9078	2	-0.22	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-10_FTMSms2hcd	60.188	106	120	38.3	5.8e-13	1.4e-15	3	46932.2	HUMAN	Beta-enolase
[4-1]	0	P13929	ENOB_HUMAN	ENO3	3	12.0	10.09	4.4e-18	788.9043	2	0.88	VNQIGSVTESIQACK	VNQIGSVTESIQACK		15	V20130429-10_FTMSms2hcd	39.376	344	358	40.4	1.5e-9	2.2e-12	2	46932.2	HUMAN	Beta-enolase
[4-2]	0	P09104	ENOG_HUMAN	ENO2	2	8.5	10.09	4.4e-18	1148.5886	2	14	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-10_FTMSms2hcd	77.765	373	394	46.0	4.4e-18	6.1e-21	3	47269.0	HUMAN	Gamma-enolase
[4-2]	0	P09104	ENOG_HUMAN	ENO2	2	8.5	10.09	4.4e-18	731.9078	2	-0.22	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-10_FTMSms2hcd	60.188	106	120	38.3	5.8e-13	1.4e-15	3	47269.0	HUMAN	Gamma-enolase
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	1006.5384	3	2.1	TATESFASDPILYRPVAVALDTKGPEIR	TATESFASDPILYRPVAVALDTKGPEIR		28	V20130429-10_FTMSms2hcd	56.437	93	120	64.7	2.4e-19	6.5e-22	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	1151.8795	3	2.6	AEGSDVANAVLDGADCIMLSGETAKGDYPLEAVR	AEGSDVANAVLDGADCIM(Oxidation)LSGETAKGDYPLEAVR	Oxidation@360	34	V20130429-10_FTMSms2hcd	61.296	343	376	49.5	4.7e-16	4.9e-19	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	1088.0652	2	2.4	LAPITSDPTEATAVGAVEASFK	LAPITSDPTEATAVGAVEASFK		22	V20130429-10_FTMSms2hcd	55.236	401	422	55.6	6.6e-14	8.9e-17	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	834.0911	3	1.9	GIFPVLCKDPVQEAWAEDVDLR	GIFPVLCKDPVQEAWAEDVDLR		22	V20130429-10_FTMSms2hcd	64.340	468	489	39.5	3.3e-12	4.2e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	803.0900	3	0.15	KGDVVIVLTGWRPGSGFTNTMR	KGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	22	V20130429-10_FTMSms2hcd	50.130	505	526	40.6	7.3e-12	1.3e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	890.4425	2	1.0	GADFLVTEVENGGSLGSK	GADFLVTEVENGGSLGSK		18	V20130429-10_FTMSms2hcd	49.157	189	206	42.0	1.8e-11	2.1e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	883.4113	4	-0.45	MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCR	M(Met-loss+Acetyl)SKPHSEAGTAFIQTQQLHAAM(Oxidation)ADTFLEHM(Oxidation)CR	Met-loss+Acetyl@1;Oxidation@22;Oxidation@30	32	V20130429-10_FTMSms2hcd	45.196	1	32	43.7	3.2e-11	3.3e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	826.4631	3	5.6	KGVNLPGAAVDLPAVSEKDIQDLK	KGVNLPGAAVDLPAVSEKDIQDLK		24	V20130429-10_FTMSms2hcd	51.467	207	230	32.5	1.5e-9	8.3e-12	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	696.7009	3	0.42	EAEAAIYHLQLFEELRR	EAEAAIYHLQLFEELRR		17	V20130429-10_FTMSms2hcd	53.454	384	400	34.2	3.0e-8	4.7e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	599.3280	2	1.1	LDIDSPPITAR	LDIDSPPITAR		11	V20130429-10_FTMSms2hcd	35.815	33	43	40.6	3.4e-8	7.9e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	697.8908	2	-0.51	IISKIENHEGVR	IISKIENHEGVR		12	V20130429-10_FTMSms2hcd	16.816	267	278	24.8	3.0e-7	8.0e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	613.3088	3	0.31	RFDEILEASDGIMVAR	RFDEILEASDGIM(Oxidation)VAR	Oxidation@291	16	V20130429-10_FTMSms2hcd	45.395	279	294	22.2	3.1e-7	3.6e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	822.4379	3	2.8	TATESFASDPILYRPVAVALDTK	TATESFASDPILYRPVAVALDTK		23	V20130429-10_FTMSms2hcd	56.594	93	115	33.3	5.0e-7	1.0e-9	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	625.9686	3	-1.8	FGVEQDVDMVFASFIR	FGVEQDVDM(Oxidation)VFASFIR	Oxidation@239	16	V20130429-10_FTMSms2hcd	73.771	231	246	17.2	1.2e-6	1.3e-9	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	420.7692	2	1.1	APIIAVTR	APIIAVTR		8	V20130429-10_FTMSms2hcd	26.829	448	455	38.5	2.6e-6	2.5e-8	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	16	55.2	10.77	2.4e-19	571.3090	2	0.69	GDLGIEIPAEK	GDLGIEIPAEK		11	V20130429-10_FTMSms2hcd	38.657	295	305	28.1	2.9e-6	6.4e-9	2	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5-1]	0	P30613	KPYR_HUMAN	PKLR	1	1.9	2.52	2.9e-6	571.3090	2	0.69	GDLGIEIPAEK	GDLGIEIPAEK		11	V20130429-10_FTMSms2hcd	38.657	338	348	28.1	2.9e-6	6.4e-9	2	61830.7	HUMAN	Pyruvate kinase isozymes R/L
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	981.5100	4	0.94	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR		34	V20130429-10_FTMSms2hcd	57.413	237	270	62.8	2.2e-19	5.3e-22	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	918.9039	2	0.57	DGQVINETSQHHDDLE	DGQVINETSQHHDDLE		16	V20130429-10_FTMSms2hcd	22.574	451	466	31.5	2.2e-13	2.8e-16	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	785.9521	2	1.1	ISLPLPNFSSLNLR	ISLPLPNFSSLNLR		14	V20130429-10_FTMSms2hcd	65.562	411	424	47.4	7.1e-11	2.5e-13	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	504.2400	3	-0.83	MFGGPGTASRPSSSR	M(Oxidation)FGGPGTASRPSSSR	Oxidation@14	15	V20130429-10_FTMSms2hcd	14.769	14	28	30.8	2.1e-10	2.8e-13	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	748.3968	2	-0.0054	TYSLGSALRPSTSR	TYSLGSALRPSTSR		14	V20130429-10_FTMSms2hcd	30.597	37	50	42.5	5.8e-10	9.0e-13	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	589.6060	3	-0.74	LQDEIQNMKEEMAR	LQDEIQNM(Oxidation)KEEM(Oxidation)AR	Oxidation@372;Oxidation@376	14	V20130429-10_FTMSms2hcd	16.402	365	378	31.1	2.1e-9	2.5e-12	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	547.2664	2	-1.6	FADLSEAANR	FADLSEAANR		10	V20130429-10_FTMSms2hcd	25.488	295	304	42.4	4.0e-9	7.1e-12	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	794.4024	2	0.15	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-10_FTMSms2hcd	26.711	101	113	50.0	5.0e-9	6.0e-12	2	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	655.3070	2	0.62	NLQEAEEWYK	NLQEAEEWYK		10	V20130429-10_FTMSms2hcd	35.548	283	292	32.7	8.3e-9	1.1e-11	2	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	770.4586	2	-0.35	ILLAELEQLKGQGK	ILLAELEQLKGQGK		14	V20130429-10_FTMSms2hcd	45.490	130	143	49.0	2.2e-8	1.7e-10	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	888.9375	2	3.0	FADLSEAANRNNDALR	FADLSEAANRNNDALR		16	V20130429-10_FTMSms2hcd	30.584	295	310	26.1	2.9e-8	3.2e-11	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	852.9200	2	6.2	VEVERDNLAEDIMR	VEVERDNLAEDIM(Oxidation)R	Oxidation@183	14	V20130429-10_FTMSms2hcd	30.807	171	184	13.2	9.9e-7	1.1e-9	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	457.7328	2	0.59	SYVTTSTR	SYVTTSTR		8	V20130429-10_FTMSms2hcd	11.365	29	36	30.6	5.4e-6	1.1e-8	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	561.2958	2	0.54	EYQDLLNVK	EYQDLLNVK		9	V20130429-10_FTMSms2hcd	36.653	382	390	20.8	8.3e-6	1.3e-8	6	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	544.7696	2	-1.1	QDVDNASLAR	QDVDNASLAR		10	V20130429-10_FTMSms2hcd	15.619	208	217	28.1	2.5e-5	4.2e-8	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	774.0548	3	2.1	QVQSLTCEVDALKGTNESLER	QVQSLTCEVDALKGTNESLER		21	V20130429-10_FTMSms2hcd	43.733	322	342	19.6	8.4e-5	9.4e-8	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	17	49.6	10.80	2.2e-19	375.8736	3	1.0	FANYIDKVR	FANYIDKVR		9	V20130429-10_FTMSms2hcd	28.183	114	122	17.6	1.9e-4	3.9e-7	1	53652.1	HUMAN	Vimentin
[6-1]	0	P17661	DESM_HUMAN	DES	2	4.7	5.20	5.0e-9	794.4024	2	0.15	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-10_FTMSms2hcd	26.711	106	118	50.0	5.0e-9	6.0e-12	2	53536.2	HUMAN	Desmin
[6-1]	0	P17661	DESM_HUMAN	DES	2	4.7	5.20	5.0e-9	561.2958	2	0.54	EYQDLLNVK	EYQDLLNVK		9	V20130429-10_FTMSms2hcd	36.653	387	395	20.8	8.3e-6	1.3e-8	6	53536.2	HUMAN	Desmin
[6-2]	0	P41219	PERI_HUMAN	PRPH	1	2.1	4.35	8.3e-9	655.3070	2	0.62	NLQEAEEWYK	NLQEAEEWYK		10	V20130429-10_FTMSms2hcd	35.548	279	288	32.7	8.3e-9	1.1e-11	2	53651.3	HUMAN	Peripherin
[6-3]	0	P07196	NFL_HUMAN	NEFL	1	1.7	1.54	8.3e-6	561.2958	2	0.54	EYQDLLNVK	EYQDLLNVK		9	V20130429-10_FTMSms2hcd	36.653	371	379	20.8	8.3e-6	1.3e-8	6	61517.1	HUMAN	Neurofilament light polypeptide
[6-4]	0	P07197	NFM_HUMAN	NEFM	1	1.0	1.54	8.3e-6	561.2958	2	0.54	EYQDLLNVK	EYQDLLNVK		9	V20130429-10_FTMSms2hcd	36.653	383	391	20.8	8.3e-6	1.3e-8	6	102472.8	HUMAN	Neurofilament medium polypeptide
[6-5]	0	P12036	NFH_HUMAN	NEFH	1	0.9	1.54	8.3e-6	561.2958	2	0.54	EYQDLLNVK	EYQDLLNVK		9	V20130429-10_FTMSms2hcd	36.653	384	392	20.8	8.3e-6	1.3e-8	6	112479.8	HUMAN	Neurofilament heavy polypeptide
[6-6]	0	Q16352	AINX_HUMAN	INA	1	1.8	1.54	8.3e-6	561.2958	2	0.54	EYQDLLNVK	EYQDLLNVK		9	V20130429-10_FTMSms2hcd	36.653	378	386	20.8	8.3e-6	1.3e-8	6	55391.1	HUMAN	Alpha-internexin
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	990.7915	3	-2.8	SGDAAIVDMVPGKPMCVESFSDYPPLGR	SGDAAIVDM(Oxidation)VPGKPM(Oxidation)CVESFSDYPPLGR	Oxidation@404;Oxidation@410	28	V20130429-10_FTMSms2hcd	49.996	396	423	58.1	9.7e-20	8.9e-23	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	794.9440	2	0.099	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-10_FTMSms2hcd	81.627	6	20	40.5	2.5e-16	5.9e-19	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	897.4933	3	1.1	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-10_FTMSms2hcd	37.946	6	30	51.6	4.9e-16	2.1e-18	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	813.9052	2	-0.75	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-10_FTMSms2hcd	21.617	38	51	53.2	2.8e-14	3.2e-17	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	1307.7009	3	2.3	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-10_FTMSms2hcd	74.210	220	255	35.2	3.1e-12	1.3e-14	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	844.4716	3	8.4	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-10_FTMSms2hcd	51.239	267	290	42.4	3.1e-11	1.5e-13	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	839.1318	3	-1.3	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGMVVTFAPVNVTTEVK		24	V20130429-10_FTMSms2hcd	55.530	267	290	35.6	2.6e-10	1.2e-12	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	1013.0500	4	1.0	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-10_FTMSms2hcd	70.041	219	255	40.5	4.8e-10	2.6e-12	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	560.8034	2	-0.16	STTTGHLIYK	STTTGHLIYK		10	V20130429-10_FTMSms2hcd	17.845	21	30	35.1	9.3e-9	1.6e-11	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	513.3090	2	0.51	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-10_FTMSms2hcd	31.248	256	266	46.2	5.2e-7	3.9e-9	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[7]		P68104	EF1A1_HUMAN	EEF1A1	11	32.0	10.99	9.7e-20	457.7873	2	0.42	QTVAVGVIK	QTVAVGVIK		9	V20130429-10_FTMSms2hcd	26.577	431	439	32.1	6.4e-6	1.9e-8	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	990.7915	3	-2.8	SGDAAIVDMVPGKPMCVESFSDYPPLGR	SGDAAIVDM(Oxidation)VPGKPM(Oxidation)CVESFSDYPPLGR	Oxidation@404;Oxidation@410	28	V20130429-10_FTMSms2hcd	49.996	396	423	58.1	9.7e-20	8.9e-23	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	794.9440	2	0.099	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-10_FTMSms2hcd	81.627	6	20	40.5	2.5e-16	5.9e-19	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	897.4933	3	1.1	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-10_FTMSms2hcd	37.946	6	30	51.6	4.9e-16	2.1e-18	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	813.9052	2	-0.75	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-10_FTMSms2hcd	21.617	38	51	53.2	2.8e-14	3.2e-17	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	1307.7009	3	2.3	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-10_FTMSms2hcd	74.210	220	255	35.2	3.1e-12	1.3e-14	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	844.4716	3	8.4	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-10_FTMSms2hcd	51.239	267	290	42.4	3.1e-11	1.5e-13	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	839.1318	3	-1.3	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGMVVTFAPVNVTTEVK		24	V20130429-10_FTMSms2hcd	55.530	267	290	35.6	2.6e-10	1.2e-12	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	1013.0500	4	1.0	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-10_FTMSms2hcd	70.041	219	255	40.5	4.8e-10	2.6e-12	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	560.8034	2	-0.16	STTTGHLIYK	STTTGHLIYK		10	V20130429-10_FTMSms2hcd	17.845	21	30	35.1	9.3e-9	1.6e-11	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	513.3090	2	0.51	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-10_FTMSms2hcd	31.248	256	266	46.2	5.2e-7	3.9e-9	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	11	32.0	10.99	9.7e-20	457.7873	2	0.42	QTVAVGVIK	QTVAVGVIK		9	V20130429-10_FTMSms2hcd	26.577	431	439	32.1	6.4e-6	1.9e-8	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[7-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	9.14	2.5e-16	794.9440	2	0.099	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-10_FTMSms2hcd	81.627	6	20	40.5	2.5e-16	5.9e-19	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[7-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	9.14	2.5e-16	897.4933	3	1.1	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-10_FTMSms2hcd	37.946	6	30	51.6	4.9e-16	2.1e-18	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[7-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	9.14	2.5e-16	813.9052	2	-0.75	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-10_FTMSms2hcd	21.617	38	51	53.2	2.8e-14	3.2e-17	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[7-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	9.14	2.5e-16	560.8034	2	-0.16	STTTGHLIYK	STTTGHLIYK		10	V20130429-10_FTMSms2hcd	17.845	21	30	35.1	9.3e-9	1.6e-11	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[7-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	9.14	2.5e-16	513.3090	2	0.51	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-10_FTMSms2hcd	31.248	256	266	46.2	5.2e-7	3.9e-9	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[7-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	6	12.7	9.14	2.5e-16	457.7873	2	0.42	QTVAVGVIK	QTVAVGVIK		9	V20130429-10_FTMSms2hcd	26.577	431	439	32.1	6.4e-6	1.9e-8	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	973.3992	2	0.055	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@255=58	17	V20130429-10_FTMSms2hcd	12.114	250	266	38.3	7.5e-14	1.2e-16	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	683.3680	2	-0.49	TLTLVDTGIGMTK	TLTLVDTGIGM(Oxidation)TK	Oxidation@93	13	V20130429-10_FTMSms2hcd	38.360	83	95	34.9	2.0e-13	3.1e-16	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	594.9888	3	1.2	HLEINPDHPIVETLR	HLEINPDHPIVETLR		15	V20130429-10_FTMSms2hcd	38.266	625	639	46.2	1.7e-12	3.0e-15	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	757.3973	2	1.1	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-10_FTMSms2hcd	44.379	379	392	49.2	4.8e-12	7.3e-15	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	478.5167	4	0.16	KHLEINPDHPIVETLR	KHLEINPDHPIVETLR		16	V20130429-10_FTMSms2hcd	33.528	624	639	25.9	6.6e-10	1.9e-12	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	381.1915	3	0.28	LGIHEDSTNR	LGIHEDSTNR		10	V20130429-10_FTMSms2hcd	12.765	439	448	40.0	7.8e-10	1.3e-12	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	580.7953	2	-0.050	SIYYITGESK	SIYYITGESK		10	V20130429-10_FTMSms2hcd	29.972	482	491	30.0	4.1e-8	6.3e-11	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	576.2830	2	0.72	YIDQEELNK	YIDQEELNK		9	V20130429-10_FTMSms2hcd	20.661	276	284	26.9	2.0e-7	2.9e-10	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	625.3129	2	1.1	EQVANSAFVER	EQVANSAFVER		11	V20130429-10_FTMSms2hcd	24.009	492	502	37.1	3.8e-7	5.1e-10	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	476.7492	2	-0.99	AKFENLCK	AKFENLCK		8	V20130429-10_FTMSms2hcd	19.748	558	565	36.1	1.6e-5	2.7e-8	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	621.8547	2	-2.5	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-10_FTMSms2hcd	43.950	96	107	21.9	1.8e-5	4.0e-8	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	377.1800	2	-9.6	FENLCK	FENLCK		6	V20130429-10_FTMSms2hcd	20.080	560	565	19.1	8.5e-5	2.0e-7	5	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	13	17.4	7.81	7.5e-14	365.7263	2	-0.61	LSELLR	LSELLR		6	V20130429-10_FTMSms2hcd	26.163	451	456	28.2	0.078	1.2e-4	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8-1]	0	P07900	HS90A_HUMAN	HSP90AA1	6	8.2	7.58	2.0e-13	683.3680	2	-0.49	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@98	13	V20130429-10_FTMSms2hcd	38.360	88	100	34.9	2.0e-13	3.1e-16	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-1]	0	P07900	HS90A_HUMAN	HSP90AA1	6	8.2	7.58	2.0e-13	757.3973	2	1.1	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-10_FTMSms2hcd	44.379	387	400	49.2	4.8e-12	7.3e-15	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-1]	0	P07900	HS90A_HUMAN	HSP90AA1	6	8.2	7.58	2.0e-13	576.2830	2	0.72	YIDQEELNK	YIDQEELNK		9	V20130429-10_FTMSms2hcd	20.661	284	292	26.9	2.0e-7	2.9e-10	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-1]	0	P07900	HS90A_HUMAN	HSP90AA1	6	8.2	7.58	2.0e-13	621.8547	2	-2.5	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-10_FTMSms2hcd	43.950	101	112	21.9	1.8e-5	4.0e-8	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-1]	0	P07900	HS90A_HUMAN	HSP90AA1	6	8.2	7.58	2.0e-13	377.1800	2	-9.6	FENLCK	FENLCK		6	V20130429-10_FTMSms2hcd	20.080	568	573	19.1	8.5e-5	2.0e-7	5	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-1]	0	P07900	HS90A_HUMAN	HSP90AA1	6	8.2	7.58	2.0e-13	365.7263	2	-0.61	LSELLR	LSELLR		6	V20130429-10_FTMSms2hcd	26.163	459	464	28.2	0.078	1.2e-4	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	14.7	7.64	7.5e-14	973.3992	2	0.055	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@177=58	17	V20130429-10_FTMSms2hcd	12.114	172	188	38.3	7.5e-14	1.2e-16	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	14.7	7.64	7.5e-14	580.7953	2	-0.050	SIYYITGESK	SIYYITGESK		10	V20130429-10_FTMSms2hcd	29.972	258	267	30.0	4.1e-8	6.3e-11	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	14.7	7.64	7.5e-14	576.2830	2	0.72	YIDQEELNK	YIDQEELNK		9	V20130429-10_FTMSms2hcd	20.661	198	206	26.9	2.0e-7	2.9e-10	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	14.7	7.64	7.5e-14	476.7492	2	-0.99	AKFENLCK	AKFENLCK		8	V20130429-10_FTMSms2hcd	19.748	331	338	36.1	1.6e-5	2.7e-8	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	14.7	7.64	7.5e-14	621.8547	2	-2.5	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-10_FTMSms2hcd	43.950	96	107	21.9	1.8e-5	4.0e-8	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	14.7	7.64	7.5e-14	377.1800	2	-9.6	FENLCK	FENLCK		6	V20130429-10_FTMSms2hcd	20.080	333	338	19.1	8.5e-5	2.0e-7	5	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[8-3]	1	Q58FF7	H90B3_HUMAN	HSP90AB3P	3	5.0	4.16	1.3e-7	718.8180	2	-7.0	IKDVGSDEEDDSK	IKDVGSDEEDDSK		13	V20130429-10_FTMSms2hcd	23.182	229	241	18.2	1.3e-7	1.9e-10	1	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[8-3]	1	Q58FF7	H90B3_HUMAN	HSP90AB3P	3	5.0	4.16	1.3e-7	625.3129	2	1.1	EQVANSAFVER	EQVANSAFVER		11	V20130429-10_FTMSms2hcd	24.009	365	375	37.1	3.8e-7	5.1e-10	2	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[8-3]	1	Q58FF7	H90B3_HUMAN	HSP90AB3P	3	5.0	4.16	1.3e-7	377.1800	2	-9.6	FENLCK	FENLCK		6	V20130429-10_FTMSms2hcd	20.080	433	438	19.1	8.5e-5	2.0e-7	5	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[8-4]	0	Q58FG1	HS904_HUMAN	HSP90AA4P	1	3.1	7.07	2.0e-13	683.3680	2	-0.49	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@38	13	V20130429-10_FTMSms2hcd	38.360	28	40	34.9	2.0e-13	3.1e-16	3	47712.3	HUMAN	Putative heat shock protein HSP 90-alpha A4
[8-5]	0	Q12931	TRAP1_HUMAN	TRAP1	1	2.0	6.83	4.8e-12	757.3973	2	1.1	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR		14	V20130429-10_FTMSms2hcd	44.379	389	402	49.2	4.8e-12	7.3e-15	3	80110.7	HUMAN	Heat shock protein 75 kDa, mitochondrial
[8-6]	0	Q14568	HS902_HUMAN	HSP90AA2	2	6.1	3.03	2.0e-7	576.2830	2	0.72	YIDQEELNK	YIDQEELNK		9	V20130429-10_FTMSms2hcd	20.661	283	291	26.9	2.0e-7	2.9e-10	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[8-6]	0	Q14568	HS902_HUMAN	HSP90AA2	2	6.1	3.03	2.0e-7	621.8547	2	-2.5	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-10_FTMSms2hcd	43.950	101	112	21.9	1.8e-5	4.0e-8	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[8-7]	0	Q58FG0	HS905_HUMAN	HSP90AA5P	1	1.8	0.83	8.5e-5	377.1800	2	-9.6	FENLCK	FENLCK		6	V20130429-10_FTMSms2hcd	20.080	253	258	19.1	8.5e-5	2.0e-7	5	38738.3	HUMAN	Putative heat shock protein HSP 90-alpha A5
[8-8]	0	Q92538	GBF1_HUMAN	GBF1	1	0.3	0.14	0.078	365.7263	2	-0.61	LSELLR	LSELLR		6	V20130429-10_FTMSms2hcd	26.163	173	178	28.2	0.078	1.2e-4	3	206447.8	HUMAN	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	744.3558	2	2.1	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-10_FTMSms2hcd	34.870	37	49	41.6	5.4e-13	6.7e-16	6	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	991.5062	2	3.7	TVTNAVVTVPAYFNDSQR	TVTNAVVTVPAYFNDSQR		18	V20130429-10_FTMSms2hcd	46.041	138	155	43.0	2.1e-12	2.7e-15	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	846.3662	2	-0.27	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-10_FTMSms2hcd	22.942	221	236	48.0	1.1e-11	1.5e-14	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	821.7506	3	1.5	MSKGPAVGIDLGTTYSCVGVFQHGK	M(Met-loss+Acetyl)SKGPAVGIDLGTTYSCVGVFQHGK	Met-loss+Acetyl@1	25	V20130429-10_FTMSms2hcd	53.820	1	25	43.8	1.2e-11	1.4e-14	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	596.6685	3	0.43	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-10_FTMSms2hcd	43.065	172	188	43.3	3.6e-11	1.1e-13	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	600.3398	2	-1.6	DAGTIAGLNVLR	DAGTIAGLNVLR		12	V20130429-10_FTMSms2hcd	45.451	160	171	36.2	3.0e-10	6.1e-13	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	614.8180	2	0.56	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-10_FTMSms2hcd	20.648	26	36	48.0	8.2e-10	1.2e-12	7	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	607.9661	3	-4.1	NQVAMNPTNTVFDAKR	NQVAM(Oxidation)NPTNTVFDAKR	Oxidation@61	16	V20130429-10_FTMSms2hcd	27.447	57	72	41.5	1.5e-9	1.6e-12	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	522.6158	3	0.40	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-10_FTMSms2hcd	45.356	349	361	26.8	7.9e-8	1.4e-10	3	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	627.3115	2	-0.28	FEELNADLFR	FEELNADLFR		10	V20130429-10_FTMSms2hcd	48.476	302	311	41.6	2.8e-6	3.2e-9	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	590.8124	2	-2.8	VQVEYKGETK	VQVEYKGETK		10	V20130429-10_FTMSms2hcd	13.305	103	112	18.4	1.0e-5	1.5e-8	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9]		P11142	HSP7C_HUMAN	HSPA8	12	26.2	7.34	5.4e-13	495.2664	2	-0.68	LSKEDIER	LSKEDIER		8	V20130429-10_FTMSms2hcd	13.490	510	517	29.4	0.0044	7.1e-6	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[9-1]	0	P54652	HSP72_HUMAN	HSPA2	7	14.1	7.34	5.4e-13	744.3558	2	2.1	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-10_FTMSms2hcd	34.870	38	50	41.6	5.4e-13	6.7e-16	6	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[9-1]	0	P54652	HSP72_HUMAN	HSPA2	7	14.1	7.34	5.4e-13	846.3662	2	-0.27	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-10_FTMSms2hcd	22.942	224	239	48.0	1.1e-11	1.5e-14	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[9-1]	0	P54652	HSP72_HUMAN	HSPA2	7	14.1	7.34	5.4e-13	596.6685	3	0.43	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-10_FTMSms2hcd	43.065	173	189	43.3	3.6e-11	1.1e-13	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[9-1]	0	P54652	HSP72_HUMAN	HSPA2	7	14.1	7.34	5.4e-13	614.8180	2	0.56	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-10_FTMSms2hcd	20.648	27	37	48.0	8.2e-10	1.2e-12	7	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[9-1]	0	P54652	HSP72_HUMAN	HSPA2	7	14.1	7.34	5.4e-13	522.6158	3	0.40	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-10_FTMSms2hcd	45.356	352	364	26.8	7.9e-8	1.4e-10	3	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[9-1]	0	P54652	HSP72_HUMAN	HSPA2	7	14.1	7.34	5.4e-13	627.3115	2	-0.28	FEELNADLFR	FEELNADLFR		10	V20130429-10_FTMSms2hcd	48.476	305	314	41.6	2.8e-6	3.2e-9	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[9-1]	0	P54652	HSP72_HUMAN	HSPA2	7	14.1	7.34	5.4e-13	590.8124	2	-2.8	VQVEYKGETK	VQVEYKGETK		10	V20130429-10_FTMSms2hcd	13.305	104	113	18.4	1.0e-5	1.5e-8	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[9-2]	2	P08107	HSP71_HUMAN	HSPA1A	4	9.8	7.34	5.4e-13	744.3558	2	2.1	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-10_FTMSms2hcd	34.870	37	49	41.6	5.4e-13	6.7e-16	6	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[9-2]	2	P08107	HSP71_HUMAN	HSPA1A	4	9.8	7.34	5.4e-13	1000.1638	3	1.4	ELEQVCNPIISGLYQGAGGPGPGGFGAQGPK	ELEQVCNPIISGLYQGAGGPGPGGFGAQGPK		31	V20130429-10_FTMSms2hcd	60.456	598	628	38.7	3.1e-10	3.6e-13	1	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[9-2]	2	P08107	HSP71_HUMAN	HSPA1A	4	9.8	7.34	5.4e-13	614.8180	2	0.56	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-10_FTMSms2hcd	20.648	26	36	48.0	8.2e-10	1.2e-12	7	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[9-2]	2	P08107	HSP71_HUMAN	HSPA1A	4	9.8	7.34	5.4e-13	502.2746	2	0.072	LSKEEIER	LSKEEIER		8	V20130429-10_FTMSms2hcd	12.310	510	517	37.9	9.9e-4	1.6e-6	2	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[9-3]	0	P17066	HSP76_HUMAN	HSPA6	3	5.8	7.34	5.4e-13	744.3558	2	2.1	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-10_FTMSms2hcd	34.870	39	51	41.6	5.4e-13	6.7e-16	6	71028.7	HUMAN	Heat shock 70 kDa protein 6
[9-3]	0	P17066	HSP76_HUMAN	HSPA6	3	5.8	7.34	5.4e-13	614.8180	2	0.56	VEILANDQGNR	VEILANDQGNR		11	V20130429-10_FTMSms2hcd	20.648	28	38	48.0	8.2e-10	1.2e-12	7	71028.7	HUMAN	Heat shock 70 kDa protein 6
[9-3]	0	P17066	HSP76_HUMAN	HSPA6	3	5.8	7.34	5.4e-13	522.6158	3	0.40	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-10_FTMSms2hcd	45.356	351	363	26.8	7.9e-8	1.4e-10	3	71028.7	HUMAN	Heat shock 70 kDa protein 6
[9-4]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	7.34	5.4e-13	744.3558	2	2.1	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-10_FTMSms2hcd	34.870	39	51	41.6	5.4e-13	6.7e-16	6	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[9-4]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	7.34	5.4e-13	614.8180	2	0.56	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-10_FTMSms2hcd	20.648	28	38	48.0	8.2e-10	1.2e-12	7	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[9-4]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	7.34	5.4e-13	502.2746	2	0.072	LSKEEIER	LSKEEIER		8	V20130429-10_FTMSms2hcd	12.310	512	519	37.9	9.9e-4	1.6e-6	2	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[9-5]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	7.34	5.4e-13	744.3558	2	2.1	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-10_FTMSms2hcd	34.870	39	51	41.6	5.4e-13	6.7e-16	6	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[9-5]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	7.34	5.4e-13	614.8180	2	0.56	VEILANDQGNR	VEILANDQGNR		11	V20130429-10_FTMSms2hcd	20.648	28	38	48.0	8.2e-10	1.2e-12	7	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[9-6]	1	P11021	GRP78_HUMAN	HSPA5	2	3.5	5.63	8.2e-10	614.8180	2	0.56	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-10_FTMSms2hcd	20.648	50	60	48.0	8.2e-10	1.2e-12	7	72333.5	HUMAN	78 kDa glucose-regulated protein
[9-6]	1	P11021	GRP78_HUMAN	HSPA5	2	3.5	5.63	8.2e-10	715.8502	2	1.5	TWNDPSVQQDIK	TWNDPSVQQDIK		12	V20130429-10_FTMSms2hcd	30.673	102	113	33.1	3.4e-9	3.9e-12	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[10]		P07355	ANXA2_HUMAN	ANXA2	9	36.0	7.39	4.4e-13	860.9254	2	0.77	GLGTDEDSLIEIICSR	GLGTDEDSLIEIICSR		16	V20130429-10_FTMSms2hcd	66.273	120	135	58.6	4.4e-13	4.6e-16	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	9	36.0	7.39	4.4e-13	550.9978	3	-0.022	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-10_FTMSms2hcd	69.661	89	104	42.6	1.3e-11	1.9e-13	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	9	36.0	7.39	4.4e-13	922.9575	2	2.8	LSLEGDHSTPPSAYGSVK	LSLEGDHSTPPSAYGSVK		18	V20130429-10_FTMSms2hcd	30.373	11	28	37.7	1.7e-11	1.9e-14	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	9	36.0	7.39	4.4e-13	485.7466	4	2.0	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-10_FTMSms2hcd	40.731	153	169	30.9	4.2e-11	5.0e-14	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	9	36.0	7.39	4.4e-13	771.9221	2	-7.6	GVDEVTIVNILTNR	GVDEVTIVNILTNR		14	V20130429-10_FTMSms2hcd	59.490	50	63	38.8	5.6e-10	1.2e-12	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	9	36.0	7.39	4.4e-13	536.2787	2	-0.17	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-10_FTMSms2hcd	34.140	1	10	37.6	9.6e-10	1.7e-12	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	9	36.0	7.39	4.4e-13	828.4000	2	-1.1	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-10_FTMSms2hcd	21.368	105	119	26.8	1.3e-8	1.5e-11	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	9	36.0	7.39	4.4e-13	556.2805	2	0.58	QDIAFAYQR	QDIAFAYQR		9	V20130429-10_FTMSms2hcd	30.686	69	77	37.8	3.7e-7	5.3e-10	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	9	36.0	7.39	4.4e-13	381.2332	2	0.20	LMVALAK	LM(Oxidation)VALAK	Oxidation@171	7	V20130429-10_FTMSms2hcd	25.330	170	176	19.9	2.2e-6	7.6e-9	2	38604.4	HUMAN	Annexin A2
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	7	29.2	7.39	4.4e-13	860.9254	2	0.77	GLGTDEDSLIEIICSR	GLGTDEDSLIEIICSR		16	V20130429-10_FTMSms2hcd	66.273	120	135	58.6	4.4e-13	4.6e-16	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	7	29.2	7.39	4.4e-13	550.9978	3	-0.022	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-10_FTMSms2hcd	69.661	89	104	42.6	1.3e-11	1.9e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	7	29.2	7.39	4.4e-13	922.9575	2	2.8	LSLEGDHSTPPSAYGSVK	LSLEGDHSTPPSAYGSVK		18	V20130429-10_FTMSms2hcd	30.373	11	28	37.7	1.7e-11	1.9e-14	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	7	29.2	7.39	4.4e-13	485.7466	4	2.0	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-10_FTMSms2hcd	40.731	153	169	30.9	4.2e-11	5.0e-14	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	7	29.2	7.39	4.4e-13	536.2787	2	-0.17	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-10_FTMSms2hcd	34.140	1	10	37.6	9.6e-10	1.7e-12	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	7	29.2	7.39	4.4e-13	828.4000	2	-1.1	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-10_FTMSms2hcd	21.368	105	119	26.8	1.3e-8	1.5e-11	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	7	29.2	7.39	4.4e-13	381.2332	2	0.20	LMVALAK	LM(Oxidation)VALAK	Oxidation@171	7	V20130429-10_FTMSms2hcd	25.330	170	176	19.9	2.2e-6	7.6e-9	2	38659.3	HUMAN	Putative annexin A2-like protein
[11]		P62937	PPIA_HUMAN	PPIA	8	63.6	13.57	1.6e-24	779.3660	2	3.8	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-10_FTMSms2hcd	42.852	56	69	53.4	1.6e-24	1.9e-27	2	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	8	63.6	13.57	1.6e-24	917.4412	3	2.4	HTGPGILSMANAGPNTNGSQFFICTAK	HTGPGILSM(Oxidation)ANAGPNTNGSQFFICTAK	Oxidation@100	27	V20130429-10_FTMSms2hcd	47.956	92	118	56.6	1.3e-14	1.3e-17	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	8	63.6	13.57	1.6e-24	769.3719	2	1.1	VKEGMNIVEAMER	VKEGM(Oxidation)NIVEAM(Oxidation)ER	Oxidation@136;Oxidation@142	13	V20130429-10_FTMSms2hcd	18.100	132	144	40.3	4.3e-11	5.3e-14	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	8	63.6	13.57	1.6e-24	758.4011	2	-0.34	TEWLDGKHVVFGK	TEWLDGKHVVFGK		13	V20130429-10_FTMSms2hcd	36.773	119	131	40.5	2.9e-10	4.6e-13	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	8	63.6	13.57	1.6e-24	577.7896	2	-0.77	FEDENFILK	FEDENFILK		9	V20130429-10_FTMSms2hcd	41.780	83	91	28.2	9.3e-9	1.3e-11	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	8	63.6	13.57	1.6e-24	611.3091	3	0.81	SIYGEKFEDENFILK	SIYGEKFEDENFILK		15	V20130429-10_FTMSms2hcd	46.540	77	91	18.1	3.5e-8	4.1e-11	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	8	63.6	13.57	1.6e-24	460.5901	3	-0.86	VSFELFADKVPK	VSFELFADKVPK		12	V20130429-10_FTMSms2hcd	47.340	20	31	29.0	7.4e-7	1.6e-9	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11]		P62937	PPIA_HUMAN	PPIA	8	63.6	13.57	1.6e-24	595.8087	2	1.3	KITIADCGQLE	KITIADCGQLE		11	V20130429-10_FTMSms2hcd	37.121	155	165	16.0	3.2e-4	4.8e-7	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[11-1]	0	Q9Y536	PAL4A_HUMAN	PPIAL4A	1	8.5	13.57	1.6e-24	779.3660	2	3.8	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-10_FTMSms2hcd	42.852	56	69	53.4	1.6e-24	1.9e-27	2	18182.0	HUMAN	Peptidyl-prolyl cis-trans isomerase A-like 4A/B/C
[12]		P68363	TBA1B_HUMAN	TUBA1B	8	28.4	7.69	1.2e-13	1004.4593	2	9.1	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-10_FTMSms2hcd	51.096	41	60	44.9	1.2e-13	1.3e-16	5	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	8	28.4	7.69	1.2e-13	805.7419	3	2.5	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-10_FTMSms2hcd	40.812	85	105	47.9	1.8e-12	2.1e-15	6	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	8	28.4	7.69	1.2e-13	851.4583	2	2.1	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-10_FTMSms2hcd	57.253	65	79	49.6	5.0e-11	9.0e-14	3	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	8	28.4	7.69	1.2e-13	912.9968	2	0.49	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-10_FTMSms2hcd	44.647	353	370	33.4	1.7e-9	3.8e-12	7	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	8	28.4	7.69	1.2e-13	744.4435	2	0.37	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-10_FTMSms2hcd	67.585	230	243	49.7	5.6e-9	3.2e-11	5	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	8	28.4	7.69	1.2e-13	573.6323	3	0.19	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-10_FTMSms2hcd	34.153	216	229	37.4	1.1e-8	1.5e-11	7	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	8	28.4	7.69	1.2e-13	508.2935	2	1.5	DVNAAIATIK	DVNAAIATIK		10	V20130429-10_FTMSms2hcd	32.704	327	336	35.2	4.2e-8	8.0e-11	5	50152.1	HUMAN	Tubulin alpha-1B chain
[12]		P68363	TBA1B_HUMAN	TUBA1B	8	28.4	7.69	1.2e-13	586.3245	3	-2.4	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-10_FTMSms2hcd	52.379	265	280	20.3	1.2e-6	2.9e-9	6	50152.1	HUMAN	Tubulin alpha-1B chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	8	28.5	7.69	1.2e-13	1004.4593	2	9.1	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-10_FTMSms2hcd	51.096	41	60	44.9	1.2e-13	1.3e-16	5	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	8	28.5	7.69	1.2e-13	805.7419	3	2.5	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-10_FTMSms2hcd	40.812	85	105	47.9	1.8e-12	2.1e-15	6	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	8	28.5	7.69	1.2e-13	851.4583	2	2.1	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-10_FTMSms2hcd	57.253	65	79	49.6	5.0e-11	9.0e-14	3	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	8	28.5	7.69	1.2e-13	912.9968	2	0.49	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-10_FTMSms2hcd	44.647	353	370	33.4	1.7e-9	3.8e-12	7	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	8	28.5	7.69	1.2e-13	744.4435	2	0.37	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-10_FTMSms2hcd	67.585	230	243	49.7	5.6e-9	3.2e-11	5	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	8	28.5	7.69	1.2e-13	573.6323	3	0.19	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-10_FTMSms2hcd	34.153	216	229	37.4	1.1e-8	1.5e-11	7	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	8	28.5	7.69	1.2e-13	508.2935	2	1.5	DVNAAIATIK	DVNAAIATIK		10	V20130429-10_FTMSms2hcd	32.704	327	336	35.2	4.2e-8	8.0e-11	5	49895.8	HUMAN	Tubulin alpha-1C chain
[12-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	8	28.5	7.69	1.2e-13	586.3245	3	-2.4	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-10_FTMSms2hcd	52.379	265	280	20.3	1.2e-6	2.9e-9	6	49895.8	HUMAN	Tubulin alpha-1C chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	7	25.3	7.69	1.2e-13	1004.4593	2	9.1	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-10_FTMSms2hcd	51.096	41	60	44.9	1.2e-13	1.3e-16	5	50136.1	HUMAN	Tubulin alpha-1A chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	7	25.3	7.69	1.2e-13	805.7419	3	2.5	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-10_FTMSms2hcd	40.812	85	105	47.9	1.8e-12	2.1e-15	6	50136.1	HUMAN	Tubulin alpha-1A chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	7	25.3	7.69	1.2e-13	851.4583	2	2.1	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-10_FTMSms2hcd	57.253	65	79	49.6	5.0e-11	9.0e-14	3	50136.1	HUMAN	Tubulin alpha-1A chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	7	25.3	7.69	1.2e-13	912.9968	2	0.49	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-10_FTMSms2hcd	44.647	353	370	33.4	1.7e-9	3.8e-12	7	50136.1	HUMAN	Tubulin alpha-1A chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	7	25.3	7.69	1.2e-13	573.6323	3	0.19	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-10_FTMSms2hcd	34.153	216	229	37.4	1.1e-8	1.5e-11	7	50136.1	HUMAN	Tubulin alpha-1A chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	7	25.3	7.69	1.2e-13	508.2935	2	1.5	DVNAAIATIK	DVNAAIATIK		10	V20130429-10_FTMSms2hcd	32.704	327	336	35.2	4.2e-8	8.0e-11	5	50136.1	HUMAN	Tubulin alpha-1A chain
[12-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	7	25.3	7.69	1.2e-13	586.3245	3	-2.4	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-10_FTMSms2hcd	52.379	265	280	20.3	1.2e-6	2.9e-9	6	50136.1	HUMAN	Tubulin alpha-1A chain
[12-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	6	22.0	7.69	1.2e-13	1004.4593	2	9.1	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-10_FTMSms2hcd	51.096	41	60	44.9	1.2e-13	1.3e-16	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[12-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	6	22.0	7.69	1.2e-13	805.7419	3	2.5	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-10_FTMSms2hcd	40.812	85	105	47.9	1.8e-12	2.1e-15	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[12-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	6	22.0	7.69	1.2e-13	912.9968	2	0.49	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-10_FTMSms2hcd	44.647	353	370	33.4	1.7e-9	3.8e-12	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[12-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	6	22.0	7.69	1.2e-13	573.6323	3	0.19	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-10_FTMSms2hcd	34.153	216	229	37.4	1.1e-8	1.5e-11	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[12-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	6	22.0	7.69	1.2e-13	508.2935	2	1.5	DVNAAIATIK	DVNAAIATIK		10	V20130429-10_FTMSms2hcd	32.704	327	336	35.2	4.2e-8	8.0e-11	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[12-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	6	22.0	7.69	1.2e-13	586.3245	3	-2.4	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-10_FTMSms2hcd	52.379	265	280	20.3	1.2e-6	2.9e-9	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[12-4]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	7.69	1.2e-13	1004.4593	2	9.1	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-10_FTMSms2hcd	51.096	41	60	44.9	1.2e-13	1.3e-16	5	49859.0	HUMAN	Tubulin alpha-3E chain
[12-4]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	7.69	1.2e-13	912.9968	2	0.49	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-10_FTMSms2hcd	44.647	353	370	33.4	1.7e-9	3.8e-12	7	49859.0	HUMAN	Tubulin alpha-3E chain
[12-4]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	7.69	1.2e-13	573.6323	3	0.19	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-10_FTMSms2hcd	34.153	216	229	37.4	1.1e-8	1.5e-11	7	49859.0	HUMAN	Tubulin alpha-3E chain
[12-4]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	7.69	1.2e-13	508.2935	2	1.5	DVNAAIATIK	DVNAAIATIK		10	V20130429-10_FTMSms2hcd	32.704	327	336	35.2	4.2e-8	8.0e-11	5	49859.0	HUMAN	Tubulin alpha-3E chain
[12-4]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	7.69	1.2e-13	586.3245	3	-2.4	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-10_FTMSms2hcd	52.379	265	280	20.3	1.2e-6	2.9e-9	6	49859.0	HUMAN	Tubulin alpha-3E chain
[12-5]	0	P68366	TBA4A_HUMAN	TUBA4A	5	18.5	7.06	1.8e-12	805.7419	3	2.5	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-10_FTMSms2hcd	40.812	85	105	47.9	1.8e-12	2.1e-15	6	49924.9	HUMAN	Tubulin alpha-4A chain
[12-5]	0	P68366	TBA4A_HUMAN	TUBA4A	5	18.5	7.06	1.8e-12	912.9968	2	0.49	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-10_FTMSms2hcd	44.647	353	370	33.4	1.7e-9	3.8e-12	7	49924.9	HUMAN	Tubulin alpha-4A chain
[12-5]	0	P68366	TBA4A_HUMAN	TUBA4A	5	18.5	7.06	1.8e-12	744.4435	2	0.37	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-10_FTMSms2hcd	67.585	230	243	49.7	5.6e-9	3.2e-11	5	49924.9	HUMAN	Tubulin alpha-4A chain
[12-5]	0	P68366	TBA4A_HUMAN	TUBA4A	5	18.5	7.06	1.8e-12	573.6323	3	0.19	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-10_FTMSms2hcd	34.153	216	229	37.4	1.1e-8	1.5e-11	7	49924.9	HUMAN	Tubulin alpha-4A chain
[12-5]	0	P68366	TBA4A_HUMAN	TUBA4A	5	18.5	7.06	1.8e-12	586.3245	3	-2.4	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-10_FTMSms2hcd	52.379	265	280	20.3	1.2e-6	2.9e-9	6	49924.9	HUMAN	Tubulin alpha-4A chain
[12-6]	0	Q9NY65	TBA8_HUMAN	TUBA8	4	14.9	7.06	1.8e-12	805.7419	3	2.5	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-10_FTMSms2hcd	40.812	85	105	47.9	1.8e-12	2.1e-15	6	50094.0	HUMAN	Tubulin alpha-8 chain
[12-6]	0	Q9NY65	TBA8_HUMAN	TUBA8	4	14.9	7.06	1.8e-12	912.9968	2	0.49	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-10_FTMSms2hcd	44.647	353	370	33.4	1.7e-9	3.8e-12	7	50094.0	HUMAN	Tubulin alpha-8 chain
[12-6]	0	Q9NY65	TBA8_HUMAN	TUBA8	4	14.9	7.06	1.8e-12	744.4435	2	0.37	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-10_FTMSms2hcd	67.585	230	243	49.7	5.6e-9	3.2e-11	5	50094.0	HUMAN	Tubulin alpha-8 chain
[12-6]	0	Q9NY65	TBA8_HUMAN	TUBA8	4	14.9	7.06	1.8e-12	573.6323	3	0.19	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-10_FTMSms2hcd	34.153	216	229	37.4	1.1e-8	1.5e-11	7	50094.0	HUMAN	Tubulin alpha-8 chain
[12-7]	0	Q9H853	TBA4B_HUMAN	TUBA4B	1	5.8	5.18	5.6e-9	744.4435	2	0.37	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-10_FTMSms2hcd	67.585	169	182	49.7	5.6e-9	3.2e-11	5	27551.5	HUMAN	Putative tubulin-like protein alpha-4B
[13]		P60174	TPIS_HUMAN	TPI1	8	44.1	8.76	1.3e-15	1068.0293	2	1.7	VPADTEVVCAPPTAYIDFAR	VPADTEVVCAPPTAYIDFAR		20	V20130429-10_FTMSms2hcd	56.254	71	90	47.5	1.3e-15	1.4e-18	1	30791.3	HUMAN	Triosephosphate isomerase
[13]		P60174	TPIS_HUMAN	TPI1	8	44.1	8.76	1.3e-15	801.9487	2	0.70	VVLAYEPVWAIGTGK	VVLAYEPVWAIGTGK		15	V20130429-10_FTMSms2hcd	55.624	198	212	41.4	3.5e-11	8.8e-14	1	30791.3	HUMAN	Triosephosphate isomerase
[13]		P60174	TPIS_HUMAN	TPI1	8	44.1	8.76	1.3e-15	540.7789	2	-0.11	IAVAAQNCYK	IAVAAQNCYK		10	V20130429-10_FTMSms2hcd	22.303	97	106	37.7	1.6e-10	2.3e-13	1	30791.3	HUMAN	Triosephosphate isomerase
[13]		P60174	TPIS_HUMAN	TPI1	8	44.1	8.76	1.3e-15	635.3302	2	1.9	IIYGGSVTGATCK	IIYGGSVTGATCK		13	V20130429-10_FTMSms2hcd	27.672	244	256	32.2	1.6e-10	2.9e-13	1	30791.3	HUMAN	Triosephosphate isomerase
[13]		P60174	TPIS_HUMAN	TPI1	8	44.1	8.76	1.3e-15	477.7460	2	1.6	FFVGGNWK	FFVGGNWK		8	V20130429-10_FTMSms2hcd	40.035	44	51	26.6	3.0e-9	5.3e-12	1	30791.3	HUMAN	Triosephosphate isomerase
[13]		P60174	TPIS_HUMAN	TPI1	8	44.1	8.76	1.3e-15	617.8054	2	1.1	SNVSDAVAQSTR	SNVSDAVAQSTR		12	V20130429-10_FTMSms2hcd	18.521	232	243	45.6	1.6e-8	2.2e-11	1	30791.3	HUMAN	Triosephosphate isomerase
[13]		P60174	TPIS_HUMAN	TPI1	8	44.1	8.76	1.3e-15	584.3225	3	0.53	VAHALAEGLGVIACIGEK	VAHALAEGLGVIACIGEK		18	V20130429-10_FTMSms2hcd	55.314	151	168	17.6	3.7e-6	9.4e-9	1	30791.3	HUMAN	Triosephosphate isomerase
[13]		P60174	TPIS_HUMAN	TPI1	8	44.1	8.76	1.3e-15	1053.2162	3	-2.4	ELASQPDVDGFLVGGASLKPEFVDIINAKQ	ELASQPDVDGFLVGGASLKPEFVDIINAKQ		30	V20130429-10_FTMSms2hcd	66.110	257	286	15.8	4.0e-4	7.9e-7	1	30791.3	HUMAN	Triosephosphate isomerase
[14]		P62805	H4_HUMAN	HIST1H4A	9	56.3	5.80	3.9e-10	494.9388	3	2.3	TVTAMDVVYALKR	TVTAM(Oxidation)DVVYALKR	Oxidation@85	13	V20130429-10_FTMSms2hcd	40.679	81	93	41.5	3.9e-10	9.2e-13	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	9	56.3	5.80	3.9e-10	489.6055	3	-1.1	TVTAMDVVYALKR	TVTAMDVVYALKR		13	V20130429-10_FTMSms2hcd	48.795	81	93	28.4	4.0e-10	9.2e-13	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	9	56.3	5.80	3.9e-10	702.3826	3	15	VFLENVIRDAVTYTEHAK	VFLENVIRDAVTYTEHAK		18	V20130429-10_FTMSms2hcd	62.938	61	78	35.1	3.7e-9	8.4e-12	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	9	56.3	5.80	3.9e-10	567.7744	2	-0.93	DAVTYTEHAK	DAVTYTEHAK		10	V20130429-10_FTMSms2hcd	12.192	69	78	33.8	4.8e-9	7.5e-12	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	9	56.3	5.80	3.9e-10	663.3777	2	-4.1	DNIQGITKPAIR	DNIQGITKPAIR		12	V20130429-10_FTMSms2hcd	27.382	25	36	38.8	1.6e-8	5.4e-11	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	9	56.3	5.80	3.9e-10	590.8145	2	0.76	ISGLIYEETR	ISGLIYEETR		10	V20130429-10_FTMSms2hcd	33.210	47	56	37.8	1.8e-7	2.7e-10	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	9	56.3	5.80	3.9e-10	494.6235	3	0.85	DNIQGITKPAIRR	DNIQGITKPAIRR		13	V20130429-10_FTMSms2hcd	23.712	25	37	26.3	4.5e-7	2.4e-9	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	9	56.3	5.80	3.9e-10	526.6353	3	1.0	ISGLIYEETRGVLK	ISGLIYEETRGVLK		14	V20130429-10_FTMSms2hcd	43.626	47	60	19.4	5.5e-6	1.9e-8	1	11367.4	HUMAN	Histone H4
[14]		P62805	H4_HUMAN	HIST1H4A	9	56.3	5.80	3.9e-10	663.8524	2	0.12	TVTAMDVVYALK	TVTAM(Oxidation)DVVYALK	Oxidation@85	12	V20130429-10_FTMSms2hcd	44.432	81	92	16.6	5.5e-6	9.9e-9	1	11367.4	HUMAN	Histone H4
[15]		P02765	FETUA_HUMAN	AHSG	7	5.2	7.29	6.9e-13	704.8043	2	0.30	CDSSPDSAEDVRK	CDSSPDSAEDVRK		13	V20130429-10_FTMSms2hcd	9.721	132	144	42.1	6.9e-13	1.2e-15	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[15]		P02765	FETUA_HUMAN	AHSG	7	5.2	7.29	6.9e-13	680.7414	2	2.4	CDSSPDSAEDVR	CDSSPDS(Phospho)AEDVR	Phospho@138=18	12	V20130429-10_FTMSms2hcd	15.010	132	143	36.6	1.6e-12	6.8e-15	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[15]		P02765	FETUA_HUMAN	AHSG	7	5.2	7.29	6.9e-13	640.7564	2	-0.32	CDSSPDSAEDVR	CDSSPDSAEDVR		12	V20130429-10_FTMSms2hcd	13.228	132	143	31.6	3.2e-12	7.7e-15	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[15]		P02765	FETUA_HUMAN	AHSG	7	5.2	7.29	6.9e-13	744.7870	2	-0.34	CDSSPDSAEDVRK	CDSSPDS(Phospho)AEDVRK	Phospho@138=18	13	V20130429-10_FTMSms2hcd	10.518	132	144	29.9	1.5e-9	4.1e-12	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[15]		P02765	FETUA_HUMAN	AHSG	7	5.2	7.29	6.9e-13	744.7894	2	2.9	CDSSPDSAEDVRK	CDS(Phospho)SPDSAEDVRK	Phospho@134|135	13	V20130429-10_FTMSms2hcd	11.482	132	144	20.6	7.6e-7	2.0e-9	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[15]		P02765	FETUA_HUMAN	AHSG	7	5.2	7.29	6.9e-13	784.7700	2	-0.53	CDSSPDSAEDVRK	CDS(Phospho)SPDS(Phospho)AEDVRK	Phospho@138=11;Phospho@134|135	13	V20130429-10_FTMSms2hcd	12.296	132	144	16.1	8.6e-7	4.1e-9	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[15]		P02765	FETUA_HUMAN	AHSG	7	5.2	7.29	6.9e-13	373.1711	2	1.5	QYGFCK	QYGFCK		6	V20130429-10_FTMSms2hcd	19.497	226	231	14.2	2.5e-4	7.1e-7	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[16]		P22626	ROA2_HUMAN	HNRNPA2B1	7	29.5	6.43	2.7e-11	956.4681	3	0.38	LFIGGLSFETTEESLRNYYEQWGK	LFIGGLSFETTEESLRNYYEQWGK		24	V20130429-10_FTMSms2hcd	69.502	23	46	46.4	2.7e-11	2.9e-14	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[16]		P22626	ROA2_HUMAN	HNRNPA2B1	7	29.5	6.43	2.7e-11	402.4566	4	0.37	LTDCVVMRDPASKR	LTDCVVM(Oxidation)RDPASKR	Oxidation@53	14	V20130429-10_FTMSms2hcd	18.534	47	60	30.7	2.5e-9	3.0e-12	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[16]		P22626	ROA2_HUMAN	HNRNPA2B1	7	29.5	6.43	2.7e-11	507.2245	2	-1.8	GGNFGFGDSR	GGNFGFGDSR		10	V20130429-10_FTMSms2hcd	25.686	204	213	24.9	4.3e-9	9.8e-12	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[16]		P22626	ROA2_HUMAN	HNRNPA2B1	7	29.5	6.43	2.7e-11	759.7242	3	1.3	GFGFVTFDDHDPVDKIVLQK	GFGFVTFDDHDPVDKIVLQK		20	V20130429-10_FTMSms2hcd	55.517	154	173	28.2	1.6e-8	2.0e-11	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[16]		P22626	ROA2_HUMAN	HNRNPA2B1	7	29.5	6.43	2.7e-11	529.2983	2	0.49	TLETVPLER	TLETVPLER		9	V20130429-10_FTMSms2hcd	30.452	4	12	31.9	4.5e-7	9.9e-10	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[16]		P22626	ROA2_HUMAN	HNRNPA2B1	7	29.5	6.43	2.7e-11	689.3182	2	-0.23	GGGGNFGPGPGSNFR	GGGGNFGPGPGSNFR		15	V20130429-10_FTMSms2hcd	27.326	214	228	21.3	6.3e-7	8.6e-10	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[16]		P22626	ROA2_HUMAN	HNRNPA2B1	7	29.5	6.43	2.7e-11	470.9007	3	0.18	YHTINGHNAEVR	YHTINGHNAEVR		12	V20130429-10_FTMSms2hcd	12.349	174	185	16.4	6.5e-5	7.9e-8	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[17]		P09651	ROA1_HUMAN	HNRNPA1	6	25.5	10.05	5.3e-18	847.8519	2	-2.1	NQGGYGGSSSSSSYGSGR	NQGGYGGSSSSSSYGSGR		18	V20130429-10_FTMSms2hcd	12.009	353	370	51.0	5.3e-18	7.8e-21	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	6	25.5	10.05	5.3e-18	814.8940	2	-0.53	SSGPYGGGGQYFAKPR	SSGPYGGGGQYFAKPR		16	V20130429-10_FTMSms2hcd	25.552	337	352	39.5	6.9e-14	7.9e-17	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	6	25.5	10.05	5.3e-18	892.9578	2	1.0	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-10_FTMSms2hcd	58.163	16	31	43.3	3.3e-12	4.3e-15	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	6	25.5	10.05	5.3e-18	761.0555	3	0.89	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-10_FTMSms2hcd	52.620	147	166	28.1	2.2e-6	2.9e-9	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	6	25.5	10.05	5.3e-18	476.5876	3	-0.45	SESPKEPEQLRK	SESPKEPEQLRK		12	V20130429-10_FTMSms2hcd	12.270	4	15	10.9	0.018	2.7e-5	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17]		P09651	ROA1_HUMAN	HNRNPA1	6	25.5	10.05	5.3e-18	719.3765	2	0.87	EDSQRPGAHLTVK	EDSQRPGAHLTVK		13	V20130429-10_FTMSms2hcd	14.437	93	105	11.9	0.025	3.4e-5	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[17-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	3	15.3	6.92	3.3e-12	892.9578	2	1.0	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-10_FTMSms2hcd	58.163	16	31	43.3	3.3e-12	4.3e-15	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[17-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	3	15.3	6.92	3.3e-12	761.0555	3	0.89	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-10_FTMSms2hcd	52.620	147	166	28.1	2.2e-6	2.9e-9	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[17-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	3	15.3	6.92	3.3e-12	719.3765	2	0.87	EDSQRPGAHLTVK	EDSQRPGAHLTVK		13	V20130429-10_FTMSms2hcd	14.437	93	105	11.9	0.025	3.4e-5	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[18]		P10809	CH60_HUMAN	HSPD1	5	12.6	9.48	6.0e-17	715.7157	3	1.5	ALMLQGVDLLADAVAVTMGPK	ALM(Oxidation)LQGVDLLADAVAVTM(Oxidation)GPK	Oxidation@40;Oxidation@55	21	V20130429-10_FTMSms2hcd	70.276	38	58	54.4	6.0e-17	1.1e-19	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[18]		P10809	CH60_HUMAN	HSPD1	5	12.6	9.48	6.0e-17	524.9777	3	9.9	GVMLAVDAVIAELKK	GVM(Oxidation)LAVDAVIAELKK	Oxidation@145	15	V20130429-10_FTMSms2hcd	59.262	143	157	36.1	1.3e-10	8.1e-13	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[18]		P10809	CH60_HUMAN	HSPD1	5	12.6	9.48	6.0e-17	816.9126	2	-0.51	VGGTSDVEVNEKKDR	VGGTSDVEVNEKKDR		15	V20130429-10_FTMSms2hcd	11.247	406	420	56.9	4.8e-10	5.6e-13	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[18]		P10809	CH60_HUMAN	HSPD1	5	12.6	9.48	6.0e-17	672.8616	2	0.097	TVIIEQSWGSPK	TVIIEQSWGSPK		12	V20130429-10_FTMSms2hcd	36.786	61	72	37.0	3.0e-8	4.6e-11	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[18]		P10809	CH60_HUMAN	HSPD1	5	12.6	9.48	6.0e-17	458.7827	2	13	GVITVKDGK	GVITVKDGK		9	V20130429-10_FTMSms2hcd	37.665	197	205	17.0	0.0016	8.0e-6	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	6.36	3.6e-11	639.0264	3	-0.048	TFVNITPAEVGVLVGKDR	TFVNITPAEVGVLVGKDR		18	V20130429-10_FTMSms2hcd	54.505	39	56	46.8	3.6e-11	1.4e-13	1	15054.4	HUMAN	Profilin-1
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	6.36	3.6e-11	735.8856	2	3.5	SSFYVNGLTLGGQK	SSFYVNGLTLGGQK		14	V20130429-10_FTMSms2hcd	44.164	57	70	39.8	1.3e-10	1.9e-13	1	15054.4	HUMAN	Profilin-1
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	6.36	3.6e-11	445.7730	2	0.87	TLVLLMGK	TLVLLM(Oxidation)GK	Oxidation@114	8	V20130429-10_FTMSms2hcd	34.939	109	116	28.1	2.5e-8	1.6e-10	1	15054.4	HUMAN	Profilin-1
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	6.36	3.6e-11	690.3614	2	-0.72	STGGAPTFNVTVTK	STGGAPTFNVTVTK		14	V20130429-10_FTMSms2hcd	33.103	92	105	29.2	5.7e-8	7.8e-11	1	15054.4	HUMAN	Profilin-1
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	6.36	3.6e-11	563.2445	2	0.13	CYEMASHLR	CYEM(Oxidation)ASHLR	Oxidation@131	9	V20130429-10_FTMSms2hcd	12.453	128	136	24.3	1.4e-6	3.0e-9	1	15054.4	HUMAN	Profilin-1
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	6.36	3.6e-11	595.2347	2	7.7	CYEMASHLR	CY(Phospho)EMASHLR	Phospho@129=26	9	V20130429-10_FTMSms2hcd	18.452	128	136	12.7	0.0010	3.2e-6	1	15054.4	HUMAN	Profilin-1
[20]		O43707	ACTN4_HUMAN	ACTN4	5	5.4	6.71	8.1e-12	675.3248	3	0.80	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@258	18	V20130429-10_FTMSms2hcd	53.120	256	273	33.0	8.1e-12	8.2e-15	2	104854.9	HUMAN	Alpha-actinin-4
[20]		O43707	ACTN4_HUMAN	ACTN4	5	5.4	6.71	8.1e-12	669.9934	3	1.2	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-10_FTMSms2hcd	61.028	256	273	27.8	9.0e-12	9.5e-15	2	104854.9	HUMAN	Alpha-actinin-4
[20]		O43707	ACTN4_HUMAN	ACTN4	5	5.4	6.71	8.1e-12	693.8909	2	0.39	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-10_FTMSms2hcd	65.670	734	745	42.3	4.3e-11	8.8e-14	2	104854.9	HUMAN	Alpha-actinin-4
[20]		O43707	ACTN4_HUMAN	ACTN4	5	5.4	6.71	8.1e-12	715.3871	2	1.7	TINEVENQILTR	TINEVENQILTR		12	V20130429-10_FTMSms2hcd	38.804	746	757	33.1	2.1e-7	3.5e-10	2	104854.9	HUMAN	Alpha-actinin-4
[20]		O43707	ACTN4_HUMAN	ACTN4	5	5.4	6.71	8.1e-12	685.0826	4	1.7	AIMTYVSSFYHAFSGAQKAETAANR	AIM(Oxidation)TYVSSFYHAFSGAQKAETAANR	Oxidation@258	25	V20130429-10_FTMSms2hcd	51.333	256	280	18.1	1.0e-5	1.0e-8	2	104854.9	HUMAN	Alpha-actinin-4
[20-1]	0	P12814	ACTN1_HUMAN	ACTN1	5	5.5	6.71	8.1e-12	675.3248	3	0.80	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@239	18	V20130429-10_FTMSms2hcd	53.120	237	254	33.0	8.1e-12	8.2e-15	2	103058.4	HUMAN	Alpha-actinin-1
[20-1]	0	P12814	ACTN1_HUMAN	ACTN1	5	5.5	6.71	8.1e-12	669.9934	3	1.2	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-10_FTMSms2hcd	61.028	237	254	27.8	9.0e-12	9.5e-15	2	103058.4	HUMAN	Alpha-actinin-1
[20-1]	0	P12814	ACTN1_HUMAN	ACTN1	5	5.5	6.71	8.1e-12	693.8909	2	0.39	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-10_FTMSms2hcd	65.670	715	726	42.3	4.3e-11	8.8e-14	2	103058.4	HUMAN	Alpha-actinin-1
[20-1]	0	P12814	ACTN1_HUMAN	ACTN1	5	5.5	6.71	8.1e-12	715.3871	2	1.7	TINEVENQILTR	TINEVENQILTR		12	V20130429-10_FTMSms2hcd	38.804	727	738	33.1	2.1e-7	3.5e-10	2	103058.4	HUMAN	Alpha-actinin-1
[20-1]	0	P12814	ACTN1_HUMAN	ACTN1	5	5.5	6.71	8.1e-12	685.0826	4	1.7	AIMTYVSSFYHAFSGAQKAETAANR	AIM(Oxidation)TYVSSFYHAFSGAQKAETAANR	Oxidation@239	25	V20130429-10_FTMSms2hcd	51.333	237	261	18.1	1.0e-5	1.0e-8	2	103058.4	HUMAN	Alpha-actinin-1
[21]		P23528	COF1_HUMAN	CFL1	5	49.4	7.07	1.7e-12	1021.5385	3	2.5	NIILEEGKEILVGDVGQTVDDPYATFVK	NIILEEGKEILVGDVGQTVDDPYATFVK		28	V20130429-10_FTMSms2hcd	64.461	46	73	47.0	1.7e-12	3.8e-15	1	18502.7	HUMAN	Cofilin-1
[21]		P23528	COF1_HUMAN	CFL1	5	49.4	7.07	1.7e-12	669.3188	2	3.3	YALYDATYETK	YALYDATYETK		11	V20130429-10_FTMSms2hcd	32.558	82	92	38.5	2.8e-10	4.2e-13	2	18502.7	HUMAN	Cofilin-1
[21]		P23528	COF1_HUMAN	CFL1	5	49.4	7.07	1.7e-12	562.2853	4	-1.8	LTGIKHELQANCYEEVKDR	LTGIKHELQANCYEEVKDR		19	V20130429-10_FTMSms2hcd	29.959	128	146	25.2	3.6e-9	4.4e-12	1	18502.7	HUMAN	Cofilin-1
[21]		P23528	COF1_HUMAN	CFL1	5	49.4	7.07	1.7e-12	418.2247	3	-0.83	AVLFCLSEDKK	AVLFCLSEDKK		11	V20130429-10_FTMSms2hcd	38.429	35	45	31.3	6.0e-8	9.4e-11	1	18502.7	HUMAN	Cofilin-1
[21]		P23528	COF1_HUMAN	CFL1	5	49.4	7.07	1.7e-12	572.8147	2	1.1	MASGVAVSDGVIK	M(Met-loss+Acetyl)ASGVAVSDGVIK	Met-loss+Acetyl@1	13	V20130429-10_FTMSms2hcd	35.561	1	13	37.6	2.4e-7	4.2e-10	1	18502.7	HUMAN	Cofilin-1
[21-1]	0	Q9Y281	COF2_HUMAN	CFL2	1	6.6	5.73	2.8e-10	669.3188	2	3.3	YALYDATYETK	YALYDATYETK		11	V20130429-10_FTMSms2hcd	32.558	82	92	38.5	2.8e-10	4.2e-13	2	18736.8	HUMAN	Cofilin-2
[22]		P19338	NUCL_HUMAN	NCL	5	10.0	9.63	3.1e-17	1251.1401	2	2.9	TLVLSNLSYSATEETLQEVFEK	TLVLSNLSYSATEETLQEVFEK		22	V20130429-10_FTMSms2hcd	70.873	487	508	50.5	3.1e-17	4.4e-20	1	76615.0	HUMAN	Nucleolin
[22]		P19338	NUCL_HUMAN	NCL	5	10.0	9.63	3.1e-17	734.0141	3	1.2	GLSEDTTEETLKESFDGSVR	GLSEDTTEETLKESFDGSVR		20	V20130429-10_FTMSms2hcd	42.745	578	597	29.6	3.9e-12	3.8e-15	1	76615.0	HUMAN	Nucleolin
[22]		P19338	NUCL_HUMAN	NCL	5	10.0	9.63	3.1e-17	469.2531	2	1.7e-4	TGISDVFAK	TGISDVFAK		9	V20130429-10_FTMSms2hcd	35.493	325	333	26.1	4.3e-7	8.5e-10	1	76615.0	HUMAN	Nucleolin
[22]		P19338	NUCL_HUMAN	NCL	5	10.0	9.63	3.1e-17	752.0200	3	-0.68	TEADAEKTFEEKQGTEIDGR	TEADAEKTFEEKQGTEIDGR		20	V20130429-10_FTMSms2hcd	25.578	438	457	18.4	9.9e-7	9.2e-10	1	76615.0	HUMAN	Nucleolin
[22]		P19338	NUCL_HUMAN	NCL	5	10.0	9.63	3.1e-17	699.3220	2	-4.5	TEADAEKTFEEK	TEADAEKTFEEK		12	V20130429-10_FTMSms2hcd	18.216	438	449	12.6	0.017	2.3e-5	1	76615.0	HUMAN	Nucleolin
[23]		Q13268	DHRS2_HUMAN	DHRS2	5	20.5	8.09	2.2e-14	887.5078	3	-1.7	RGAVILVSSIAAYNPVVALGVYNVSK	RGAVILVSSIAAYNPVVALGVYNVSK		26	V20130429-10_FTMSms2hcd	68.449	142	167	46.2	2.2e-14	2.4e-16	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[23]		Q13268	DHRS2_HUMAN	DHRS2	5	20.5	8.09	2.2e-14	835.4772	3	1.9	GAVILVSSIAAYNPVVALGVYNVSK	GAVILVSSIAAYNPVVALGVYNVSK		25	V20130429-10_FTMSms2hcd	73.948	143	167	30.5	1.8e-12	1.5e-14	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[23]		Q13268	DHRS2_HUMAN	DHRS2	5	20.5	8.09	2.2e-14	520.7780	2	0.38	DGAHVVISSR	DGAHVVISSR		10	V20130429-10_FTMSms2hcd	14.795	37	46	27.9	1.6e-7	3.3e-10	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[23]		Q13268	DHRS2_HUMAN	DHRS2	5	20.5	8.09	2.2e-14	478.2950	2	0.49	TLALELAPK	TLALELAPK		9	V20130429-10_FTMSms2hcd	38.373	176	184	33.3	7.0e-7	4.0e-9	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[23]		Q13268	DHRS2_HUMAN	DHRS2	5	20.5	8.09	2.2e-14	422.7668	2	1.5	TALLGLTR	TALLGLTR		8	V20130429-10_FTMSms2hcd	34.952	168	175	28.2	9.2e-4	2.6e-6	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[24]		O60814	H2B1K_HUMAN	HIST1H2BK	5	38.1	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13890.3	HUMAN	Histone H2B type 1-K
[24]		O60814	H2B1K_HUMAN	HIST1H2BK	5	38.1	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13890.3	HUMAN	Histone H2B type 1-K
[24]		O60814	H2B1K_HUMAN	HIST1H2BK	5	38.1	6.99	2.5e-12	633.3241	2	-0.24	KESYSVYVYK	KESYSVYVYK		10	V20130429-10_FTMSms2hcd	25.767	35	44	38.1	9.4e-10	1.1e-12	9	13890.3	HUMAN	Histone H2B type 1-K
[24]		O60814	H2B1K_HUMAN	HIST1H2BK	5	38.1	6.99	2.5e-12	569.2780	2	2.2	ESYSVYVYK	ESYSVYVYK		9	V20130429-10_FTMSms2hcd	30.660	36	44	22.1	8.5e-7	1.3e-9	9	13890.3	HUMAN	Histone H2B type 1-K
[24]		O60814	H2B1K_HUMAN	HIST1H2BK	5	38.1	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13890.3	HUMAN	Histone H2B type 1-K
[24-1]	0	P57053	H2BFS_HUMAN	H2BFS	5	38.1	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13944.3	HUMAN	Histone H2B type F-S
[24-1]	0	P57053	H2BFS_HUMAN	H2BFS	5	38.1	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13944.3	HUMAN	Histone H2B type F-S
[24-1]	0	P57053	H2BFS_HUMAN	H2BFS	5	38.1	6.99	2.5e-12	633.3241	2	-0.24	KESYSVYVYK	KESYSVYVYK		10	V20130429-10_FTMSms2hcd	25.767	35	44	38.1	9.4e-10	1.1e-12	9	13944.3	HUMAN	Histone H2B type F-S
[24-1]	0	P57053	H2BFS_HUMAN	H2BFS	5	38.1	6.99	2.5e-12	569.2780	2	2.2	ESYSVYVYK	ESYSVYVYK		9	V20130429-10_FTMSms2hcd	30.660	36	44	22.1	8.5e-7	1.3e-9	9	13944.3	HUMAN	Histone H2B type F-S
[24-1]	0	P57053	H2BFS_HUMAN	H2BFS	5	38.1	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13944.3	HUMAN	Histone H2B type F-S
[24-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	5	38.1	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13936.3	HUMAN	Histone H2B type 1-D
[24-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	5	38.1	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13936.3	HUMAN	Histone H2B type 1-D
[24-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	5	38.1	6.99	2.5e-12	633.3241	2	-0.24	KESYSVYVYK	KESYSVYVYK		10	V20130429-10_FTMSms2hcd	25.767	35	44	38.1	9.4e-10	1.1e-12	9	13936.3	HUMAN	Histone H2B type 1-D
[24-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	5	38.1	6.99	2.5e-12	569.2780	2	2.2	ESYSVYVYK	ESYSVYVYK		9	V20130429-10_FTMSms2hcd	30.660	36	44	22.1	8.5e-7	1.3e-9	9	13936.3	HUMAN	Histone H2B type 1-D
[24-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	5	38.1	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13936.3	HUMAN	Histone H2B type 1-D
[24-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	5	38.1	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[24-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	5	38.1	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[24-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	5	38.1	6.99	2.5e-12	633.3241	2	-0.24	KESYSVYVYK	KESYSVYVYK		10	V20130429-10_FTMSms2hcd	25.767	35	44	38.1	9.4e-10	1.1e-12	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[24-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	5	38.1	6.99	2.5e-12	569.2780	2	2.2	ESYSVYVYK	ESYSVYVYK		9	V20130429-10_FTMSms2hcd	30.660	36	44	22.1	8.5e-7	1.3e-9	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[24-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	5	38.1	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[24-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	5	38.1	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13920.3	HUMAN	Histone H2B type 2-F
[24-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	5	38.1	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13920.3	HUMAN	Histone H2B type 2-F
[24-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	5	38.1	6.99	2.5e-12	633.3241	2	-0.24	KESYSVYVYK	KESYSVYVYK		10	V20130429-10_FTMSms2hcd	25.767	35	44	38.1	9.4e-10	1.1e-12	9	13920.3	HUMAN	Histone H2B type 2-F
[24-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	5	38.1	6.99	2.5e-12	569.2780	2	2.2	ESYSVYVYK	ESYSVYVYK		9	V20130429-10_FTMSms2hcd	30.660	36	44	22.1	8.5e-7	1.3e-9	9	13920.3	HUMAN	Histone H2B type 2-F
[24-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	5	38.1	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13920.3	HUMAN	Histone H2B type 2-F
[24-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	5	38.1	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13892.2	HUMAN	Histone H2B type 1-H
[24-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	5	38.1	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13892.2	HUMAN	Histone H2B type 1-H
[24-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	5	38.1	6.99	2.5e-12	633.3241	2	-0.24	KESYSVYVYK	KESYSVYVYK		10	V20130429-10_FTMSms2hcd	25.767	35	44	38.1	9.4e-10	1.1e-12	9	13892.2	HUMAN	Histone H2B type 1-H
[24-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	5	38.1	6.99	2.5e-12	569.2780	2	2.2	ESYSVYVYK	ESYSVYVYK		9	V20130429-10_FTMSms2hcd	30.660	36	44	22.1	8.5e-7	1.3e-9	9	13892.2	HUMAN	Histone H2B type 1-H
[24-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	5	38.1	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13892.2	HUMAN	Histone H2B type 1-H
[24-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	5	38.1	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13922.3	HUMAN	Histone H2B type 1-N
[24-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	5	38.1	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13922.3	HUMAN	Histone H2B type 1-N
[24-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	5	38.1	6.99	2.5e-12	633.3241	2	-0.24	KESYSVYVYK	KESYSVYVYK		10	V20130429-10_FTMSms2hcd	25.767	35	44	38.1	9.4e-10	1.1e-12	9	13922.3	HUMAN	Histone H2B type 1-N
[24-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	5	38.1	6.99	2.5e-12	569.2780	2	2.2	ESYSVYVYK	ESYSVYVYK		9	V20130429-10_FTMSms2hcd	30.660	36	44	22.1	8.5e-7	1.3e-9	9	13922.3	HUMAN	Histone H2B type 1-N
[24-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	5	38.1	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13922.3	HUMAN	Histone H2B type 1-N
[24-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	5	38.1	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13989.4	HUMAN	Histone H2B type 1-M
[24-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	5	38.1	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13989.4	HUMAN	Histone H2B type 1-M
[24-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	5	38.1	6.99	2.5e-12	633.3241	2	-0.24	KESYSVYVYK	KESYSVYVYK		10	V20130429-10_FTMSms2hcd	25.767	35	44	38.1	9.4e-10	1.1e-12	9	13989.4	HUMAN	Histone H2B type 1-M
[24-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	5	38.1	6.99	2.5e-12	569.2780	2	2.2	ESYSVYVYK	ESYSVYVYK		9	V20130429-10_FTMSms2hcd	30.660	36	44	22.1	8.5e-7	1.3e-9	9	13989.4	HUMAN	Histone H2B type 1-M
[24-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	5	38.1	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13989.4	HUMAN	Histone H2B type 1-M
[24-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	5	38.1	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13952.3	HUMAN	Histone H2B type 1-L
[24-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	5	38.1	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13952.3	HUMAN	Histone H2B type 1-L
[24-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	5	38.1	6.99	2.5e-12	633.3241	2	-0.24	KESYSVYVYK	KESYSVYVYK		10	V20130429-10_FTMSms2hcd	25.767	35	44	38.1	9.4e-10	1.1e-12	9	13952.3	HUMAN	Histone H2B type 1-L
[24-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	5	38.1	6.99	2.5e-12	569.2780	2	2.2	ESYSVYVYK	ESYSVYVYK		9	V20130429-10_FTMSms2hcd	30.660	36	44	22.1	8.5e-7	1.3e-9	9	13952.3	HUMAN	Histone H2B type 1-L
[24-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	5	38.1	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13952.3	HUMAN	Histone H2B type 1-L
[24-9]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	3	30.2	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13904.3	HUMAN	Histone H2B type 1-J
[24-9]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	3	30.2	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13904.3	HUMAN	Histone H2B type 1-J
[24-9]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	3	30.2	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13904.3	HUMAN	Histone H2B type 1-J
[24-10]	0	P23527	H2B1O_HUMAN	HIST1H2BO	3	30.2	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13906.3	HUMAN	Histone H2B type 1-O
[24-10]	0	P23527	H2B1O_HUMAN	HIST1H2BO	3	30.2	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13906.3	HUMAN	Histone H2B type 1-O
[24-10]	0	P23527	H2B1O_HUMAN	HIST1H2BO	3	30.2	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13906.3	HUMAN	Histone H2B type 1-O
[24-11]	0	P33778	H2B1B_HUMAN	HIST1H2BB	3	30.2	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13950.3	HUMAN	Histone H2B type 1-B
[24-11]	0	P33778	H2B1B_HUMAN	HIST1H2BB	3	30.2	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13950.3	HUMAN	Histone H2B type 1-B
[24-11]	0	P33778	H2B1B_HUMAN	HIST1H2BB	3	30.2	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13950.3	HUMAN	Histone H2B type 1-B
[24-12]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	3	30.2	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13920.3	HUMAN	Histone H2B type 2-E
[24-12]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	3	30.2	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13920.3	HUMAN	Histone H2B type 2-E
[24-12]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	3	30.2	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13920.3	HUMAN	Histone H2B type 2-E
[24-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	3	30.2	6.99	2.5e-12	888.4100	2	2.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-10_FTMSms2hcd	54.759	59	73	47.7	2.5e-12	2.5e-15	14	13908.2	HUMAN	Histone H2B type 3-B
[24-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	3	30.2	6.99	2.5e-12	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	45	58	38.6	5.0e-10	1.4e-12	15	13908.2	HUMAN	Histone H2B type 3-B
[24-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	3	30.2	6.99	2.5e-12	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	101	109	32.9	7.0e-6	8.5e-8	15	13908.2	HUMAN	Histone H2B type 3-B
[24-14]	0	Q96A08	H2B1A_HUMAN	HIST1H2BA	2	18.1	5.60	5.0e-10	503.6192	3	-0.047	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-10_FTMSms2hcd	17.618	46	59	38.6	5.0e-10	1.4e-12	15	14167.6	HUMAN	Histone H2B type 1-A
[24-14]	0	Q96A08	H2B1A_HUMAN	HIST1H2BA	2	18.1	5.60	5.0e-10	477.3057	2	1.2	LLLPGELAK	LLLPGELAK		9	V20130429-10_FTMSms2hcd	41.380	102	110	32.9	7.0e-6	8.5e-8	15	14167.6	HUMAN	Histone H2B type 1-A
[25]		P37802	TAGL2_HUMAN	TAGLN2	5	32.2	5.31	3.1e-9	640.2995	2	0.32	NFSDNQLQEGK	NFSDNQLQEGK		11	V20130429-10_FTMSms2hcd	20.687	161	171	34.4	3.1e-9	5.0e-12	1	22391.7	HUMAN	Transgelin-2
[25]		P37802	TAGL2_HUMAN	TAGLN2	5	32.2	5.31	3.1e-9	616.3454	2	0.65	TLMNLGGLAVAR	TLM(Oxidation)NLGGLAVAR	Oxidation@130	12	V20130429-10_FTMSms2hcd	38.576	128	139	27.4	7.6e-9	1.6e-11	1	22391.7	HUMAN	Transgelin-2
[25]		P37802	TAGL2_HUMAN	TAGLN2	5	32.2	5.31	3.1e-9	602.3151	2	0.024	MANRGPAYGLSR	M(Met-loss+Acetyl)ANRGPAYGLSR	Met-loss+Acetyl@1	12	V20130429-10_FTMSms2hcd	22.929	1	12	45.8	2.3e-8	3.4e-11	1	22391.7	HUMAN	Transgelin-2
[25]		P37802	TAGL2_HUMAN	TAGLN2	5	32.2	5.31	3.1e-9	1050.5225	2	4.4	YGINTTDIFQTVDLWEGK	YGINTTDIFQTVDLWEGK		18	V20130429-10_FTMSms2hcd	69.205	103	120	33.0	2.5e-8	2.7e-11	1	22391.7	HUMAN	Transgelin-2
[25]		P37802	TAGL2_HUMAN	TAGLN2	5	32.2	5.31	3.1e-9	609.8200	2	5.6	NVIGLQMGTNR	NVIGLQM(Oxidation)GTNR	Oxidation@178	11	V20130429-10_FTMSms2hcd	24.358	172	182	27.6	3.0e-8	4.2e-11	1	22391.7	HUMAN	Transgelin-2
[26]		P15531	NDKA_HUMAN	NME1	4	30.9	8.28	9.9e-15	901.4610	2	1.9	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@90	17	V20130429-10_FTMSms2hcd	26.365	89	105	50.9	9.9e-15	1.2e-17	3	17148.9	HUMAN	Nucleoside diphosphate kinase A
[26]		P15531	NDKA_HUMAN	NME1	4	30.9	8.28	9.9e-15	672.8865	2	1.7	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-10_FTMSms2hcd	32.226	7	18	50.1	2.4e-14	6.4e-17	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[26]		P15531	NDKA_HUMAN	NME1	4	30.9	8.28	9.9e-15	497.7429	2	1.1	GDFCIQVGR	GDFCIQVGR		9	V20130429-10_FTMSms2hcd	35.073	106	114	26.1	1.9e-8	3.8e-11	3	17148.9	HUMAN	Nucleoside diphosphate kinase A
[26]		P15531	NDKA_HUMAN	NME1	4	30.9	8.28	9.9e-15	492.8130	2	-1.3	GLVGEIIKR	GLVGEIIKR		9	V20130429-10_FTMSms2hcd	32.360	19	27	16.8	8.8e-4	5.4e-6	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[26-1]	0	P22392	NDKB_HUMAN	NME2	4	30.9	8.28	9.9e-15	901.4610	2	1.9	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@90	17	V20130429-10_FTMSms2hcd	26.365	89	105	50.9	9.9e-15	1.2e-17	3	17298.2	HUMAN	Nucleoside diphosphate kinase B
[26-1]	0	P22392	NDKB_HUMAN	NME2	4	30.9	8.28	9.9e-15	672.8865	2	1.7	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-10_FTMSms2hcd	32.226	7	18	50.1	2.4e-14	6.4e-17	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[26-1]	0	P22392	NDKB_HUMAN	NME2	4	30.9	8.28	9.9e-15	497.7429	2	1.1	GDFCIQVGR	GDFCIQVGR		9	V20130429-10_FTMSms2hcd	35.073	106	114	26.1	1.9e-8	3.8e-11	3	17298.2	HUMAN	Nucleoside diphosphate kinase B
[26-1]	0	P22392	NDKB_HUMAN	NME2	4	30.9	8.28	9.9e-15	492.8130	2	-1.3	GLVGEIIKR	GLVGEIIKR		9	V20130429-10_FTMSms2hcd	32.360	19	27	16.8	8.8e-4	5.4e-6	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[26-2]	1	O60361	NDK8_HUMAN	NME2P1	3	26.3	8.28	9.9e-15	901.4610	2	1.9	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@75	17	V20130429-10_FTMSms2hcd	26.365	74	90	50.9	9.9e-15	1.2e-17	3	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[26-2]	1	O60361	NDK8_HUMAN	NME2P1	3	26.3	8.28	9.9e-15	497.7429	2	1.1	GDFCIQVGR	GDFCIQVGR		9	V20130429-10_FTMSms2hcd	35.073	91	99	26.1	1.9e-8	3.8e-11	3	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[26-2]	1	O60361	NDK8_HUMAN	NME2P1	3	26.3	8.28	9.9e-15	634.3323	2	0.35	FKPEELVDYK	FKPEELVDYK		10	V20130429-10_FTMSms2hcd	35.802	119	128	33.3	9.9e-8	1.4e-10	1	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[27]		P04792	HSPB1_HUMAN	HSPB1	4	29.3	7.00	2.3e-12	953.5011	2	1.7	LATQSNEITIPVTFESR	LATQSNEITIPVTFESR		17	V20130429-10_FTMSms2hcd	48.622	172	188	46.8	2.3e-12	3.5e-15	1	22782.7	HUMAN	Heat shock protein beta-1
[27]		P04792	HSPB1_HUMAN	HSPB1	4	29.3	7.00	2.3e-12	822.4163	2	1.1	AQLGGPEAAKSDETAAK	AQLGGPEAAKSDETAAK		17	V20130429-10_FTMSms2hcd	15.511	189	205	49.8	2.2e-11	2.7e-14	1	22782.7	HUMAN	Heat shock protein beta-1
[27]		P04792	HSPB1_HUMAN	HSPB1	4	29.3	7.00	2.3e-12	595.3133	3	1.6	VSLDVNHFAPDELTVK	VSLDVNHFAPDELTVK		16	V20130429-10_FTMSms2hcd	46.875	97	112	35.4	6.4e-9	9.5e-12	1	22782.7	HUMAN	Heat shock protein beta-1
[27]		P04792	HSPB1_HUMAN	HSPB1	4	29.3	7.00	2.3e-12	582.3140	2	-0.040	LFDQAFGLPR	LFDQAFGLPR		10	V20130429-10_FTMSms2hcd	48.583	28	37	39.0	2.7e-8	4.4e-11	1	22782.7	HUMAN	Heat shock protein beta-1
[28]		P16403	H12_HUMAN	HIST1H1C	4	23.0	6.70	8.5e-12	789.8968	2	-0.47	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-10_FTMSms2hcd	21.247	65	79	63.1	8.5e-12	1.1e-14	5	21364.9	HUMAN	Histone H1.2
[28]		P16403	H12_HUMAN	HIST1H1C	4	23.0	6.70	8.5e-12	958.5107	2	0.92	MSETAPAAPAAAPPAEKAPVK	M(Met-loss+Acetyl)SETAPAAPAAAPPAEKAPVK	Met-loss+Acetyl@1	21	V20130429-10_FTMSms2hcd	26.538	1	21	27.4	1.9e-11	3.4e-14	1	21364.9	HUMAN	Histone H1.2
[28]		P16403	H12_HUMAN	HIST1H1C	4	23.0	6.70	8.5e-12	663.8851	2	0.14	KASGPPVSELITK	KASGPPVSELITK		13	V20130429-10_FTMSms2hcd	30.347	34	46	35.6	1.6e-7	5.4e-10	3	21364.9	HUMAN	Histone H1.2
[28]		P16403	H12_HUMAN	HIST1H1C	4	23.0	6.70	8.5e-12	554.2876	2	-0.13	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-10_FTMSms2hcd	24.840	65	75	31.7	1.9e-7	3.0e-10	5	21364.9	HUMAN	Histone H1.2
[28-1]	0	P10412	H14_HUMAN	HIST1H1E	3	12.8	6.70	8.5e-12	789.8968	2	-0.47	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-10_FTMSms2hcd	21.247	65	79	63.1	8.5e-12	1.1e-14	5	21865.4	HUMAN	Histone H1.4
[28-1]	0	P10412	H14_HUMAN	HIST1H1E	3	12.8	6.70	8.5e-12	663.8851	2	0.14	KASGPPVSELITK	KASGPPVSELITK		13	V20130429-10_FTMSms2hcd	30.347	34	46	35.6	1.6e-7	5.4e-10	3	21865.4	HUMAN	Histone H1.4
[28-1]	0	P10412	H14_HUMAN	HIST1H1E	3	12.8	6.70	8.5e-12	554.2876	2	-0.13	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-10_FTMSms2hcd	24.840	65	75	31.7	1.9e-7	3.0e-10	5	21865.4	HUMAN	Histone H1.4
[28-2]	0	P16402	H13_HUMAN	HIST1H1D	3	12.7	6.70	8.5e-12	789.8968	2	-0.47	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-10_FTMSms2hcd	21.247	66	80	63.1	8.5e-12	1.1e-14	5	22350.1	HUMAN	Histone H1.3
[28-2]	0	P16402	H13_HUMAN	HIST1H1D	3	12.7	6.70	8.5e-12	663.8851	2	0.14	KASGPPVSELITK	KASGPPVSELITK		13	V20130429-10_FTMSms2hcd	30.347	35	47	35.6	1.6e-7	5.4e-10	3	22350.1	HUMAN	Histone H1.3
[28-2]	0	P16402	H13_HUMAN	HIST1H1D	3	12.7	6.70	8.5e-12	554.2876	2	-0.13	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-10_FTMSms2hcd	24.840	66	76	31.7	1.9e-7	3.0e-10	5	22350.1	HUMAN	Histone H1.3
[28-3]	0	P22492	H1T_HUMAN	HIST1H1T	2	7.2	6.70	8.5e-12	789.8968	2	-0.47	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-10_FTMSms2hcd	21.247	69	83	63.1	8.5e-12	1.1e-14	5	22019.2	HUMAN	Histone H1t
[28-3]	0	P22492	H1T_HUMAN	HIST1H1T	2	7.2	6.70	8.5e-12	554.2876	2	-0.13	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-10_FTMSms2hcd	24.840	69	79	31.7	1.9e-7	3.0e-10	5	22019.2	HUMAN	Histone H1t
[28-4]	0	Q02539	H11_HUMAN	HIST1H1A	2	7.0	6.70	8.5e-12	789.8968	2	-0.47	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-10_FTMSms2hcd	21.247	68	82	63.1	8.5e-12	1.1e-14	5	21842.3	HUMAN	Histone H1.1
[28-4]	0	Q02539	H11_HUMAN	HIST1H1A	2	7.0	6.70	8.5e-12	554.2876	2	-0.13	ALAAAGYDVEK	ALAAAGYDVEK		11	V20130429-10_FTMSms2hcd	24.840	68	78	31.7	1.9e-7	3.0e-10	5	21842.3	HUMAN	Histone H1.1
[29]		P13639	EF2_HUMAN	EEF2	4	7.8	7.39	4.4e-13	901.4771	3	2.1	YVEPIEDVPCGNIVGLVGVDQFLVK	YVEPIEDVPCGNIVGLVGVDQFLVK		25	V20130429-10_FTMSms2hcd	74.934	457	481	43.2	4.4e-13	8.4e-16	1	95339.0	HUMAN	Elongation factor 2
[29]		P13639	EF2_HUMAN	EEF2	4	7.8	7.39	4.4e-13	785.0801	3	3.0	GVQYLNEIKDSVVAGFQWATK	GVQYLNEIKDSVVAGFQWATK		21	V20130429-10_FTMSms2hcd	68.367	668	688	43.0	3.1e-12	5.1e-15	1	95339.0	HUMAN	Elongation factor 2
[29]		P13639	EF2_HUMAN	EEF2	4	7.8	7.39	4.4e-13	485.2779	2	0.95	GGGQIIPTAR	GGGQIIPTAR		10	V20130429-10_FTMSms2hcd	23.063	717	726	20.4	7.6e-6	2.5e-8	2	95339.0	HUMAN	Elongation factor 2
[29]		P13639	EF2_HUMAN	EEF2	4	7.8	7.39	4.4e-13	554.3236	2	-0.82	VFSGLVSTGLK	VFSGLVSTGLK		11	V20130429-10_FTMSms2hcd	40.285	416	426	16.8	0.0016	6.5e-6	1	95339.0	HUMAN	Elongation factor 2
[29-1]	0	Q15029	U5S1_HUMAN	EFTUD2	1	1.0	1.53	7.6e-6	485.2779	2	0.95	GGGQIIPTAR	GGGQIIPTAR		10	V20130429-10_FTMSms2hcd	23.063	804	813	20.4	7.6e-6	2.5e-8	2	109436.7	HUMAN	116 kDa U5 small nuclear ribonucleoprotein component
[30]		P09382	LEG1_HUMAN	LGALS1	4	43.7	6.59	1.3e-11	795.8694	2	-0.88	FNAHGDANTIVCNSK	FNAHGDANTIVCNSK		15	V20130429-10_FTMSms2hcd	22.808	50	64	49.1	1.3e-11	1.6e-14	1	14715.8	HUMAN	Galectin-1
[30]		P09382	LEG1_HUMAN	LGALS1	4	43.7	6.59	1.3e-11	937.4756	3	1.9	EAVFPFQPGSVAEVCITFDQANLTVK	EAVFPFQPGSVAEVCITFDQANLTVK		26	V20130429-10_FTMSms2hcd	75.757	75	100	34.0	1.5e-10	1.8e-13	1	14715.8	HUMAN	Galectin-1
[30]		P09382	LEG1_HUMAN	LGALS1	4	43.7	6.59	1.3e-11	439.2605	2	-0.52	SFVLNLGK	SFVLNLGK		8	V20130429-10_FTMSms2hcd	41.164	30	37	26.9	5.0e-6	2.1e-8	1	14715.8	HUMAN	Galectin-1
[30]		P09382	LEG1_HUMAN	LGALS1	4	43.7	6.59	1.3e-11	538.7411	2	-0.59	DGGAWGTEQR	DGGAWGTEQR		10	V20130429-10_FTMSms2hcd	15.740	65	74	32.9	5.4e-6	1.1e-8	1	14715.8	HUMAN	Galectin-1
[31]		P09211	GSTP1_HUMAN	GSTP1	3	27.1	6.71	8.2e-12	1003.1638	3	1.7	MLLADQGQSWKEEVVTVETWQEGSLK	M(Oxidation)LLADQGQSWKEEVVTVETWQEGSLK	Oxidation@20	26	V20130429-10_FTMSms2hcd	57.534	20	45	42.7	8.2e-12	8.8e-15	1	23356.0	HUMAN	Glutathione S-transferase P
[31]		P09211	GSTP1_HUMAN	GSTP1	3	27.1	6.71	8.2e-12	669.3665	2	0.37	MPPYTVVYFPVR	M(Met-loss)PPYTVVYFPVR	Met-loss@1	12	V20130429-10_FTMSms2hcd	49.351	1	12	39.1	2.1e-11	4.4e-14	1	23356.0	HUMAN	Glutathione S-transferase P
[31]		P09211	GSTP1_HUMAN	GSTP1	3	27.1	6.71	8.2e-12	1016.5327	2	4.1	AFLASPEYVNLPINGNGKQ	AFLASPEYVNLPINGNGKQ		19	V20130429-10_FTMSms2hcd	51.454	192	210	28.9	4.5e-11	6.8e-14	1	23356.0	HUMAN	Glutathione S-transferase P
[32]		P62158	CALM_HUMAN	CALM1	2	31.5	9.80	1.6e-17	1130.5492	3	1.8	MADQLTEEQIAEFKEAFSLFDKDGDGTITTK	M(Met-loss+Acetyl)ADQLTEEQIAEFKEAFSLFDKDGDGTITTK	Met-loss+Acetyl@1	31	V20130429-10_FTMSms2hcd	72.868	1	31	53.5	1.6e-17	1.7e-20	1	16837.7	HUMAN	Calmodulin
[32]		P62158	CALM_HUMAN	CALM1	2	31.5	9.80	1.6e-17	877.9406	2	1.8	VFDKDGNGYISAAELR	VFDKDGNGYISAAELR		16	V20130429-10_FTMSms2hcd	36.679	92	107	57.4	7.1e-17	8.0e-20	1	16837.7	HUMAN	Calmodulin
[33]		P07195	LDHB_HUMAN	LDHB	5	22.8	6.50	2.0e-11	755.8904	2	-0.82	IVADKDYSVTANSK	IVADKDYSVTANSK		14	V20130429-10_FTMSms2hcd	19.029	78	91	56.5	2.0e-11	2.7e-14	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[33]		P07195	LDHB_HUMAN	LDHB	5	22.8	6.50	2.0e-11	643.8695	2	0.22	LKDDEVAQLKK	LKDDEVAQLKK		11	V20130429-10_FTMSms2hcd	17.605	309	319	31.3	7.5e-7	1.7e-9	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[33]		P07195	LDHB_HUMAN	LDHB	5	22.8	6.50	2.0e-11	457.2951	2	-0.0046	IVVVTAGVR	IVVVTAGVR		9	V20130429-10_FTMSms2hcd	27.779	92	100	28.2	3.1e-5	1.6e-7	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[33]		P07195	LDHB_HUMAN	LDHB	5	22.8	6.50	2.0e-11	1197.9860	3	-1.5	LIAPVAEEEATVPNNKITVVGVGQVGMACAISILGK	LIAPVAEEEATVPNNKITVVGVGQVGMACAISILGK		36	V20130429-10_FTMSms2hcd	75.557	8	43	19.9	1.0e-4	6.0e-7	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[33]		P07195	LDHB_HUMAN	LDHB	5	22.8	6.50	2.0e-11	371.7318	2	-0.91	LNLVQR	LNLVQR		6	V20130429-10_FTMSms2hcd	21.656	108	113	21.6	0.092	3.5e-4	3	36638.8	HUMAN	L-lactate dehydrogenase B chain
[33-1]	2	P00338	LDHA_HUMAN	LDHA	3	7.5	4.30	3.2e-8	567.7847	2	-1.4	VTLTSEEEAR	VTLTSEEEAR		10	V20130429-10_FTMSms2hcd	19.043	306	315	35.3	3.2e-8	4.8e-11	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[33-1]	2	P00338	LDHA_HUMAN	LDHA	3	7.5	4.30	3.2e-8	457.3000	2	11	LVIITAGAR	LVIITAGAR		9	V20130429-10_FTMSms2hcd	31.430	91	99	33.9	2.7e-5	1.9e-7	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[33-1]	2	P00338	LDHA_HUMAN	LDHA	3	7.5	4.30	3.2e-8	371.7318	2	-0.91	LNLVQR	LNLVQR		6	V20130429-10_FTMSms2hcd	21.656	107	112	21.6	0.092	3.5e-4	3	36689.1	HUMAN	L-lactate dehydrogenase A chain
[34]		P04075	ALDOA_HUMAN	ALDOA	3	14.6	8.06	2.6e-14	780.6510	4	-0.27	YASICQQNGIVPIVEPEILPDGDHDLKR	YASICQQNGIVPIVEPEILPDGDHDLKR		28	V20130429-10_FTMSms2hcd	54.544	174	201	50.6	2.6e-14	3.9e-17	2	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[34]		P04075	ALDOA_HUMAN	ALDOA	3	14.6	8.06	2.6e-14	538.2822	2	0.62	ALANSLACQGK	ALANSLACQGK		11	V20130429-10_FTMSms2hcd	22.221	332	342	34.4	1.3e-8	1.9e-11	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[34]		P04075	ALDOA_HUMAN	ALDOA	3	14.6	8.06	2.6e-14	823.9088	2	0.65	LQSIGTENTEENRR	LQSIGTENTEENRR		14	V20130429-10_FTMSms2hcd	16.281	44	57	33.4	1.2e-6	1.4e-9	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[34-1]	0	P09972	ALDOC_HUMAN	ALDOC	1	7.7	8.06	2.6e-14	780.6510	4	-0.27	YASICQQNGIVPIVEPEILPDGDHDLKR	YASICQQNGIVPIVEPEILPDGDHDLKR		28	V20130429-10_FTMSms2hcd	54.544	174	201	50.6	2.6e-14	3.9e-17	2	39456.2	HUMAN	Fructose-bisphosphate aldolase C
[35]		P31947	1433S_HUMAN	SFN	3	25.4	6.81	5.2e-12	844.9050	4	1.7	TTFDEAMADLHTLSEDSYKDSTLIMQLLR	TTFDEAM(Oxidation)ADLHTLSEDSYKDSTLIM(Oxidation)QLLR	Oxidation@202;Oxidation@220	29	V20130429-10_FTMSms2hcd	73.054	196	224	32.5	5.2e-12	5.2e-15	1	27774.3	HUMAN	14-3-3 protein sigma
[35]		P31947	1433S_HUMAN	SFN	3	25.4	6.81	5.2e-12	945.1629	3	-1.0	LGLALNFSVFHYEIANSPEEAISLAK	LGLALNFSVFHYEIANSPEEAISLAK		26	V20130429-10_FTMSms2hcd	70.142	170	195	45.3	2.9e-11	5.3e-14	1	27774.3	HUMAN	14-3-3 protein sigma
[35]		P31947	1433S_HUMAN	SFN	3	25.4	6.81	5.2e-12	454.2662	2	0.42	NLLSVAYK	NLLSVAYK		8	V20130429-10_FTMSms2hcd	35.777	42	49	22.5	0.0019	6.7e-6	7	27774.3	HUMAN	14-3-3 protein sigma
[35-1]	2	P63104	1433Z_HUMAN	YWHAZ	3	12.7	6.01	1.6e-10	774.8611	2	0.84	SVTEQGAELSNEER	SVTEQGAELSNEER		14	V20130429-10_FTMSms2hcd	20.791	28	41	50.7	1.6e-10	1.9e-13	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[35-1]	2	P63104	1433Z_HUMAN	YWHAZ	3	12.7	6.01	1.6e-10	581.7926	2	0.58	MDKNELVQK	Acetyl-M(Oxidation)DKNELVQK	Oxidation@1=7	9	V20130429-10_FTMSms2hcd	14.518	1	9	32.0	1.0e-7	1.5e-10	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[35-1]	2	P63104	1433Z_HUMAN	YWHAZ	3	12.7	6.01	1.6e-10	454.2662	2	0.42	NLLSVAYK	NLLSVAYK		8	V20130429-10_FTMSms2hcd	35.777	42	49	22.5	0.0019	6.7e-6	7	27745.3	HUMAN	14-3-3 protein zeta/delta
[35-2]	1	P31946	1433B_HUMAN	YWHAB	2	8.9	8.06	2.5e-14	799.8755	2	2.0	AVTEQGHELSNEER	AVTEQGHELSNEER		14	V20130429-10_FTMSms2hcd	14.544	30	43	62.5	2.5e-14	2.9e-17	1	28082.6	HUMAN	14-3-3 protein beta/alpha
[35-2]	1	P31946	1433B_HUMAN	YWHAB	2	8.9	8.06	2.5e-14	454.2662	2	0.42	NLLSVAYK	NLLSVAYK		8	V20130429-10_FTMSms2hcd	35.777	44	51	22.5	0.0019	6.7e-6	7	28082.6	HUMAN	14-3-3 protein beta/alpha
[35-3]	1	P27348	1433T_HUMAN	YWHAQ	2	9.0	5.99	1.8e-10	766.8636	2	0.79	AVTEQGAELSNEER	AVTEQGAELSNEER		14	V20130429-10_FTMSms2hcd	19.972	28	41	43.7	1.8e-10	2.2e-13	1	27764.5	HUMAN	14-3-3 protein theta
[35-3]	1	P27348	1433T_HUMAN	YWHAQ	2	9.0	5.99	1.8e-10	454.2662	2	0.42	NLLSVAYK	NLLSVAYK		8	V20130429-10_FTMSms2hcd	35.777	42	49	22.5	0.0019	6.7e-6	7	27764.5	HUMAN	14-3-3 protein theta
[35-4]	0	P61981	1433G_HUMAN	YWHAG	1	3.2	0.44	0.0019	454.2662	2	0.42	NLLSVAYK	NLLSVAYK		8	V20130429-10_FTMSms2hcd	35.777	43	50	22.5	0.0019	6.7e-6	7	28302.8	HUMAN	14-3-3 protein gamma
[35-5]	0	P62258	1433E_HUMAN	YWHAE	1	3.1	0.44	0.0019	454.2662	2	0.42	NLLSVAYK	NLLSVAYK		8	V20130429-10_FTMSms2hcd	35.777	43	50	22.5	0.0019	6.7e-6	7	29174.2	HUMAN	14-3-3 protein epsilon
[35-6]	0	Q04917	1433F_HUMAN	YWHAH	1	3.3	0.44	0.0019	454.2662	2	0.42	NLLSVAYK	NLLSVAYK		8	V20130429-10_FTMSms2hcd	35.777	43	50	22.5	0.0019	6.7e-6	7	28219.0	HUMAN	14-3-3 protein eta
[36]		P06732	KCRM_HUMAN	CKM	3	8.7	7.19	1.0e-12	659.8187	2	-0.47	GQSIDDMIPAQK	GQSIDDM(Oxidation)IPAQK	Oxidation@376	12	V20130429-10_FTMSms2hcd	23.316	370	381	38.1	1.0e-12	1.4e-15	1	43101.5	HUMAN	Creatine kinase M-type
[36]		P06732	KCRM_HUMAN	CKM	3	8.7	7.19	1.0e-12	754.4050	2	1.6	LSVEALNSLTGEFK	LSVEALNSLTGEFK		14	V20130429-10_FTMSms2hcd	55.262	157	170	45.8	2.1e-9	3.2e-12	1	43101.5	HUMAN	Creatine kinase M-type
[36]		P06732	KCRM_HUMAN	CKM	3	8.7	7.19	1.0e-12	454.2480	2	0.40	FEEILTR	FEEILTR		7	V20130429-10_FTMSms2hcd	30.213	308	314	29.7	2.3e-4	4.5e-7	1	43101.5	HUMAN	Creatine kinase M-type
[37]		P00558	PGK1_HUMAN	PGK1	3	11.5	6.70	8.3e-12	1124.5880	3	2.5	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEM(Oxidation)IIGGGM(Oxidation)AFTFLK	Oxidation@227;Oxidation@234;Oxidation@240	30	V20130429-10_FTMSms2hcd	64.072	217	246	41.1	8.3e-12	1.8e-14	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[37]		P00558	PGK1_HUMAN	PGK1	3	11.5	6.70	8.3e-12	675.0233	3	8.5	ITLPVDFVTADKFDENAK	ITLPVDFVTADKFDENAK		18	V20130429-10_FTMSms2hcd	54.355	280	297	25.2	2.3e-10	3.5e-13	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[37]		P00558	PGK1_HUMAN	PGK1	3	11.5	6.70	8.3e-12	835.7041	4	13	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNMLDKVNEM(Oxidation)IIGGGMAFTFLK	Oxidation@227|234	30	V20130429-10_FTMSms2hcd	76.171	217	246	10.1	0.0032	1.3e-5	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[38]		P61978	HNRPK_HUMAN	HNRNPK	3	10.4	7.04	2.0e-12	615.0314	3	0.54	ILSISADIETIGEILKK	ILSISADIETIGEILKK		17	V20130429-10_FTMSms2hcd	71.051	87	103	40.4	2.0e-12	2.3e-14	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[38]		P61978	HNRPK_HUMAN	HNRNPK	3	10.4	7.04	2.0e-12	518.6461	3	-1.5	IILDLISESPIKGR	IILDLISESPIKGR		14	V20130429-10_FTMSms2hcd	51.804	208	221	29.6	1.9e-6	1.4e-8	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[38]		P61978	HNRPK_HUMAN	HNRNPK	3	10.4	7.04	2.0e-12	890.9034	2	0.62	TDYNASVSVPDSSGPER	TDYNASVSVPDSSGPER		17	V20130429-10_FTMSms2hcd	28.029	70	86	27.3	5.4e-6	6.3e-9	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[39]		Q15366	PCBP2_HUMAN	PCBP2	3	13.2	6.08	2.6e-11	1103.1147	2	-0.74	QVTITGSAASISLAQYLINVR	QVTITGSAASISLAQYLINVR		21	V20130429-10_FTMSms2hcd	66.420	334	354	32.9	2.6e-11	9.8e-14	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[39]		Q15366	PCBP2_HUMAN	PCBP2	3	13.2	6.08	2.6e-11	828.4750	2	1.6	AITIAGIPQSIIECVK	AITIAGIPQSIIECVK		16	V20130429-10_FTMSms2hcd	67.194	145	160	36.5	7.6e-10	2.8e-12	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[39]		Q15366	PCBP2_HUMAN	PCBP2	3	13.2	6.08	2.6e-11	579.7910	2	-0.19	IANPVEGSTDR	IANPVEGSTDR		11	V20130429-10_FTMSms2hcd	20.012	323	333	17.5	1.9e-5	2.7e-8	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[40]		P43487	RANG_HUMAN	RANBP1	2	16.9	8.26	1.1e-14	671.3350	4	1.8	AWVWNTHADFADECPKPELLAIR	AWVWNTHADFADECPKPELLAIR		23	V20130429-10_FTMSms2hcd	59.732	119	141	41.5	1.1e-14	1.2e-17	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[40]		P43487	RANG_HUMAN	RANBP1	2	16.9	8.26	1.1e-14	691.3226	2	0.72	TLEEDEEELFK	TLEEDEEELFK		11	V20130429-10_FTMSms2hcd	44.233	40	50	36.8	1.4e-8	2.0e-11	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[41]		P20700	LMNB1_HUMAN	LMNB1	2	6.5	9.00	4.7e-16	1137.8643	3	2.1	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR		30	V20130429-10_FTMSms2hcd	61.136	548	577	50.2	4.7e-16	4.7e-19	1	66408.9	HUMAN	Lamin-B1
[41]		P20700	LMNB1_HUMAN	LMNB1	2	6.5	9.00	4.7e-16	487.7431	2	0.0075	LLEGEEER	LLEGEEER		8	V20130429-10_FTMSms2hcd	15.376	380	387	23.0	6.6e-5	1.3e-7	3	66408.9	HUMAN	Lamin-B1
[41-1]	1	P02545	LMNA_HUMAN	LMNA	2	3.3	1.83	6.2e-6	754.3762	2	2.0	TALINSTGEEVAMR	TALINSTGEEVAM(Oxidation)R	Oxidation@540	14	V20130429-10_FTMSms2hcd	28.519	528	541	16.5	6.2e-6	7.7e-9	1	74140.1	HUMAN	Prelamin-A/C
[41-1]	1	P02545	LMNA_HUMAN	LMNA	2	3.3	1.83	6.2e-6	487.7431	2	0.0075	LLEGEEER	LLEGEEER		8	V20130429-10_FTMSms2hcd	15.376	379	386	23.0	6.6e-5	1.3e-7	3	74140.1	HUMAN	Prelamin-A/C
[41-2]	0	Q03252	LMNB2_HUMAN	LMNB2	1	1.3	1.28	6.6e-5	487.7431	2	0.0075	LLEGEEER	LLEGEEER		8	V20130429-10_FTMSms2hcd	15.376	374	381	23.0	6.6e-5	1.3e-7	3	67689.4	HUMAN	Lamin-B2
[42]		P25705	ATPA_HUMAN	ATP5A1	2	5.2	6.29	4.8e-11	720.3389	2	1.6	TGTAEMSSILEER	TGTAEM(Oxidation)SSILEER	Oxidation@51	13	V20130429-10_FTMSms2hcd	26.244	46	58	40.1	4.8e-11	5.9e-14	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[42]		P25705	ATPA_HUMAN	ATP5A1	2	5.2	6.29	4.8e-11	812.9501	2	1.5	TGAIVDVPVGEELLGR	TGAIVDVPVGEELLGR		16	V20130429-10_FTMSms2hcd	54.087	134	149	31.9	2.3e-9	5.6e-12	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[43]		P68431	H31_HUMAN	HIST1H3A	4	24.3	4.22	1.7e-7	516.8011	2	0.033	YRPGTVALR	YRPGTVALR		9	V20130429-10_FTMSms2hcd	20.305	42	50	38.4	1.7e-7	4.8e-10	5	15404.2	HUMAN	Histone H3.1
[43]		P68431	H31_HUMAN	HIST1H3A	4	24.3	4.22	1.7e-7	668.3511	2	3.5	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-10_FTMSms2hcd	31.045	74	84	33.9	5.0e-6	7.8e-9	4	15404.2	HUMAN	Histone H3.1
[43]		P68431	H31_HUMAN	HIST1H3A	4	24.3	4.22	1.7e-7	416.2504	2	0.096	STELLIR	STELLIR		7	V20130429-10_FTMSms2hcd	29.037	58	64	24.8	0.0021	4.5e-6	5	15404.2	HUMAN	Histone H3.1
[43]		P68431	H31_HUMAN	HIST1H3A	4	24.3	4.22	1.7e-7	394.7426	2	0.24	KLPFQR	KLPFQR		6	V20130429-10_FTMSms2hcd	23.541	65	70	20.6	0.018	3.4e-5	5	15404.2	HUMAN	Histone H3.1
[43-1]	0	P84243	H33_HUMAN	H3F3A	4	24.3	4.22	1.7e-7	516.8011	2	0.033	YRPGTVALR	YRPGTVALR		9	V20130429-10_FTMSms2hcd	20.305	42	50	38.4	1.7e-7	4.8e-10	5	15328.0	HUMAN	Histone H3.3
[43-1]	0	P84243	H33_HUMAN	H3F3A	4	24.3	4.22	1.7e-7	668.3511	2	3.5	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-10_FTMSms2hcd	31.045	74	84	33.9	5.0e-6	7.8e-9	4	15328.0	HUMAN	Histone H3.3
[43-1]	0	P84243	H33_HUMAN	H3F3A	4	24.3	4.22	1.7e-7	416.2504	2	0.096	STELLIR	STELLIR		7	V20130429-10_FTMSms2hcd	29.037	58	64	24.8	0.0021	4.5e-6	5	15328.0	HUMAN	Histone H3.3
[43-1]	0	P84243	H33_HUMAN	H3F3A	4	24.3	4.22	1.7e-7	394.7426	2	0.24	KLPFQR	KLPFQR		6	V20130429-10_FTMSms2hcd	23.541	65	70	20.6	0.018	3.4e-5	5	15328.0	HUMAN	Histone H3.3
[43-2]	0	Q16695	H31T_HUMAN	HIST3H3	4	24.3	4.22	1.7e-7	516.8011	2	0.033	YRPGTVALR	YRPGTVALR		9	V20130429-10_FTMSms2hcd	20.305	42	50	38.4	1.7e-7	4.8e-10	5	15508.4	HUMAN	Histone H3.1t
[43-2]	0	Q16695	H31T_HUMAN	HIST3H3	4	24.3	4.22	1.7e-7	668.3511	2	3.5	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-10_FTMSms2hcd	31.045	74	84	33.9	5.0e-6	7.8e-9	4	15508.4	HUMAN	Histone H3.1t
[43-2]	0	Q16695	H31T_HUMAN	HIST3H3	4	24.3	4.22	1.7e-7	416.2504	2	0.096	STELLIR	STELLIR		7	V20130429-10_FTMSms2hcd	29.037	58	64	24.8	0.0021	4.5e-6	5	15508.4	HUMAN	Histone H3.1t
[43-2]	0	Q16695	H31T_HUMAN	HIST3H3	4	24.3	4.22	1.7e-7	394.7426	2	0.24	KLPFQR	KLPFQR		6	V20130429-10_FTMSms2hcd	23.541	65	70	20.6	0.018	3.4e-5	5	15508.4	HUMAN	Histone H3.1t
[43-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	4	24.3	4.22	1.7e-7	516.8011	2	0.033	YRPGTVALR	YRPGTVALR		9	V20130429-10_FTMSms2hcd	20.305	42	50	38.4	1.7e-7	4.8e-10	5	15388.2	HUMAN	Histone H3.2
[43-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	4	24.3	4.22	1.7e-7	668.3511	2	3.5	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-10_FTMSms2hcd	31.045	74	84	33.9	5.0e-6	7.8e-9	4	15388.2	HUMAN	Histone H3.2
[43-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	4	24.3	4.22	1.7e-7	416.2504	2	0.096	STELLIR	STELLIR		7	V20130429-10_FTMSms2hcd	29.037	58	64	24.8	0.0021	4.5e-6	5	15388.2	HUMAN	Histone H3.2
[43-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	4	24.3	4.22	1.7e-7	394.7426	2	0.24	KLPFQR	KLPFQR		6	V20130429-10_FTMSms2hcd	23.541	65	70	20.6	0.018	3.4e-5	5	15388.2	HUMAN	Histone H3.2
[43-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	3	16.3	4.22	1.7e-7	516.8011	2	0.033	YRPGTVALR	YRPGTVALR		9	V20130429-10_FTMSms2hcd	20.305	41	49	38.4	1.7e-7	4.8e-10	5	15213.9	HUMAN	Histone H3.3C
[43-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	3	16.3	4.22	1.7e-7	416.2504	2	0.096	STELLIR	STELLIR		7	V20130429-10_FTMSms2hcd	29.037	57	63	24.8	0.0021	4.5e-6	5	15213.9	HUMAN	Histone H3.3C
[43-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	3	16.3	4.22	1.7e-7	394.7426	2	0.24	KLPFQR	KLPFQR		6	V20130429-10_FTMSms2hcd	23.541	64	69	20.6	0.018	3.4e-5	5	15213.9	HUMAN	Histone H3.3C
[44]		P25398	RS12_HUMAN	RPS12	3	31.8	4.27	6.2e-8	502.7656	2	0.56	LGEWVGLCK	LGEWVGLCK		9	V20130429-10_FTMSms2hcd	42.839	85	93	36.6	6.2e-8	9.7e-11	1	14515.1	HUMAN	40S ribosomal protein S12
[44]		P25398	RS12_HUMAN	RPS12	3	31.8	4.27	6.2e-8	533.8038	2	-0.042	TALIHDGLAR	TALIHDGLAR		10	V20130429-10_FTMSms2hcd	24.250	24	33	20.0	5.1e-7	1.6e-9	1	14515.1	HUMAN	40S ribosomal protein S12
[44]		P25398	RS12_HUMAN	RPS12	3	31.8	4.27	6.2e-8	1137.0728	2	2.4	MAEEGIAAGGVMDVNTALQEVLK	M(Met-loss+Acetyl)AEEGIAAGGVM(Oxidation)DVNTALQEVLK	Met-loss+Acetyl@1;Oxidation@12	23	V20130429-10_FTMSms2hcd	71.864	1	23	18.2	9.9e-6	1.2e-8	1	14515.1	HUMAN	40S ribosomal protein S12
[45]		P04083	ANXA1_HUMAN	ANXA1	2	6.6	5.98	9.1e-11	650.3232	2	-0.82	CATSKPAFFAEK	CATSKPAFFAEK		12	V20130429-10_FTMSms2hcd	26.257	270	281	25.2	9.1e-11	1.3e-13	1	38714.6	HUMAN	Annexin A1
[45]		P04083	ANXA1_HUMAN	ANXA1	2	6.6	5.98	9.1e-11	631.8049	2	1.1	TPAQFDADELR	TPAQFDADELR		11	V20130429-10_FTMSms2hcd	31.551	114	124	38.4	5.6e-9	7.8e-12	1	38714.6	HUMAN	Annexin A1
[46]		P63313	TYB10_HUMAN	TMSB10	2	65.9	5.72	5.5e-10	791.3610	2	2.9	MADKPDMGEIASFDK	M(Met-loss+Acetyl)ADKPDM(Oxidation)GEIASFDK	Met-loss+Acetyl@1;Oxidation@7	15	V20130429-10_FTMSms2hcd	31.071	1	15	44.6	5.5e-10	7.2e-13	1	5025.7	HUMAN	Thymosin beta-10
[46]		P63313	TYB10_HUMAN	TMSB10	2	65.9	5.72	5.5e-10	562.9717	3	-0.91	NTLPTKETIEQEKR	NTLPTKETIEQEKR		14	V20130429-10_FTMSms2hcd	19.653	27	40	39.6	5.7e-9	1.0e-11	1	5025.7	HUMAN	Thymosin beta-10
[47]		P06753	TPM3_HUMAN	TPM3	2	9.5	6.71	8.1e-12	492.8985	3	-0.21	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-10_FTMSms2hcd	13.382	113	125	45.5	8.1e-12	9.4e-15	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[47]		P06753	TPM3_HUMAN	TPM3	2	9.5	6.71	8.1e-12	576.6361	3	0.86	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-10_FTMSms2hcd	37.998	92	105	28.2	1.4e-6	2.1e-9	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[47-1]	0	P07951	TPM2_HUMAN	TPM2	2	9.5	6.71	8.1e-12	492.8985	3	-0.21	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-10_FTMSms2hcd	13.382	113	125	45.5	8.1e-12	9.4e-15	4	32851.0	HUMAN	Tropomyosin beta chain
[47-1]	0	P07951	TPM2_HUMAN	TPM2	2	9.5	6.71	8.1e-12	576.6361	3	0.86	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-10_FTMSms2hcd	37.998	92	105	28.2	1.4e-6	2.1e-9	4	32851.0	HUMAN	Tropomyosin beta chain
[47-2]	0	P09493	TPM1_HUMAN	TPM1	2	9.5	6.71	8.1e-12	492.8985	3	-0.21	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-10_FTMSms2hcd	13.382	113	125	45.5	8.1e-12	9.4e-15	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[47-2]	0	P09493	TPM1_HUMAN	TPM1	2	9.5	6.71	8.1e-12	576.6361	3	0.86	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-10_FTMSms2hcd	37.998	92	105	28.2	1.4e-6	2.1e-9	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[47-3]	0	P67936	TPM4_HUMAN	TPM4	2	10.9	6.71	8.1e-12	492.8985	3	-0.21	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-10_FTMSms2hcd	13.382	77	89	45.5	8.1e-12	9.4e-15	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[47-3]	0	P67936	TPM4_HUMAN	TPM4	2	10.9	6.71	8.1e-12	576.6361	3	0.86	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-10_FTMSms2hcd	37.998	56	69	28.2	1.4e-6	2.1e-9	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[48]		P05141	ADT2_HUMAN	SLC25A5	3	12.8	5.06	6.8e-10	682.4250	2	0.53	VKLLLQVQHASK	VKLLLQVQHASK		12	V20130429-10_FTMSms2hcd	28.493	32	43	28.4	6.8e-10	1.9e-11	3	32852.5	HUMAN	ADP/ATP translocase 2
[48]		P05141	ADT2_HUMAN	SLC25A5	3	12.8	5.06	6.8e-10	674.0203	3	0.18	GMGGAFVLVLYDEIKKYT	GM(Oxidation)GGAFVLVLYDEIKKYT	Oxidation@282	18	V20130429-10_FTMSms2hcd	75.137	281	298	12.1	8.4e-6	1.2e-8	1	32852.5	HUMAN	ADP/ATP translocase 2
[48]		P05141	ADT2_HUMAN	SLC25A5	3	12.8	5.06	6.8e-10	428.7479	2	-0.20	TAVAPIER	TAVAPIER		8	V20130429-10_FTMSms2hcd	17.245	24	31	33.9	2.6e-5	9.0e-8	4	32852.5	HUMAN	ADP/ATP translocase 2
[48-1]	0	P12235	ADT1_HUMAN	SLC25A4	2	6.7	5.06	6.8e-10	682.4250	2	0.53	VKLLLQVQHASK	VKLLLQVQHASK		12	V20130429-10_FTMSms2hcd	28.493	32	43	28.4	6.8e-10	1.9e-11	3	33064.8	HUMAN	ADP/ATP translocase 1
[48-1]	0	P12235	ADT1_HUMAN	SLC25A4	2	6.7	5.06	6.8e-10	428.7479	2	-0.20	TAVAPIER	TAVAPIER		8	V20130429-10_FTMSms2hcd	17.245	24	31	33.9	2.6e-5	9.0e-8	4	33064.8	HUMAN	ADP/ATP translocase 1
[48-2]	0	P12236	ADT3_HUMAN	SLC25A6	2	6.7	5.06	6.8e-10	682.4250	2	0.53	VKLLLQVQHASK	VKLLLQVQHASK		12	V20130429-10_FTMSms2hcd	28.493	32	43	28.4	6.8e-10	1.9e-11	3	32866.6	HUMAN	ADP/ATP translocase 3
[48-2]	0	P12236	ADT3_HUMAN	SLC25A6	2	6.7	5.06	6.8e-10	428.7479	2	-0.20	TAVAPIER	TAVAPIER		8	V20130429-10_FTMSms2hcd	17.245	24	31	33.9	2.6e-5	9.0e-8	4	32866.6	HUMAN	ADP/ATP translocase 3
[48-3]	0	Q9H0C2	ADT4_HUMAN	SLC25A31	1	2.5	2.59	2.6e-5	428.7479	2	-0.20	TAVAPIER	TAVAPIER		8	V20130429-10_FTMSms2hcd	17.245	36	43	33.9	2.6e-5	9.0e-8	4	35022.2	HUMAN	ADP/ATP translocase 4
[49]		P61604	CH10_HUMAN	HSPE1	3	28.4	5.49	1.5e-9	658.3836	2	1.5	VLQATVVAVGSGSK	VLQATVVAVGSGSK		14	V20130429-10_FTMSms2hcd	30.118	41	54	50.8	1.5e-9	4.6e-12	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[49]		P61604	CH10_HUMAN	HSPE1	3	28.4	5.49	1.5e-9	454.2550	2	-0.98	FLPLFDR	FLPLFDR		7	V20130429-10_FTMSms2hcd	49.101	9	15	31.9	4.7e-4	1.1e-6	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[49]		P61604	CH10_HUMAN	HSPE1	3	28.4	5.49	1.5e-9	410.2313	2	10.0	MAGQAFRK	M(Met-loss+Acetyl)AGQAFRK	Met-loss+Acetyl@1	8	V20130429-10_FTMSms2hcd	13.643	1	8	22.1	0.0013	2.7e-6	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[50]		P30101	PDIA3_HUMAN	PDIA3	1	4.8	9.80	1.6e-17	859.1072	3	1.2	TFSHELSDFGLESTAGEIPVVAIR	TFSHELSDFGLESTAGEIPVVAIR		24	V20130429-10_FTMSms2hcd	60.309	306	329	43.6	1.6e-17	2.0e-20	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[51]		P26583	HMGB2_HUMAN	HMGB2	2	11.0	8.23	1.2e-14	728.3232	2	-0.28	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-10_FTMSms2hcd	44.727	13	24	42.1	1.2e-14	1.8e-17	3	24034.0	HUMAN	High mobility group protein B2
[51]		P26583	HMGB2_HUMAN	HMGB2	2	11.0	8.23	1.2e-14	633.3021	2	11	LGEMWSEQSAK	LGEMWSEQSAK		11	V20130429-10_FTMSms2hcd	20.132	129	139	12.5	0.068	1.1e-4	1	24034.0	HUMAN	High mobility group protein B2
[51-1]	0	P09429	HMGB1_HUMAN	HMGB1	1	5.6	8.23	1.2e-14	728.3232	2	-0.28	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-10_FTMSms2hcd	44.727	13	24	42.1	1.2e-14	1.8e-17	3	24894.0	HUMAN	High mobility group protein B1
[51-2]	0	B2RPK0	HGB1A_HUMAN	HMGB1P1	1	5.7	8.23	1.2e-14	728.3232	2	-0.28	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-10_FTMSms2hcd	44.727	13	24	42.1	1.2e-14	1.8e-17	3	24238.2	HUMAN	Putative high mobility group protein B1-like 1
[52]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.01	1.4e-8	966.0894	2	1.4	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-10_FTMSms2hcd	65.442	101	119	30.4	1.4e-8	3.9e-10	10	14091.6	HUMAN	Histone H2A type 1
[52]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.01	1.4e-8	526.8020	4	-0.54	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-10_FTMSms2hcd	45.800	83	100	29.6	7.3e-6	4.0e-8	7	14091.6	HUMAN	Histone H2A type 1
[52]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.01	1.4e-8	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	14091.6	HUMAN	Histone H2A type 1
[52]		P0C0S8	H2A1_HUMAN	HIST1H2AG	4	35.4	4.01	1.4e-8	424.8989	3	2.2	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-10_FTMSms2hcd	35.708	90	100	18.1	0.0028	4.7e-6	7	14091.6	HUMAN	Histone H2A type 1
[52-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.01	1.4e-8	966.0894	2	1.4	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-10_FTMSms2hcd	65.442	101	119	30.4	1.4e-8	3.9e-10	10	14107.6	HUMAN	Histone H2A type 1-D
[52-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.01	1.4e-8	526.8020	4	-0.54	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-10_FTMSms2hcd	45.800	83	100	29.6	7.3e-6	4.0e-8	7	14107.6	HUMAN	Histone H2A type 1-D
[52-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.01	1.4e-8	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	14107.6	HUMAN	Histone H2A type 1-D
[52-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	4	35.4	4.01	1.4e-8	424.8989	3	2.2	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-10_FTMSms2hcd	35.708	90	100	18.1	0.0028	4.7e-6	7	14107.6	HUMAN	Histone H2A type 1-D
[52-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	4.01	1.4e-8	966.0894	2	1.4	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-10_FTMSms2hcd	65.442	101	119	30.4	1.4e-8	3.9e-10	10	13988.5	HUMAN	Histone H2A type 2-C
[52-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	4.01	1.4e-8	526.8020	4	-0.54	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-10_FTMSms2hcd	45.800	83	100	29.6	7.3e-6	4.0e-8	7	13988.5	HUMAN	Histone H2A type 2-C
[52-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	4.01	1.4e-8	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	13988.5	HUMAN	Histone H2A type 2-C
[52-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	4	35.7	4.01	1.4e-8	424.8989	3	2.2	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-10_FTMSms2hcd	35.708	90	100	18.1	0.0028	4.7e-6	7	13988.5	HUMAN	Histone H2A type 2-C
[52-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	4.01	1.4e-8	966.0894	2	1.4	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-10_FTMSms2hcd	65.442	101	119	30.4	1.4e-8	3.9e-10	10	14095.6	HUMAN	Histone H2A type 2-A
[52-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	4.01	1.4e-8	526.8020	4	-0.54	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-10_FTMSms2hcd	45.800	83	100	29.6	7.3e-6	4.0e-8	7	14095.6	HUMAN	Histone H2A type 2-A
[52-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	4.01	1.4e-8	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	14095.6	HUMAN	Histone H2A type 2-A
[52-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	35.4	4.01	1.4e-8	424.8989	3	2.2	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-10_FTMSms2hcd	35.708	90	100	18.1	0.0028	4.7e-6	7	14095.6	HUMAN	Histone H2A type 2-A
[52-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.01	1.4e-8	966.0894	2	1.4	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-10_FTMSms2hcd	65.442	101	119	30.4	1.4e-8	3.9e-10	10	13906.4	HUMAN	Histone H2A type 1-H
[52-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.01	1.4e-8	526.8020	4	-0.54	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-10_FTMSms2hcd	45.800	83	100	29.6	7.3e-6	4.0e-8	7	13906.4	HUMAN	Histone H2A type 1-H
[52-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.01	1.4e-8	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	13906.4	HUMAN	Histone H2A type 1-H
[52-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	4	35.9	4.01	1.4e-8	424.8989	3	2.2	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-10_FTMSms2hcd	35.708	90	100	18.1	0.0028	4.7e-6	7	13906.4	HUMAN	Histone H2A type 1-H
[52-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.01	1.4e-8	966.0894	2	1.4	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-10_FTMSms2hcd	65.442	101	119	30.4	1.4e-8	3.9e-10	10	13936.4	HUMAN	Histone H2A type 1-J
[52-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.01	1.4e-8	526.8020	4	-0.54	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-10_FTMSms2hcd	45.800	83	100	29.6	7.3e-6	4.0e-8	7	13936.4	HUMAN	Histone H2A type 1-J
[52-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.01	1.4e-8	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	13936.4	HUMAN	Histone H2A type 1-J
[52-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	4	35.9	4.01	1.4e-8	424.8989	3	2.2	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-10_FTMSms2hcd	35.708	90	100	18.1	0.0028	4.7e-6	7	13936.4	HUMAN	Histone H2A type 1-J
[52-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.01	1.4e-8	966.0894	2	1.4	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-10_FTMSms2hcd	65.442	101	119	30.4	1.4e-8	3.9e-10	10	14019.5	HUMAN	Histone H2A.J
[52-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.01	1.4e-8	526.8020	4	-0.54	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-10_FTMSms2hcd	45.800	83	100	29.6	7.3e-6	4.0e-8	7	14019.5	HUMAN	Histone H2A.J
[52-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.01	1.4e-8	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	14019.5	HUMAN	Histone H2A.J
[52-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	4	35.7	4.01	1.4e-8	424.8989	3	2.2	NDEELNKLLGK	NDEELNKLLGK		11	V20130429-10_FTMSms2hcd	35.708	90	100	18.1	0.0028	4.7e-6	7	14019.5	HUMAN	Histone H2A.J
[52-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	2	21.5	4.01	1.4e-8	966.0894	2	1.4	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-10_FTMSms2hcd	65.442	101	119	30.4	1.4e-8	3.9e-10	10	14135.6	HUMAN	Histone H2A type 1-B/E
[52-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	2	21.5	4.01	1.4e-8	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	14135.6	HUMAN	Histone H2A type 1-B/E
[52-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	2	21.5	4.01	1.4e-8	966.0894	2	1.4	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-10_FTMSms2hcd	65.442	101	119	30.4	1.4e-8	3.9e-10	10	14121.6	HUMAN	Histone H2A type 3
[52-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	2	21.5	4.01	1.4e-8	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	14121.6	HUMAN	Histone H2A type 3
[52-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	2	21.5	4.01	1.4e-8	966.0894	2	1.4	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-10_FTMSms2hcd	65.442	101	119	30.4	1.4e-8	3.9e-10	10	14105.6	HUMAN	Histone H2A type 1-C
[52-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	2	21.5	4.01	1.4e-8	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	14105.6	HUMAN	Histone H2A type 1-C
[52-10]	0	P0C0S5	H2AZ_HUMAN	H2AFZ	1	7.0	1.29	3.7e-4	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	24	32	27.2	3.7e-4	6.2e-7	15	13552.8	HUMAN	Histone H2A.Z
[52-11]	0	P16104	H2AX_HUMAN	H2AFX	1	6.3	1.29	3.7e-4	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	15144.7	HUMAN	Histone H2A.x
[52-12]	0	Q71UI9	H2AV_HUMAN	H2AFV	1	7.0	1.29	3.7e-4	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	24	32	27.2	3.7e-4	6.2e-7	15	13508.8	HUMAN	Histone H2A.V
[52-13]	0	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	1	6.9	1.29	3.7e-4	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	13995.4	HUMAN	Histone H2A type 2-B
[52-14]	0	Q96QV6	H2A1A_HUMAN	HIST1H2AA	1	6.9	1.29	3.7e-4	472.7697	2	0.95	AGLQFPVGR	AGLQFPVGR		9	V20130429-10_FTMSms2hcd	36.619	22	30	27.2	3.7e-4	6.2e-7	15	14233.6	HUMAN	Histone H2A type 1-A
[53]		P12268	IMDH2_HUMAN	IMPDH2	2	9.9	5.31	2.3e-9	687.3594	3	0.14	FVPYLIAGIQHSCQDIGAK	FVPYLIAGIQHSCQDIGAK		19	V20130429-10_FTMSms2hcd	58.792	456	474	39.2	2.3e-9	3.0e-12	1	55805.5	HUMAN	Inosine-5'-monophosphate dehydrogenase 2
[53]		P12268	IMDH2_HUMAN	IMPDH2	2	9.9	5.31	2.3e-9	1093.8679	3	-0.62	ALALGASTVMMGSLLAATTEAPGEYFFSDGIR	ALALGASTVM(Oxidation)M(Oxidation)GSLLAATTEAPGEYFFSDGIR	Oxidation@385;Oxidation@386	32	V20130429-10_FTMSms2hcd	68.847	376	407	21.5	2.1e-6	2.1e-9	1	55805.5	HUMAN	Inosine-5'-monophosphate dehydrogenase 2
[54]		Q16658	FSCN1_HUMAN	FSCN1	1	4.9	8.90	7.1e-16	873.4485	3	2.5	VGKDELFALEQSCAQVVLQAANER	VGKDELFALEQSCAQVVLQAANER		24	V20130429-10_FTMSms2hcd	73.249	248	271	54.8	7.1e-16	1.0e-18	1	54530.4	HUMAN	Fascin
[55]		P06748	NPM_HUMAN	NPM1	2	15.6	4.51	7.4e-9	565.8068	2	1.0	GPSSVEDIKAK	GPSSVEDIKAK		11	V20130429-10_FTMSms2hcd	14.864	240	250	34.0	7.4e-9	1.2e-11	1	32575.3	HUMAN	Nucleophosmin
[55]		P06748	NPM_HUMAN	NPM1	2	15.6	4.51	7.4e-9	918.7291	4	-6.9	TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK	TVSLGAGAKDELHIVEAEAM(Oxidation)NYEGSPIKVTLATLK	Oxidation@65	35	V20130429-10_FTMSms2hcd	62.576	46	80	30.9	2.8e-8	6.7e-11	1	32575.3	HUMAN	Nucleophosmin
[56]		P62829	RL23_HUMAN	RPL23	1	14.3	8.40	5.9e-15	957.0140	2	2.4	ISLGLPVGAVINCADNTGAK	ISLGLPVGAVINCADNTGAK		20	V20130429-10_FTMSms2hcd	58.981	16	35	49.4	5.9e-15	1.2e-17	1	14865.6	HUMAN	60S ribosomal protein L23
[57]		Q15365	PCBP1_HUMAN	PCBP1	1	5.9	8.27	1.0e-14	1089.1005	2	0.58	QVTITGSAASISLAQYLINAR	QVTITGSAASISLAQYLINAR		21	V20130429-10_FTMSms2hcd	63.873	326	346	53.4	1.0e-14	3.3e-17	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[58]		P52272	HNRPM_HUMAN	HNRNPM	1	4.5	8.21	1.3e-14	924.7224	4	3.2	GIGTVTFEQSIEAVQAISMFNGQLLFDRPMHVK	GIGTVTFEQSIEAVQAISM(Oxidation)FNGQLLFDRPM(Oxidation)HVK	Oxidation@263;Oxidation@274	33	V20130429-10_FTMSms2hcd	76.093	245	277	50.5	1.3e-14	2.3e-17	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[59]		P08865	RSSA_HUMAN	RPSA	1	9.2	8.08	2.3e-14	980.4885	3	-2.0	ADHQPLTEASYVNLPTIALCNTDSPLR	ADHQPLTEASYVNLPTIALCNTDSPLR		27	V20130429-10_FTMSms2hcd	59.999	129	155	47.9	2.3e-14	2.8e-17	1	32854.4	HUMAN	40S ribosomal protein SA
[60]		O75531	BAF_HUMAN	BANF1	2	14.6	4.27	6.1e-9	493.3098	3	0.51	AYVVLGQFLVLKK	AYVVLGQFLVLKK		13	V20130429-10_FTMSms2hcd	56.004	42	54	29.1	6.1e-9	2.4e-10	1	10058.7	HUMAN	Barrier-to-autointegration factor
[60]		O75531	BAF_HUMAN	BANF1	2	14.6	4.27	6.1e-9	675.4139	2	1.0	AYVVLGQFLVLK	AYVVLGQFLVLK		12	V20130429-10_FTMSms2hcd	64.114	42	53	31.1	6.4e-8	1.1e-9	1	10058.7	HUMAN	Barrier-to-autointegration factor
[61]		P14174	MIF_HUMAN	MIF	2	18.3	4.79	2.5e-8	652.3438	2	-1.8	MPMFIVNTNVPR	M(Met-loss)PM(Oxidation)FIVNTNVPR	Met-loss@1;Oxidation@3	12	V20130429-10_FTMSms2hcd	36.855	1	12	29.4	2.5e-8	3.4e-11	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[61]		P14174	MIF_HUMAN	MIF	2	18.3	4.79	2.5e-8	494.2866	2	0.36	LLCGLLAER	LLCGLLAER		9	V20130429-10_FTMSms2hcd	46.742	79	87	39.7	2.9e-5	5.0e-8	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[62]		P38646	GRP75_HUMAN	HSPA9	2	3.4	5.19	2.1e-10	725.8639	2	2.3	TTPSVVAFTADGER	TTPSVVAFTADGER		14	V20130429-10_FTMSms2hcd	35.936	86	99	32.5	2.1e-10	2.8e-13	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[62]		P38646	GRP75_HUMAN	HSPA9	2	3.4	5.19	2.1e-10	479.7511	2	-0.32	VLENAEGAR	VLENAEGAR		9	V20130429-10_FTMSms2hcd	10.922	77	85	25.8	1.2e-5	2.2e-8	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[63]		P05387	RLA2_HUMAN	RPLP2	2	24.3	4.45	4.9e-9	591.6400	3	1.7	ILDSVGIEADDDRLNK	ILDSVGIEADDDRLNK		16	V20130429-10_FTMSms2hcd	35.232	26	41	24.7	4.9e-9	6.5e-12	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[63]		P05387	RLA2_HUMAN	RPLP2	2	24.3	4.45	4.9e-9	628.8456	2	-0.45	NIEDVIAQGIGK	NIEDVIAQGIGK		12	V20130429-10_FTMSms2hcd	47.525	50	61	32.4	6.2e-7	1.2e-9	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[64]		P11940	PABP1_HUMAN	PABPC1	1	2.5	7.69	1.2e-13	875.4286	2	-0.98	ALYDTFSAFGNILSCK	ALYDTFSAFGNILSCK		16	V20130429-10_FTMSms2hcd	67.972	114	129	40.8	1.2e-13	1.3e-16	2	70671.5	HUMAN	Polyadenylate-binding protein 1
[64-1]	0	Q13310	PABP4_HUMAN	PABPC4	1	2.5	7.69	1.2e-13	875.4286	2	-0.98	ALYDTFSAFGNILSCK	ALYDTFSAFGNILSCK		16	V20130429-10_FTMSms2hcd	67.972	114	129	40.8	1.2e-13	1.3e-16	2	70783.5	HUMAN	Polyadenylate-binding protein 4
[65]		P50991	TCPD_HUMAN	CCT4	1	4.8	7.51	1.9e-13	855.4285	3	-2.0	AQDIEAGDGTTSVVIIAGSLLDSCTK	AQDIEAGDGTTSVVIIAGSLLDSCTK		26	V20130429-10_FTMSms2hcd	73.719	97	122	39.2	1.9e-13	2.2e-16	1	57924.8	HUMAN	T-complex protein 1 subunit delta
[66]		P35232	PHB_HUMAN	PHB	1	8.8	7.28	7.3e-13	791.0919	3	4.0	FGLALAVAGGVVNSALYNVDAGHR	FGLALAVAGGVVNSALYNVDAGHR		24	V20130429-10_FTMSms2hcd	66.928	12	35	40.8	7.3e-13	1.6e-15	1	29804.3	HUMAN	Prohibitin
[67]		P00441	SODC_HUMAN	SOD1	1	23.4	7.27	7.4e-13	916.7029	4	-0.58	HVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGR	HVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGR		36	V20130429-10_FTMSms2hcd	57.400	81	116	42.8	7.4e-13	8.6e-16	1	15935.9	HUMAN	Superoxide dismutase [Cu-Zn]
[68]		P11586	C1TC_HUMAN	MTHFD1	2	2.5	5.48	1.5e-9	752.8599	2	-0.023	TDPTTLTDEEINR	TDPTTLTDEEINR		13	V20130429-10_FTMSms2hcd	29.985	505	517	42.0	1.5e-9	1.9e-12	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[68]		P11586	C1TC_HUMAN	MTHFD1	2	2.5	5.48	1.5e-9	456.7610	2	-0.20	MAPAEILNGK	M(Met-loss)APAEILNGK	Met-loss@1	10	V20130429-10_FTMSms2hcd	43.600	1	10	12.8	0.012	5.1e-5	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[69]		O43175	SERA_HUMAN	PHGDH	1	6.4	7.04	5.5e-13	889.2310	4	5.2	SLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMR	SLTGVVNAQALTSAFSPHTKPWIGLAEALGTLM(Oxidation)R	Oxidation@343	34	V20130429-10_FTMSms2hcd	74.801	311	344	37.0	5.5e-13	2.5e-15	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[70]		Q15843	NEDD8_HUMAN	NEDD8	1	17.3	6.70	1.3e-13	730.9685	2	-0.97	ILGGSVLHLVLALR	ILGGSVLHLVLALR		14	V20130429-10_FTMSms2hcd	67.541	61	74	30.3	1.3e-13	1.2e-14	1	9071.6	HUMAN	NEDD8
[71]		Q5JRK9	GGEE3_HUMAN	PAGE2B	1	10.8	6.69	6.8e-12	649.7967	2	0.17	IEDEPGDGPDVR	IEDEPGDGPDVR		12	V20130429-10_FTMSms2hcd	19.773	80	91	39.4	6.8e-12	9.8e-15	2	12041.1	HUMAN	Putative G antigen family E member 3
[71-1]	0	Q7Z2X7	GGEE2_HUMAN	PAGE2	1	10.8	6.69	6.8e-12	649.7967	2	0.17	IEDEPGDGPDVR	IEDEPGDGPDVR		12	V20130429-10_FTMSms2hcd	19.773	80	91	39.4	6.8e-12	9.8e-15	2	12090.2	HUMAN	G antigen family E member 2
[72]		P78371	TCPB_HUMAN	CCT2	1	2.8	6.56	1.8e-12	759.4506	2	0.11	LTSFIGAIAIGDLVK	LTSFIGAIAIGDLVK		15	V20130429-10_FTMSms2hcd	67.718	26	40	35.0	1.8e-12	1.3e-14	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[73]		Q00610	CLH1_HUMAN	CLTC	1	0.7	6.56	1.6e-11	667.8202	2	-0.30	IYIDSNNNPER	IYIDSNNNPER		11	V20130429-10_FTMSms2hcd	21.325	882	892	41.4	1.6e-11	2.0e-14	1	191616.3	HUMAN	Clathrin heavy chain 1
[74]		P11766	ADHX_HUMAN	ADH5	1	7.5	6.49	1.0e-11	948.1921	3	14	GWGVSVVVGVAASGEEIATRPFQLVTGR	GWGVSVVVGVAASGEEIATRPFQLVTGR		28	V20130429-10_FTMSms2hcd	76.425	285	312	38.4	1.0e-11	5.5e-14	1	39724.6	HUMAN	Alcohol dehydrogenase class-3
[75]		P18124	RL7_HUMAN	RPL7	1	7.7	6.17	2.2e-12	705.9979	3	-0.51	TTHFVEGGDAGNREDQINR	TTHFVEGGDAGNREDQINR		19	V20130429-10_FTMSms2hcd	19.666	224	242	31.6	2.2e-12	2.2e-15	1	29226.0	HUMAN	60S ribosomal protein L7
[76]		P02768	ALBU_HUMAN	ALB	3	4.3	2.71	1.6e-5	693.8146	2	0.98	YICENQDSISSK	YICENQDSISSK		12	V20130429-10_FTMSms2hcd	22.170	287	298	20.9	1.6e-5	2.2e-8	1	69367.4	HUMAN	Serum albumin
[76]		P02768	ALBU_HUMAN	ALB	3	4.3	2.71	1.6e-5	464.2507	2	0.73	YLYEIAR	YLYEIAR		7	V20130429-10_FTMSms2hcd	31.140	162	168	32.6	0.0012	2.8e-6	1	69367.4	HUMAN	Serum albumin
[76]		P02768	ALBU_HUMAN	ALB	3	4.3	2.71	1.6e-5	395.2397	2	0.60	LVTDLTK	LVTDLTK		7	V20130429-10_FTMSms2hcd	21.980	258	264	33.9	0.0013	3.5e-6	1	69367.4	HUMAN	Serum albumin
[77]		P46776	RL27A_HUMAN	RPL27A	1	7.4	5.98	1.1e-10	556.3265	2	-1.1	TGAAPIIDVVR	TGAAPIIDVVR		11	V20130429-10_FTMSms2hcd	39.092	95	105	38.8	1.1e-10	5.5e-13	1	16561.5	HUMAN	60S ribosomal protein L27a
[78]		P35579	MYH9_HUMAN	MYH9	2	1.5	4.57	3.0e-10	808.0017	2	1.2	VISGVLQLGNIVFKK	VISGVLQLGNIVFKK		15	V20130429-10_FTMSms2hcd	57.948	342	356	27.1	3.0e-10	8.8e-12	1	226534.2	HUMAN	Myosin-9
[78]		P35579	MYH9_HUMAN	MYH9	2	1.5	4.57	3.0e-10	572.9149	3	-0.064	TEMEDLMSSKDDVGK	TEM(Oxidation)EDLM(Oxidation)SSKDDVGK	Oxidation@1506;Oxidation@1510	15	V20130429-10_FTMSms2hcd	15.645	1504	1518	15.2	5.3e-4	7.5e-7	1	226534.2	HUMAN	Myosin-9
[79]		P62701	RS4X_HUMAN	RPS4X	2	6.5	3.78	3.3e-7	608.8602	2	0.74	ECLPLIIFLR	ECLPLIIFLR		10	V20130429-10_FTMSms2hcd	73.002	40	49	35.6	3.3e-7	1.1e-9	1	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[79]		P62701	RS4X_HUMAN	RPS4X	2	6.5	3.78	3.3e-7	416.2326	2	1.0	LTIAEER	LTIAEER		7	V20130429-10_FTMSms2hcd	19.308	246	252	14.4	8.1e-4	1.2e-6	2	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[80]		P13804	ETFA_HUMAN	ETFA	1	7.8	5.71	9.7e-11	675.1210	4	-0.83	IVAPELYIAVGISGAIQHLAGMKDSK	IVAPELYIAVGISGAIQHLAGM(Oxidation)KDSK	Oxidation@290	26	V20130429-10_FTMSms2hcd	74.624	269	294	35.8	9.7e-11	3.0e-13	1	35079.9	HUMAN	Electron transfer flavoprotein subunit alpha, mitochondrial
[81]		P46782	RS5_HUMAN	RPS5	1	7.4	5.30	3.5e-10	787.9092	2	1.1	TIAECLADELINAAK	TIAECLADELINAAK		15	V20130429-10_FTMSms2hcd	66.058	168	182	34.7	3.5e-10	4.7e-13	1	22876.6	HUMAN	40S ribosomal protein S5
[82]		Q02878	RL6_HUMAN	RPL6	2	11.5	4.27	1.9e-9	628.0507	4	-1.3	HQEGEIFDTEKEKYEITEQR	HQEGEIFDTEKEKYEITEQR		20	V20130429-10_FTMSms2hcd	31.802	227	246	28.4	1.9e-9	1.8e-12	1	32728.2	HUMAN	60S ribosomal protein L6
[82]		Q02878	RL6_HUMAN	RPL6	2	11.5	4.27	1.9e-9	823.9031	2	3.7	NPVLVRGIGRYSR	NPVLVRGIGRY(Phospho)S(Phospho)R	Phospho@57;Phospho@58	13	V20130429-10_FTMSms2hcd	41.284	47	59	12.8	0.0024	2.8e-6	1	32728.2	HUMAN	60S ribosomal protein L6
[83]		P46777	RL5_HUMAN	RPL5	1	6.1	5.17	4.7e-9	624.0010	3	-0.37	VGLTNYAAAYCTGLLLAR	VGLTNYAAAYCTGLLLAR		18	V20130429-10_FTMSms2hcd	67.489	90	107	39.5	4.7e-9	8.3e-12	1	34362.9	HUMAN	60S ribosomal protein L5
[84]		P32322	P5CR1_HUMAN	PYCR1	1	3.1	5.09	2.8e-10	568.2853	2	3.1	CMTNTPVVVR	CM(Oxidation)TNTPVVVR	Oxidation@121	10	V20130429-10_FTMSms2hcd	20.739	120	129	32.1	2.8e-10	4.2e-13	1	33360.9	HUMAN	Pyrroline-5-carboxylate reductase 1, mitochondrial
[85]		P26599	PTBP1_HUMAN	PTBP1	1	3.4	4.93	9.4e-10	680.3716	3	2.1	VTPQSLFILFGVYGDVQR	VTPQSLFILFGVYGDVQR		18	V20130429-10_FTMSms2hcd	74.827	349	366	33.4	9.4e-10	2.2e-12	1	57221.8	HUMAN	Polypyrimidine tract-binding protein 1
[86]		P62847	RS24_HUMAN	RPS24	1	9.0	4.91	7.0e-10	699.8757	2	1.8	TTPDVIFVFGFR	TTPDVIFVFGFR		12	V20130429-10_FTMSms2hcd	65.589	50	61	32.5	7.0e-10	1.3e-12	1	15423.3	HUMAN	40S ribosomal protein S24
[87]		P62081	RS7_HUMAN	RPS7	1	11.9	4.90	3.4e-9	631.6016	4	1.1	TLTAVHDAILEDLVFPSEIVGKR	TLTAVHDAILEDLVFPSEIVGKR		23	V20130429-10_FTMSms2hcd	64.963	121	143	36.1	3.4e-9	1.4e-11	1	22127.0	HUMAN	40S ribosomal protein S7
[88]		P17844	DDX5_HUMAN	DDX5	2	3.4	3.68	6.0e-9	648.3304	2	4.4	TTYLVLDEADR	TTYLVLDEADR		11	V20130429-10_FTMSms2hcd	38.132	242	252	25.2	6.0e-9	7.7e-12	1	69148.7	HUMAN	Probable ATP-dependent RNA helicase DDX5
[88]		P17844	DDX5_HUMAN	DDX5	2	3.4	3.68	6.0e-9	626.8182	2	0.86	TAQEVETYRR	TAQEVETYRR		10	V20130429-10_FTMSms2hcd	11.633	69	78	15.7	2.6e-4	3.5e-7	1	69148.7	HUMAN	Probable ATP-dependent RNA helicase DDX5
[89]		O60812	HNRCL_HUMAN	HNRNPCL1	1	4.1	4.76	3.2e-9	658.8999	2	-0.85	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-10_FTMSms2hcd	51.830	18	29	34.5	3.2e-9	2.7e-11	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[89-1]	0	P07910	HNRPC_HUMAN	HNRNPC	1	3.9	4.76	3.2e-9	658.8999	2	-0.85	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-10_FTMSms2hcd	51.830	18	29	34.5	3.2e-9	2.7e-11	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[90]		P23284	PPIB_HUMAN	PPIB	1	6.0	4.70	4.2e-8	682.8589	2	3.6	TVDNFVALATGEK	TVDNFVALATGEK		13	V20130429-10_FTMSms2hcd	45.382	72	84	41.2	4.2e-8	6.1e-11	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[91]		Q15417	CNN3_HUMAN	CNN3	1	4.0	4.62	2.9e-11	666.7872	2	0.021	CASQAGMTAYGTR	CASQAGM(Oxidation)TAYGTR	Oxidation@179	13	V20130429-10_FTMSms2hcd	10.686	173	185	22.1	2.9e-11	5.7e-14	1	36414.0	HUMAN	Calponin-3
[92]		O00299	CLIC1_HUMAN	CLIC1	1	3.3	4.57	1.2e-9	533.3118	2	-0.20	LFMVLWLK	LFM(Oxidation)VLWLK	Oxidation@32	8	V20130429-10_FTMSms2hcd	60.227	30	37	30.2	1.2e-9	4.5e-12	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[93]		P05388	RLA0_HUMAN	RPLP0	2	6.6	3.03	5.5e-7	609.3423	2	-0.24	IIQLLDDYPK	IIQLLDDYPK		10	V20130429-10_FTMSms2hcd	45.986	17	26	29.3	5.5e-7	1.1e-9	2	34273.8	HUMAN	60S acidic ribosomal protein P0
[93]		P05388	RLA0_HUMAN	RPLP0	2	6.6	3.03	5.5e-7	611.3159	2	1.9	GHLENNPALEK	GHLENNPALEK		11	V20130429-10_FTMSms2hcd	15.023	67	77	22.5	3.7e-4	5.6e-7	2	34273.8	HUMAN	60S acidic ribosomal protein P0
[93-1]	0	Q8NHW5	RLA0L_HUMAN	RPLP0P6	2	6.6	3.03	5.5e-7	609.3423	2	-0.24	IIQLLDDYPK	IIQLLDDYPK		10	V20130429-10_FTMSms2hcd	45.986	17	26	29.3	5.5e-7	1.1e-9	2	34364.8	HUMAN	60S acidic ribosomal protein P0-like
[93-1]	0	Q8NHW5	RLA0L_HUMAN	RPLP0P6	2	6.6	3.03	5.5e-7	611.3159	2	1.9	GHLENNPALEK	GHLENNPALEK		11	V20130429-10_FTMSms2hcd	15.023	67	77	22.5	3.7e-4	5.6e-7	2	34364.8	HUMAN	60S acidic ribosomal protein P0-like
[94]		Q00839	HNRPU_HUMAN	HNRNPU	1	3.3	4.46	3.2e-10	1044.1722	3	3.0	GNFTLPEVAECFDEITYVELQKEEAQK	GNFTLPEVAECFDEITYVELQKEEAQK		27	V20130429-10_FTMSms2hcd	74.490	638	664	26.1	3.2e-10	3.2e-13	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[95]		P29692	EF1D_HUMAN	EEF1D	1	3.6	4.42	2.8e-8	536.7744	2	-0.62	MATNFLAHEK	M(Met-loss+Acetyl)ATNFLAHEK	Met-loss+Acetyl@1	10	V20130429-10_FTMSms2hcd	32.489	1	10	36.2	2.8e-8	4.7e-11	1	31122.1	HUMAN	Elongation factor 1-delta
[96]		Q06830	PRDX1_HUMAN	PRDX1	1	5.0	4.29	3.6e-9	554.3079	2	3.7	TIAQDYGVLK	TIAQDYGVLK		10	V20130429-10_FTMSms2hcd	32.756	111	120	30.1	3.6e-9	7.6e-12	1	22110.5	HUMAN	Peroxiredoxin-1
[97]		P50990	TCPQ_HUMAN	CCT8	3	9.5	3.08	9.2e-7	575.7988	2	1.0	FAEAFEAIPR	FAEAFEAIPR		10	V20130429-10_FTMSms2hcd	41.470	441	450	31.0	9.2e-7	1.6e-9	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[97]		P50990	TCPQ_HUMAN	CCT8	3	9.5	3.08	9.2e-7	929.4883	4	15	NVGLDIEAEVPAVKDMLEAGILDTYLGKYWAIK	NVGLDIEAEVPAVKDMLEAGILDT(Phospho)YLGKYWAIK	Phospho@500=11	33	V20130429-10_FTMSms2hcd	66.623	477	509	12.8	0.021	5.1e-5	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[97]		P50990	TCPQ_HUMAN	CCT8	3	9.5	3.08	9.2e-7	443.2618	2	1.2	TVGATALPR	TVGATALPR		9	V20130429-10_FTMSms2hcd	39.509	327	335	16.4	0.091	3.2e-4	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[98]		P62913	RL11_HUMAN	RPL11	1	7.9	4.12	3.2e-9	773.9280	2	0.77	VLEQLTGQTPVFSK	VLEQLTGQTPVFSK		14	V20130429-10_FTMSms2hcd	42.516	39	52	28.1	3.2e-9	7.3e-12	1	20252.6	HUMAN	60S ribosomal protein L11
[99]		P31949	S10AB_HUMAN	S100A11	1	8.6	4.11	9.6e-8	510.2538	2	-0.055	ISSPTETER	ISSPTETER		9	V20130429-10_FTMSms2hcd	12.178	4	12	36.0	9.6e-8	1.6e-10	1	11740.6	HUMAN	Protein S100-A11
[100]		Q9NR30	DDX21_HUMAN	DDX21	1	1.4	3.78	4.9e-7	633.3616	2	1.5	TFSFAIPLIEK	TFSFAIPLIEK		11	V20130429-10_FTMSms2hcd	62.154	237	247	36.5	4.9e-7	1.6e-9	1	87345.1	HUMAN	Nucleolar RNA helicase 2
[101]		P55854	SUMO3_HUMAN	SUMO3	1	11.7	3.68	1.2e-8	617.8238	2	-1.9	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-10_FTMSms2hcd	27.339	21	32	26.8	1.2e-8	1.8e-11	3	11637.1	HUMAN	Small ubiquitin-related modifier 3
[101-1]	0	P61956	SUMO2_HUMAN	SUMO2	1	12.6	3.68	1.2e-8	617.8238	2	-1.9	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-10_FTMSms2hcd	27.339	22	33	26.8	1.2e-8	1.8e-11	3	10871.3	HUMAN	Small ubiquitin-related modifier 2
[101-2]	0	Q6EEV6	SUMO4_HUMAN	SUMO4	1	12.6	3.68	1.2e-8	617.8238	2	-1.9	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-10_FTMSms2hcd	27.339	22	33	26.8	1.2e-8	1.8e-11	3	10685.2	HUMAN	Small ubiquitin-related modifier 4
[102]		P22234	PUR6_HUMAN	PAICS	1	2.8	3.56	9.1e-8	593.3455	2	-0.034	MATAEVLNIGKK	M(Met-loss+Acetyl)ATAEVLNIGKK	Met-loss+Acetyl@1	12	V20130429-10_FTMSms2hcd	37.147	1	12	30.4	9.1e-8	1.9e-10	1	47079.7	HUMAN	Multifunctional protein ADE2
[103]		P07237	PDIA1_HUMAN	P4HB	1	1.8	3.52	1.2e-7	533.7624	2	1.1	TVIDYNGER	TVIDYNGER		9	V20130429-10_FTMSms2hcd	21.114	453	461	30.7	1.2e-7	2.0e-10	1	57116.8	HUMAN	Protein disulfide-isomerase
[104]		P49006	MRP_HUMAN	MARCKSL1	1	4.1	3.45	7.8e-8	494.2549	2	0.22	LSGLSFKR	LSGLS(Phospho)FKR	Phospho@104=19	8	V20130429-10_FTMSms2hcd	30.187	100	107	28.9	7.8e-8	1.4e-10	1	19528.9	HUMAN	MARCKS-related protein
[105]		P05386	RLA1_HUMAN	RPLP1	1	14.0	3.39	1.2e-8	851.9532	2	2.3	AAGVNVEPFWPGLFAK	AAGVNVEPFWPGLFAK		16	V20130429-10_FTMSms2hcd	64.525	34	49	23.9	1.2e-8	1.9e-11	1	11514.0	HUMAN	60S acidic ribosomal protein P1
[106]		P46778	RL21_HUMAN	RPL21	1	11.2	3.38	7.9e-9	1047.5094	2	0.73	TNGKEPELLEPIPYEFMA	TNGKEPELLEPIPYEFM(Oxidation)A	Oxidation@159	18	V20130429-10_FTMSms2hcd	57.439	143	160	22.8	7.9e-9	7.8e-12	1	18565.0	HUMAN	60S ribosomal protein L21
[107]		P42025	ACTY_HUMAN	ACTR1B	1	5.1	3.37	5.5e-9	700.7194	3	2.9	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-10_FTMSms2hcd	70.423	337	355	21.9	5.5e-9	1.4e-11	2	42293.8	HUMAN	Beta-centractin
[107-1]	0	P61163	ACTZ_HUMAN	ACTR1A	1	5.1	3.37	5.5e-9	700.7194	3	2.9	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-10_FTMSms2hcd	70.423	337	355	21.9	5.5e-9	1.4e-11	2	42614.1	HUMAN	Alpha-centractin
[108]		Q6UXB4	CLC4G_HUMAN	CLEC4G	1	3.8	3.32	8.1e-7	597.3415	2	10	AALLDGHDLLR	AALLDGHDLLR		11	V20130429-10_FTMSms2hcd	37.226	61	71	33.1	8.1e-7	2.6e-9	1	32562.0	HUMAN	C-type lectin domain family 4 member G
[109]		P62826	RAN_HUMAN	RAN	1	6.5	3.24	1.5e-8	595.6417	3	-0.74	SNYNFEKPFLWLAR	SNYNFEKPFLWLAR		14	V20130429-10_FTMSms2hcd	58.055	153	166	23.0	1.5e-8	2.0e-11	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[110]		P14625	ENPL_HUMAN	HSP90B1	1	0.9	3.07	7.5e-8	438.7330	2	1.5	TFEINPR	TFEINPR		7	V20130429-10_FTMSms2hcd	26.124	684	690	25.0	7.5e-8	1.2e-10	2	92469.6	HUMAN	Endoplasmin
[110-1]	0	Q58FF3	ENPLL_HUMAN	HSP90B2P	1	1.8	3.07	7.5e-8	438.7330	2	1.5	TFEINPR	TFEINPR		7	V20130429-10_FTMSms2hcd	26.124	323	329	25.0	7.5e-8	1.2e-10	2	45859.4	HUMAN	Putative endoplasmin-like protein
[111]		P62851	RS25_HUMAN	RPS25	1	7.2	2.72	6.2e-6	486.7899	2	0.10	AALQELLSK	AALQELLSK		9	V20130429-10_FTMSms2hcd	39.428	86	94	31.9	6.2e-6	1.3e-8	1	13742.2	HUMAN	40S ribosomal protein S25
[112]		Q01469	FABP5_HUMAN	FABP5	1	7.4	2.53	2.4e-6	522.2783	2	1.3	MATVQQLEGR	M(Met-loss+Acetyl)ATVQQLEGR	Met-loss+Acetyl@1	10	V20130429-10_FTMSms2hcd	30.859	1	10	27.8	2.4e-6	4.5e-9	1	15164.6	HUMAN	Fatty acid-binding protein, epidermal
[113]		Q8NC51	PAIRB_HUMAN	SERBP1	1	5.1	2.53	2.6e-8	1052.4929	2	3.3	TDKSSASAPDVDDPEAFPALA	TDKSSASAPDVDDPEAFPALA		21	V20130429-10_FTMSms2hcd	45.999	388	408	17.1	2.6e-8	2.7e-11	1	44965.7	HUMAN	Plasminogen activator inhibitor 1 RNA-binding protein
[114]		P61254	RL26_HUMAN	RPL26	1	6.2	2.43	1.5e-7	360.1899	3	0.98	HFNAPSHIR	HFNAPSHIR		9	V20130429-10_FTMSms2hcd	14.972	18	26	20.3	1.5e-7	2.3e-10	1	17258.4	HUMAN	60S ribosomal protein L26
[115]		P62750	RL23A_HUMAN	RPL23A	1	7.7	2.33	6.4e-6	685.3930	2	-0.78	VNTLIRPDGEKK	VNTLIRPDGEKK		12	V20130429-10_FTMSms2hcd	16.480	124	135	28.1	6.4e-6	2.1e-8	1	17695.2	HUMAN	60S ribosomal protein L23a
[116]		Q9NR33	DPOE4_HUMAN	POLE4	1	9.4	2.30	2.3e-7	636.3214	2	5.7	AAELFVETIAK	AAELFVET(Phospho)IAK	Phospho@77	11	V20130429-10_FTMSms2hcd	35.206	70	80	19.9	2.3e-7	3.4e-10	1	12208.9	HUMAN	DNA polymerase epsilon subunit 4
[117]		P13010	XRCC5_HUMAN	XRCC5	1	1.2	2.18	1.5e-6	516.3109	2	0.93	TLFPLIEAK	TLFPLIEAK		9	V20130429-10_FTMSms2hcd	50.976	535	543	23.1	1.5e-6	6.2e-9	1	82705.3	HUMAN	X-ray repair cross-complementing protein 5
[118]		Q12882	DPYD_HUMAN	DPYD	2	1.5	1.10	0.0016	920.4275	2	14	SLSVNEMTLSTLKEK	SLSVNEMT(Phospho)LS(Phospho)TLKEK	Phospho@267&269|267&270|269&270	15	V20130429-10_FTMSms2hcd	28.612	260	274	28.6	0.0016	1.7e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[118]		Q12882	DPYD_HUMAN	DPYD	2	1.5	1.10	0.0016	928.4114	2	-0.25	SLSVNEMTLSTLKEK	S(Phospho)LSVNEM(Oxidation)T(Phospho)LSTLKEK	Oxidation@266;Phospho@260&262|260&267|260&269|260&270|262&267|262&269|262&270|267&269|267&270|269&270	15	V20130429-10_FTMSms2hcd	28.814	260	274	18.6	0.0052	5.9e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[119]		Q68DN1	CB016_HUMAN	C2orf16	1	0.6	1.83	1.0e-6	709.2800	2	8.1	IGATQTSTASLK	IGATQT(Phospho)S(Phospho)T(Phospho)ASLK	Phospho@1332=17;Phospho@1333=17;Phospho@1334=17	12	V20130429-10_FTMSms2hcd	14.808	1327	1338	18.8	1.0e-6	2.7e-9	1	224323.2	HUMAN	Uncharacterized protein C2orf16
[120]		Q6ZQQ6	WDR87_HUMAN	WDR87	1	0.3	1.64	1.1e-5	610.8130	2	-0.32	EEKALNLEMK	EEKALNLEM(Oxidation)K	Oxidation@1967	10	V20130429-10_FTMSms2hcd	37.479	1959	1968	22.4	1.1e-5	1.6e-8	1	333188.0	HUMAN	WD repeat-containing protein 87
[121]		P21291	CSRP1_HUMAN	CSRP1	1	5.2	1.54	5.5e-5	535.2528	2	0.049	CSQAVYAAEK	CSQAVYAAEK		10	V20130429-10_FTMSms2hcd	12.897	122	131	25.2	5.5e-5	8.5e-8	1	20567.6	HUMAN	Cysteine and glycine-rich protein 1
[122]		P62316	SMD2_HUMAN	SNRPD2	2	16.9	1.13	3.7e-5	507.6260	3	1.1	MFLRGDSVIVVLR	M(Oxidation)FLRGDSVIVVLR	Oxidation@99	13	V20130429-10_FTMSms2hcd	47.048	99	111	20.2	3.7e-5	1.4e-7	1	13527.0	HUMAN	Small nuclear ribonucleoprotein Sm D2
[122]		P62316	SMD2_HUMAN	SNRPD2	2	16.9	1.13	3.7e-5	554.3274	4	3.9	MFLRGDSVIVVLRNPLIAGK	M(Oxidation)FLRGDSVIVVLRNPLIAGK	Oxidation@99	20	V20130429-10_FTMSms2hcd	56.715	99	118	13.7	8.3e-4	1.4e-5	1	13527.0	HUMAN	Small nuclear ribonucleoprotein Sm D2
[123]		A6NHP6	YR011_HUMAN		1	3.1	1.33	3.4e-7	727.2906	2	-6.5	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-10_FTMSms2hcd	29.168	173	182	11.2	3.4e-7	7.9e-10	2	37918.4	HUMAN	NPIP-like protein LOC729602
[123-1]	0	A8MZ50	NPIL4_HUMAN		1	3.0	1.33	3.4e-7	727.2906	2	-6.5	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-10_FTMSms2hcd	29.168	173	182	11.2	3.4e-7	7.9e-10	2	38380.9	HUMAN	Putative NPIP-like protein ENSP00000381263
[124]		P62753	RS6_HUMAN	RPS6	1	3.2	1.32	1.5e-4	494.7513	2	0.77	LIEVDDER	LIEVDDER		8	V20130429-10_FTMSms2hcd	22.247	15	22	25.4	1.5e-4	2.9e-7	1	28680.9	HUMAN	40S ribosomal protein S6
[125]		Q7Z2K8	GRIN1_HUMAN	GPRIN1	1	1.6	1.25	1.8e-4	807.4532	2	-7.3	VGSLPLEKGSPVTTTK	VGSLPLEKGSPVTTTK		16	V20130429-10_FTMSms2hcd	74.262	606	621	25.1	1.8e-4	4.9e-7	1	102400.1	HUMAN	G protein-regulated inducer of neurite outgrowth 1
[126]		P15153	RAC2_HUMAN	RAC2	1	4.2	1.21	1.4e-5	475.7503	2	-0.89	TVFDEAIR	TVFDEAIR		8	V20130429-10_FTMSms2hcd	32.515	167	174	18.7	1.4e-5	2.7e-8	3	21429.0	HUMAN	Ras-related C3 botulinum toxin substrate 2
[126-1]	0	P60763	RAC3_HUMAN	RAC3	1	4.2	1.21	1.4e-5	475.7503	2	-0.89	TVFDEAIR	TVFDEAIR		8	V20130429-10_FTMSms2hcd	32.515	167	174	18.7	1.4e-5	2.7e-8	3	21379.1	HUMAN	Ras-related C3 botulinum toxin substrate 3
[126-2]	0	P63000	RAC1_HUMAN	RAC1	1	4.2	1.21	1.4e-5	475.7503	2	-0.89	TVFDEAIR	TVFDEAIR		8	V20130429-10_FTMSms2hcd	32.515	167	174	18.7	1.4e-5	2.7e-8	3	21450.3	HUMAN	Ras-related C3 botulinum toxin substrate 1
[127]		Q8IUG5	MY18B_HUMAN	MYO18B	1	0.3	1.18	1.0e-4	442.7368	2	0.54	QMVLHEK	QMVLHEK		7	V20130429-10_FTMSms2hcd	33.998	1769	1775	23.1	1.0e-4	2.4e-7	1	285187.1	HUMAN	Unconventional myosin-XVIIIb
[128]		Q9BZ72	PITM2_HUMAN	PITPNM2	1	0.5	1.18	0.0028	435.2580	2	-0.43	LEPLLER	LEPLLER		7	V20130429-10_FTMSms2hcd	30.889	769	775	30.8	0.0028	1.2e-5	1	148934.5	HUMAN	Membrane-associated phosphatidylinositol transfer protein 2
[129]		Q5VVM6	CCD30_HUMAN	CCDC30	1	1.5	1.13	8.6e-5	695.3239	2	3.8	EGQKEEGSQQNR	EGQKEEGSQQNR		12	V20130429-10_FTMSms2hcd	25.277	166	177	22.1	8.6e-5	1.1e-7	1	91334.1	HUMAN	Coiled-coil domain-containing protein 30
[130]		Q6ZVZ8	ASB18_HUMAN	ASB18	1	4.9	1.07	1.0e-4	1106.0571	2	12	GAHVDARNGRGETALSAACGAAR	GAHVDARNGRGETALSAACGAAR		23	V20130429-10_FTMSms2hcd	45.558	242	264	22.0	1.0e-4	1.2e-7	1	50803.8	HUMAN	Ankyrin repeat and SOCS box protein 18
[131]		P84074	HPCA_HUMAN	HPCA	1	5.2	1.04	0.0012	643.8455	2	-3.7	LRPEMLQDLR	LRPEM(Oxidation)LQDLR	Oxidation@12	10	V20130429-10_FTMSms2hcd	15.472	8	17	27.4	0.0012	1.9e-6	1	22427.6	HUMAN	Neuron-specific calcium-binding protein hippocalcin
[132]		Q9UHC7	MKRN1_HUMAN	MKRN1	1	2.3	0.95	2.8e-5	760.7844	2	-13	VGTSSRYRAQR	VGT(Phospho)SS(Phospho)RY(Phospho)RAQR	Phospho@407=20;Phospho@409=29;Phospho@411=49	11	V20130429-10_FTMSms2hcd	12.440	405	415	17.7	2.8e-5	9.7e-8	1	53350.0	HUMAN	E3 ubiquitin-protein ligase makorin-1
[133]		O75369	FLNB_HUMAN	FLNB	1	0.3	0.80	1.2e-4	504.2689	2	3.6	IQQNTFTR	IQQNTFTR		8	V20130429-10_FTMSms2hcd	15.993	17	24	19.7	1.2e-4	2.3e-7	3	278166.3	HUMAN	Filamin-B
[133-1]	0	P21333	FLNA_HUMAN	FLNA	1	0.3	0.80	1.2e-4	504.2689	2	3.6	IQQNTFTR	IQQNTFTR		8	V20130429-10_FTMSms2hcd	15.993	44	51	19.7	1.2e-4	2.3e-7	3	280741.3	HUMAN	Filamin-A
[133-2]	0	Q14315	FLNC_HUMAN	FLNC	1	0.3	0.80	1.2e-4	504.2689	2	3.6	IQQNTFTR	IQQNTFTR		8	V20130429-10_FTMSms2hcd	15.993	37	44	19.7	1.2e-4	2.3e-7	3	291024.6	HUMAN	Filamin-C
[134]		Q9UNH5	CC14A_HUMAN	CDC14A	1	2.7	0.76	1.2e-5	890.4020	2	19	ILSGLDDMSIGGNLSK	ILS(Phospho)GLDDMS(Phospho)IGGNLSK	Phospho@357=20;Phospho@363|369	16	V20130429-10_FTMSms2hcd	44.031	355	370	13.9	1.2e-5	1.4e-8	1	66574.5	HUMAN	Dual specificity protein phosphatase CDC14A
[135]		O95466	FMNL_HUMAN	FMNL1	1	0.9	0.74	7.6e-4	569.2689	2	0.48	RDSELGPGVK	RDS(Phospho)ELGPGVK	Phospho@624	10	V20130429-10_FTMSms2hcd	16.891	622	631	23.4	7.6e-4	1.4e-6	1	121854.6	HUMAN	Formin-like protein 1
[136]		Q5UIP0	RIF1_HUMAN	RIF1	1	0.3	0.65	7.3e-4	478.2446	2	-1.4	TLRRSSR	TLRRS(Phospho)SR	Phospho@1417=8	7	V20130429-10_FTMSms2hcd	13.477	1413	1419	22.4	7.3e-4	1.3e-6	1	274468.0	HUMAN	Telomere-associated protein RIF1
[137]		Q96MH6	TMM68_HUMAN	TMEM68	1	3.7	0.60	0.015	665.3610	2	-3.6	IPGNIMSALLER	IPGNIM(Oxidation)SALLER	Oxidation@316	12	V20130429-10_FTMSms2hcd	19.816	311	322	29.0	0.015	2.7e-5	1	37425.1	HUMAN	Transmembrane protein 68
[138]		Q8NG11	TSN14_HUMAN	TSPAN14	1	3.0	0.50	0.0050	416.7425	2	0.32	GVLSDLTK	GVLSDLTK		8	V20130429-10_FTMSms2hcd	44.835	45	52	25.4	0.0050	9.9e-6	1	30691.1	HUMAN	Tetraspanin-14
[139]		O94772	LY6H_HUMAN	LY6H	1	9.3	0.50	9.6e-5	728.7955	2	17	QCQPSDTVCASVR	Q(Gln->pyro-Glu)CQPSDTVCAS(Phospho)VR	Gln->pyro-Glu@44;Phospho@54=10	13	V20130429-10_FTMSms2hcd	11.943	44	56	16.1	9.6e-5	2.1e-7	1	14669.2	HUMAN	Lymphocyte antigen 6H
[140]		Q0D2J5	ZN763_HUMAN	ZNF763	1	2.8	0.47	3.1e-4	668.3322	2	17	ALSYKFSNTPK	ALSYKFS(Phospho)NTPK	Phospho@382|384	11	V20130429-10_FTMSms2hcd	29.488	376	386	18.6	3.1e-4	4.2e-7	1	46099.6	HUMAN	Zinc finger protein 763
[141]		P60866	RS20_HUMAN	RPS20	1	16.0	0.47	4.4e-5	510.0246	4	0.10	MAFKDTGKTPVEPEVAIHR	M(Met-loss+Acetyl)AFKDTGKTPVEPEVAIHR	Met-loss+Acetyl@1	19	V20130429-10_FTMSms2hcd	34.063	1	19	14.0	4.4e-5	7.9e-8	1	13372.8	HUMAN	40S ribosomal protein S20
[142]		Q8NEF9	SRFB1_HUMAN	SRFBP1	1	3.3	0.42	7.3e-4	754.8710	2	-0.59	AVTIANSPSKPSEK	AVTIANSPSKPS(Phospho)EK	Phospho@208=24	14	V20130429-10_FTMSms2hcd	41.043	197	210	20.1	7.3e-4	8.5e-7	1	48634.3	HUMAN	Serum response factor-binding protein 1
[143]		P08069	IGF1R_HUMAN	IGF1R	1	0.5	0.41	1.1e-4	523.7280	2	3.1	YRPPDYR	YRPPDY(Phospho)R	Phospho@517=43	7	V20130429-10_FTMSms2hcd	15.807	512	518	15.5	1.1e-4	2.2e-7	1	154794.5	HUMAN	Insulin-like growth factor 1 receptor
[144]		O95747	OXSR1_HUMAN	OXSR1	1	1.7	0.40	3.6e-4	536.2740	2	-2.0	IVEEPQSNR	IVEEPQSNR		9	V20130429-10_FTMSms2hcd	14.303	489	497	18.2	3.6e-4	6.3e-7	1	58022.7	HUMAN	Serine/threonine-protein kinase OSR1
[145]		Q96PL5	ERMAP_HUMAN	ERMAP	1	8.2	0.31	7.2e-4	1004.5344	4	12	LSVHVSGHAGDAGKFHVALLGGTAELLCPLSLWPGTVPK	LSVHVSGHAGDAGKFHVALLGGT(Phospho)AELLCPLSLWPGTVPK	Phospho@24|28|45	39	V20130429-10_FTMSms2hcd	63.163	23	61	18.9	7.2e-4	2.7e-6	1	52605.2	HUMAN	Erythroid membrane-associated protein
[146]		Q8NDV7	TNR6A_HUMAN	TNRC6A	1	1.0	0.26	2.7e-5	1136.9757	2	15	MEIDDGTSAWGDPSKYNYK	M(Oxidation)EIDDGTSAWGDPSKY(Phospho)NYK	Oxidation@999;Phospho@1012|1014|1016	19	V20130429-10_FTMSms2hcd	43.535	999	1017	10.7	2.7e-5	3.5e-8	1	210298.9	HUMAN	Trinucleotide repeat-containing gene 6A protein
[147]		O14744	ANM5_HUMAN	PRMT5	1	3.3	0.24	6.3e-4	775.7697	3	-1.6	AAILPTSIFLTNKKGFPVLSK	AAILPTSIFLTNKKGFPVLS(Phospho)K	Phospho@238|247	21	V20130429-10_FTMSms2hcd	59.839	228	248	17.9	6.3e-4	3.2e-6	1	72684.5	HUMAN	Protein arginine N-methyltransferase 5
[148]		Q9NXG0	CNTLN_HUMAN	CNTLN	1	0.7	0.23	0.0071	376.5477	3	0.50	RQVAEANALR	RQVAEANALR		10	V20130429-10_FTMSms2hcd	16.046	776	785	23.5	0.0071	2.2e-5	1	161604.6	HUMAN	Centlein
[149]		Q8IU53	CASC2_HUMAN	CASC2	1	14.5	0.22	5.6e-4	642.4020	2	-18	KLPQGIIIVFR	KLPQGIIIVFR		11	V20130429-10_FTMSms2hcd	56.849	39	49	17.4	5.6e-4	4.6e-6	1	8607.3	HUMAN	Protein CASC2, isoforms 1/2
[150]		Q9UKZ4	TEN1_HUMAN	ODZ1	1	0.3	0.21	5.5e-4	535.8170	2	-8.4	RVLYKYTK	RVLYKYTK		8	V20130429-10_FTMSms2hcd	45.063	1967	1974	17.3	5.5e-4	1.7e-6	1	305014.0	HUMAN	Teneurin-1
[151]		Q8N3U4	STAG2_HUMAN	STAG2	1	0.8	0.17	0.0024	617.8673	2	-8.5	HLDALLRQIR	HLDALLRQIR		10	V20130429-10_FTMSms2hcd	47.061	608	617	20.3	0.0024	1.2e-5	1	141327.7	HUMAN	Cohesin subunit SA-2
[152]		Q15617	OR8G1_HUMAN	OR8G1	1	8.4	0.11	6.7e-4	957.1400	3	13	ACFSLILGVYIIGLVCASVHTGCMFR	ACFSLILGVYIIGLVCASVHT(Phospho)GCM(Oxidation)FR	Oxidation@163;Phospho@157|160	26	V20130429-10_FTMSms2hcd	77.176	140	165	16.8	6.7e-4	7.3e-7	1	34904.1	HUMAN	Olfactory receptor 8G1
[153]		Q8NC26	ZN114_HUMAN	ZNF114	1	5.3	0.11	0.0016	646.5634	4	-7.0	RTFPEANRVCLTSISSQHSTLR	RTFPEANRVCLTSISS(Phospho)QHSTLR	Phospho@81|84|85	22	V20130429-10_FTMSms2hcd	27.883	66	87	18.8	0.0016	1.6e-6	1	47747.1	HUMAN	Zinc finger protein 114
[154]		P26639	SYTC_HUMAN	TARS	1	1.1	0.10	6.2e-4	474.7531	2	-0.77	TISETIER	TISETIER		8	V20130429-10_FTMSms2hcd	19.428	700	707	16.5	6.2e-4	1.1e-6	1	83435.8	HUMAN	Threonine--tRNA ligase, cytoplasmic
[155]		P15311	EZRI_HUMAN	EZR	1	4.4	0.10	2.3e-4	922.8061	3	4.7	EGILSDEIYCPPETAVLLGSYAVQAK	EGILSDEIYCPPETAVLLGSYAVQAK		26	V20130429-10_FTMSms2hcd	69.458	108	133	14.1	2.3e-4	3.1e-7	1	69413.4	HUMAN	Ezrin
[156]		Q4VCS5	AMOT_HUMAN	AMOT	1	0.6	0.10	0.0036	412.2433	2	-13	RHIEIR	RHIEIR		6	V20130429-10_FTMSms2hcd	38.722	570	575	20.6	0.0036	1.4e-5	1	118086.4	HUMAN	Angiomotin
[157]		P48643	TCPE_HUMAN	CCT5	1	1.8	0.08	4.8e-4	547.2673	2	0.055	IADGYEQAAR	IADGYEQAAR		10	V20130429-10_FTMSms2hcd	16.359	133	142	15.7	4.8e-4	8.8e-7	1	59671.6	HUMAN	T-complex protein 1 subunit epsilon
[158]		Q8TF40	FNIP1_HUMAN	FNIP1	1	1.2	0.05	6.2e-4	726.3600	2	-4.9	IVPASFSCEAAQTK	IVPASFSCEAAQTK		14	V20130429-10_FTMSms2hcd	22.613	737	750	16.0	6.2e-4	7.4e-7	1	130556.5	HUMAN	Folliculin-interacting protein 1
[159]		Q8IUE0	TF2LY_HUMAN	TGIF2LY	1	18.9	0.01	0.0021	895.9100	4	2.0	MEAAADGPAETQSPVEKDSPAKTQSPAQDTSIMSR	M(Met-loss)EAAADGPAET(Phospho)QSPVEKDSPAKTQSPAQDTSIMSR	Met-loss@1;Phospho@11=9	35	V20130429-10_FTMSms2hcd	44.608	1	35	18.5	0.0021	2.2e-6	2	20813.9	HUMAN	Homeobox protein TGIF2LY
[159-1]	0	Q8IUE1	TF2LX_HUMAN	TGIF2LX	1	14.5	0.01	0.0021	895.9100	4	2.0	MEAAADGPAETQSPVEKDSPAKTQSPAQDTSIMSR	M(Met-loss)EAAADGPAET(Phospho)QSPVEKDSPAKTQSPAQDTSIMSR	Met-loss@1;Phospho@11=9	35	V20130429-10_FTMSms2hcd	44.608	1	35	18.5	0.0021	2.2e-6	2	26675.4	HUMAN	Homeobox protein TGIF2LX
